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Meiosis is a specialized cell division that produces haploid gametes from a 
diploid progenitor cell. It consists of one round of DNA replication followed by 
two consecutive rounds of chromosome segregation. Homologous chromosomes 
segregate in meiosis I and sister chromatids segregate in meiosis II. Failure to 
correctly regulate meiosis can result in aneuploidy, where daughter cells inherit 
an incorrect number of chromosomes. Aneuploidy is usually poorly tolerated in 
eukaryotes, and is associated with infertility, miscarriages and birth defects.  
At the meiosis I to meiosis II transition, DNA replication does not occur between 
chromosome segregation steps despite the need for Spindle Pole Bodies (SPBs) 
to be re-licensed in order to build meiosis II spindles. The mechanisms that make 
this distinction are not yet known. 
In budding yeast, the protein phosphatase Cdc14 is essential for the progression 
of cells into meiosis II.  Cdc14 is sequestered for the majority of the cell cycle in 
the nucleolus by the inhibitor Cfi1/Net, and is only released in anaphase. We 
have observed Cdc14 localizing to and interacting with SPB components when 
nucleolar sequestration is inhibited. Through fluorescence microscopy and EM 
analysis, we have determined that Cdc14 is required for the re-duplication of 
SPBs after meiosis I. Our data implies a role for Cdc14 in the phospho-regulation 
of SPB half-bridge component Sfi1. Cdc14 is therefore essential for the re-
licensing of SPB duplication, a crucial step necessary to ensure accurate 
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1. Introduction  
Eukaryotic cell divisions can be classified into two distinct types termed mitosis 
and meiosis. Mitosis is a form of asexual reproduction, during which a parental 
diploid cell divides and segregates sister chromatids to generate two diploid 
daughter cells that are genetically identical to the parental cell (Fig. 1) (reviewed 
by Marston and Amon 2004). Meiosis, conversely, is a specialised cell division 
required for sexual reproduction. Unlike in mitosis, four haploid gametes are 
produced from a diploid progenitor cell through two consecutive rounds of 
chromosome segregation (reviewed by Marston and Amon 2004). Homologous 
chromosomes segregate in meiosis I, referred to as a reductional division since 
the chromosome number is halved, and sister chromatids segregate in meiosis II 
in an equational division, analogous to mitosis (Fig. 1). 
 
The transition between meiosis I and meiosis II is unique due to the absence of 
an intervening S-phase between meiotic chromosome divisions, as is present 
after every mitotic division (reviewed by Marston and Amon 2004). In mitosis, S-
phase is linked to the completion of M-phase through coupling of late anaphase 
events with the re-firing of DNA origins (reviewed by Petronczki, Siomos et al. 
2003). Once cells exit mitosis, the conditions within the cell become permissible 
for re-replication of DNA. Similarly, the replication of DNA initiates mitotic 
events. This interdependency between S-phase and M-phase ensures the proper 
progression of cells through the cell cycle (reviewed by Dalton 1998). Meiotic 
events, on the other hand, appear to be differently regulated. Despite the lack of 
a second round of DNA replication following meiosis I, the molecular machinery 




segregation of sister chromatids in meiosis II (Fig. 1). Failure to do so can lead to 
aneuploidy, where daughter cells contain an abnormal number of chromosomes. 
Aneuploidy is poorly tolerated in most animal species, observed through 
infertility, miscarriage and birth defects such as Down syndrome and Turner 
syndrome (reviewed by Hassold and Hunt 2001). In humans, the incidence of 
aneuploidy as a result of meiotic error in live births is only 0.3%, despite the 
much higher incidence of aneuploidy in conception of ~10% (reviewed by 
Hassold and Hunt 2001). 
 
Currently, little is known about the regulation of the meiosis I-meiosis II 
transition. In this study, I set out to determine how the mitotic molecular 
machinery has been adapted during meiosis to allow for the specialised cell 









1.1 The mitotic cell cycle  
Prior to mitosis, DNA is replicated in S-phase. This chromosome duplication step 
results in the production of two identical sister chromatids, physically bound 
together by cohesin ring complexes (Uhlmann and Nasmyth 1998). Whilst 
cohesin is enriched at centromeres, it is also localised along chromosome arms, 
ensuring that sister chromatids are paired (Blat and Kleckner 1999, Megee, 
Mistrot et al. 1999, Tanaka, Cosma et al. 1999, Laloraya, Guacci et al. 2000).  
 
In prophase, cells separate their microtubule organising centres, termed 
centrosomes, which duplicate in G1-phase but are linked to each other until 
entry into mitosis (reviewed by Jaspersen and Winey 2004). Following 
separation, these two centrosomes migrate to opposite sides of the nucleus 
through the action of interpolar microtubules and microtubules-associated 
motor proteins (reviewed by Winey and Bloom 2012)(Fig. 1. 1). Microtubules, 
emanating from centrosomes at opposite poles of the cell, attach to sister 
kinetochores and exert pulling forces on the chromosomes. This results in the 
alignment of chromosomes along the metaphase plate and tension across bi-
oriented sister chromatids (reviewed by Guo, Kim et al. 2013). Once all sister 
chromatids have correctly bi-oriented, cells progress into anaphase.  
 
Upon anaphase onset, the anaphase-promoting complex (APC), an E3 ubiquitin 
ligase, associates with its activator, Cdc20, and APCCdc20 targets the anaphase 
inhibitor securin for degradation (Cohen-Fix, Peters et al. 1996, Funabiki, 
Yamano et al. 1996, Zachariae, Schwab et al. 1998). Loss of securin initiates 




between sister chromatids (Fig. 1. 1) (Ciosk, Zachariae et al. 1998, Uhlmann, 
Lottspeich et al. 1999, Hornig, Knowles et al. 2002, Waizenegger, Gimenez-Abian 
et al. 2002). Without cohesin to oppose kinetochore microtubule pulling forces, 
sister chromatids segregate to opposite poles of the cell (Uhlmann, Lottspeich et 
al. 1999, Uhlmann, Wernic et al. 2000). Interpolar microtubules lengthen, 
pushing chromosome sets apart and ensuring that each daughter cell receives 
one copy of each chromosome before nuclear division in late mitosis.  
 
Following the separation of sister chromatids in anaphase, the cell must exit 
mitosis and re-set itself for entry into a succeeding G1 phase. Mitotic structures, 
such as the mitotic spindle, must disassemble and mitotic regulators must be 
inactivated. One key regulator of mitosis that must be down-regulated for mitotic 
exit is Cdc28, the budding yeast cyclin-dependent kinase (CDK) (Ghiara, 








1.1.1 CDKs in mitosis 
CDKs play a vital role in regulating the cell cycle during mitosis. In budding yeast, 
multiple CDKs are formed through the association of a sole kinase, Cdc28, with 
different regulatory cyclin subunits (reviewed by Hartwell 1991, Nasmyth, Dirick 
et al. 1991). These cyclins can be divided into three main groups based on their 
timing of expression; G1-phase cyclins, Cln1-3, S-phase cyclins, Clb5-6, and M-
phase cyclins, Clb1-4 (Richardson, Wittenberg et al. 1989, Epstein and Cross 
1992, Fitch, Dahmann et al. 1992, Schwob and Nasmyth 1993). Cyclin subunits 
bind to Cdc28 to form cyclin-CDK complexes, which are implicated in distinct 
stages of the cell cycle and are required for a wide variety of cellular events. 
CDK-dependent phosphorylation of target proteins can affect substrate activity, 
localisation and stabilisation to promote the occurrence of specific downstream 
events at the appropriate stage of the cell cycle. These events include cell 
budding, spindle pole body (SPB) duplication, DNA replication, mitotic spindle 
formation and activation of the mitotic exit network (MEN) (reviewed in 
Mendenhall and Hodge 1998).  
 
Oscillations in stage-specific cyclin levels regulate CDK function and trigger the 
activation of subsequent cyclins to ensure proper progression of cells through 
mitosis. For example, in addition to promoting bud emergence and SPB 
duplication, G1-phase cyclins activate B-type cyclins required in S-phase 
(Richardson, Wittenberg et al. 1989). G1 cyclins are then repressed by S-phase 




1.1.1.1 Downstream cellular events of CDK phospho-regulation 
CDKs are able to recognise multiple substrates and, therefore, are able to 
coordinate numerous events that occur during each cell cycle phase. In addition, 
the phase-specific expression of differential cyclins enables multiple cyclin-CDK 
complexes to drive protein signal transduction pathways throughout the cell 
cycle.   
 
1.1.1.1.1 SPB duplication 
One such CDK-regulated pathway is the SPB duplication pathway (Fig. 1. 1. 1. 1. 
1B). SPBs are microtubule-organising centres, functionally comparable to 
centrosomes in higher eukaryotes (reviewed in Jaspersen and Winey 2004). 
They are composed of at least 19 proteins, assembled into a cylindrical organelle 
that is embedded in the nuclear envelope (Rout and Kilmartin 1990)(Fig. 1. 1. 1. 
1. 1A). The SPB core, made up of a central, an outer and an inner plaque, 
traverses the nuclear envelope. It interacts with cytoplasmic and nuclear 
microtubules via γ-tubulin complexes formed at the outer and inner plaque 
respectively (Knop and Schiebel 1997, O'Toole, Winey et al. 1999). Membrane 
proteins, including Ndc1, Mps2 and Bbp1, localise to the SPB periphery, 
anchoring the SPB within the nuclear envelope (Winey, Hoyt et al. 1993). A half-
bridge bilayer, consisting of Kar1, Mps3, Sfi1 and Cdc31, extends from the SPB 
and acts as the site for new SPB assembly (Baum, Furlong et al. 1986, Rose and 
Fink 1987, Spang, Courtney et al. 1993, Vallen, Ho et al. 1994, Jaspersen, Giddings 
et al. 2002, Kilmartin 2003). The SPB is highly phosphorylated (Wigge, Jensen et 




(Ubersax, Woodbury et al. 2003) suggesting that CDK-dependent 
phosphorylation of the SPB may contribute to its assembly and function. 
 
The compilation of numerous EM studies using SPB mutants has revealed an 
extensive model for SPB duplication. In G1, SPB duplication is initiated by half-
bridge elongation (Byers and Goetsch 1974). Once a full-bridge structure has 
formed, satellite material is deposited at the distal cytoplasmic tip of the bridge 
and expands into a duplication plaque, which resembles the cytoplasmic half of a 
mature SPB (Byers and Goetsch 1974, Adams and Kilmartin 1999). The plaque is 
then inserted into the nuclear envelope. Following this embedding step, inner 
plaque proteins assemble at the nuclear face of the newly duplicated SPB 
(Kilmartin and Goh 1996, Sundberg, Goetsch et al. 1996, Sundberg and Davis 
1997).  At the close of G1, two duplicated SPBs have fully assembled side-by-side 
physically connected by a full-bridge (Byers and Goetsch 1974). The bridge is 
then severed in mitosis, allowing the separation of SPBs and the formation of the 
mitotic spindle.   
 
Multiple components of the SPB duplication pathway are believed to be 
phospho-regulated by Cdc28. Cln-CDK activity in G1 has been shown as sufficient 
to initiate SPB duplication (Haase, Winey et al. 2001).  Cdc28 phosphorylates and 
stabilises another kinase, Mps1. Mps1p, alongside Cdc28, aids the self-assembly 
of the core SPB component, Spc42, into the higher-order structure required for 





In S-phase, Clb5- and Clb6-CDK activity promotes the severing of the full-bridge 
structure and subsequent SPB separation (Fig. 1. 1. 1. 1. 1B). This step is 
achieved via two mechanisms. Firstly, Cdc28 phosphorylates the bridge 
component, Sfi1. Phosphorylated Sfi1 is unable to form C-C end terminal dimers, 
resulting in the splitting of full-bridge structures between the two duplicated 
SPBs (Avena, Burns et al. 2014, Elserafy, Saric et al. 2014). Secondly, Cdc28-
dependent inhibition of APCCdh1 results in the accumulation of Cin8p and Kip1p 
motor proteins in the cell (Zachariae, Schwab et al. 1998, Crasta and Surana 
2006, Crasta, Lim et al. 2008). Cin8 and Kip1 act to cross-link antiparallel non-
kinetochore microtubules that exert pushing forces on SPBs, resulting in 
separation of the poles (Saunders and Hoyt 1992, Geiser, Schott et al. 1997, 
Hildebrandt and Hoyt 2001). The timely separation of duplicated SPBs is 
required for the assembly of a bipolar spindle in metaphase (Haase, Winey et al. 
2001). 
 
In M-phase, Clb1-4-CDK activity inhibits SPB re-duplication (Haase, Winey et al. 
2001). This ensures that SPBs only duplicate once during the cell cycle (Fig. 1. 1. 
1. 1. 1B). It has been suggested that Cdc28-dependent phosphorylation of Sfi1 
prevents SPBs from re-duplication by preventing the initiation of half-bridge 
elongation (Avena, Burns et al. 2014, Elserafy, Saric et al. 2014, Bouhlel, Ohta et 
al. 2015). In order for SPBs to re-duplicate in the following G1-phase, Sfi1 must 
be dephosphorylated and Clb-CDKs inhibited. Oscillations in CDK activities, 









1.1.1.1.2 DNA replication 
Cdc28-dependent phosphorylation is required for both initiation and inhibition 
of DNA replication (Loog and Morgan 2005). DNA synthesis is licensed in G1-
phase by formation of the pre-replicative complex (pre-RC) at origins of 
replication. Pre-RCs, consisting of Cdh1, Cdc6 and the helicase heterohexamer 
Mcm2-7, are recruited specifically to origins by origin recognition complexes 
(ORCs) but remain inactive until S-phase. Clb5- and Clb6-CDKs as well as the 
Dbf4-Cdc7 kinase (DDK) complex trigger pre-RC activation (reviewed by Labib 
2010). Sld3 and the helicase-activating protein, Cdc45, are recruited to Mcm2-7 
via DDK-dependent phosphorylation (Heller, Kang et al. 2011). Clb5-CDK 
phosphorylates replication proteins Sld2 and Sld3, which interact with Cdc45 
and lead to the recruitment of Dpb11 at origins. Another complex known as GINS 
is then recruited. GINS has also been shown to maintain the association of Cdc45 
with Mcm2-7 at replication forks (Gambus, Jones et al. 2006). The formation of 
the Cdc45-Mcm2-7-GINS complex activates the helicase and triggers unwinding 
of the double-stranded DNA. DNA polymerase can then be recruited, initiating 
DNA synthesis (Masumoto, Sugino et al. 2000, Masumoto, Muramatsu et al. 
2002). Once origins have fired, the pre-RC then disassembles (reviewed by 
Bloom and Cross 2007). 
 
To restrict DNA replication to once per cell cycle, the formation of the pre-RC 
must be prevented during mitosis. This is achieved through the phosphorylation 
of Cdc6, a component of the pre-RC, by Clb-CDKs (Elsasser, Lou et al. 1996). 
Cdc6p is targeted for ubiquitination and subsequent degradation, resulting in the 




2004).  Additionally, Clb-CDKs phosphorylate other subunits of the pre-RC, Mcm 
proteins, which leads to their nuclear exclusion and displacement from ORCs 
(Labib, Diffley et al. 1999, Nguyen, Co et al. 2001) 
 
A further mechanism of premature re-replicative prevention is through 
inhibition of ORC function. Orc2 and Orc6 are phosphorylated by Clb5-CDK in 
late G1, after origin firing. In order for re-replication of DNA, these ORC subunits 
must be hypophosphorylated. This occurs in early G1, when Cln-CDKs are active 
and Clb-CDK activity is low (Nguyen, Co et al. 2001).  
 
Individually, inhibition of any of these three mechanisms, Cdc6 degradation, 
Mcm export or ORC phosphorylation, is not sufficient to cause DNA re-
replication in cells. However, when all three mechanisms are disrupted, DNA 
synthesis is initiated (Nguyen, Co et al. 2001). This suggests coordinated, 
multiple level regulation of DNA replication is required to ensure origin firing 











1.1.1.1.3 Mitotic spindle assembly 
SPBs are able to polymerize tubulin and assemble kinetochore microtubules, 
which attach to centromeric regions of the chromosome and aid the separation 
of sister chromatids in anaphase. SPBs also assemble astral and interpolar 
microtubules. It is these interpolar microtubules that play a role in moving SPBs 
to opposite poles of the cell. Cyclin-CDK complexes have been shown to 
phosphorylate a number of microtubule-associated proteins (Ubersax, 
Woodbury et al. 2003), which help regulate the assembly and disassembly of the 
mitotic spindle.  
 
Ase1 is a microtubule bundling protein that localises at the mitotic spindle mid-
zone and is crucial for its integrity (Pellman, Bagget et al. 1995, Schuyler, Liu et 
al. 2003). Phosphorylation of Ase1 by Clb-CDKs promotes Ase1p recruitment to 
the spindle, stabilising microtubules to promote spindle elongation. In late 
anaphase, Ase1 is degraded through APC-mediated proteolysis and spindles 
disassemble (Juang, Huang et al. 1997), resulting in the exit of cells from mitosis.  
 
Kar9, a cortical protein required for spindle positioning, and Dyn1, cytoplasmic 
dynein, are also regulated by CDK phosphorylation. Both Kar9p and Dyn1p 
localise preferentially to the daughter cell-bound SPB (Miller and Rose 1998, 
Liakopoulos, Kusch et al. 2003, Grava, Schaerer et al. 2006). CDK-mediated 
asymmetry of microtubule-associated proteins is essential for correct spindle 




1.1.1.2 Mechanisms for CDK down-regulation 
CDKs are regulated extensively through control of cyclin levels. Cyclins are 
regulated by two main mechanisms; transcriptional control of cyclin gene 
expression and cyclin proteolysis.  
 
1.1.1.2.1 Transcriptional regulation 
Transcriptional regulation of cyclins is crucial for the differential regulation of 
G1 and B-type cyclins during the cell cycle. During S-phase, B-type cyclins, 
primarily Clb5 and Clb6, initiate DNA replication. Following the increase of Clb 
levels, transcription of G1-specific cyclins is repressed through phosphorylation 
and inhibition of G1-specific cyclin transcription factors (Amon, Tyers et al. 
1993, Siegmund and Nasmyth 1996). Conversely, transcription of G2/M-phase 
cyclins is increased through phosphorylation and recruitment of distinct 
transcription factors to Clb promoters, enabling the transition of cells into M-
phase (Darieva, Pic-Taylor et al. 2003, Reynolds, Shi et al. 2003). Activation of 
Clb1-Clb4 subsequently promotes the stimulation of downstream proteins 
involved in chromosome condensation and mitotic spindle assembly (Fitch, 





1.1.1.2.2 Cyclin proteolysis 
Ubiquitin-mediated cyclin proteolysis ensures the specific degradation and 
subsequent inhibition of CDKs. Cyclins are polyubiquitinated by E3 ubiquitin 
ligases, targeting them for degradation by the 26S proteasome. Two ubiquitin 
ligases are crucial during the cell cycle. The multi-protein SCF complex is 
required to mark G1 and G2 cyclins for destruction, to enable the transitions 
between G1/S-phase and G2/M-phase respectively (Barral, Jentsch et al. 1995, 
Skowyra, Craig et al. 1997), whereas the APC targets mitotic cyclins for 
proteolysis (Visintin, Prinz et al. 1997). APC activity can be specifically regulated 
during mitosis through binding to activating subunits; Cdc20 and Cdh1. APCCdc20 
mediates the metaphase-anaphase transition through degradation of the 
anaphase inhibitor securin and M-phase cyclins (Cohen-Fix, Peters et al. 1996, 
Funabiki, Yamano et al. 1996). To allow cells to exit from mitosis into a following 
G1, Clb-CDKs require inactivation through complete M-phase cyclin proteolysis 
(revieweb by Morgan 1997, Visintin, Prinz et al. 1997, Shirayama, Zachariae et al. 
1998). This cyclin degradation step is catalysed by APCCdh1 activity (Zachariae, 
Schwab et al. 1998). Inhibition of Clb-CDK activity allows for relicensing of 
replication origins for progression into the next round of DNA replication in S-





1.1.1.2.3 Inhibitor binding 
A third mechanism of CDK regulation is through the binding of stoichiometric 
inhibitors. Clb-CDK activity is repressed when bound to the inhibitor, Sic1 
(Schwob, Bohm et al. 1994). In order to alleviate Sic1 inhibitory binding to CDKs, 
ubiquitin-mediated proteolysis of Sic1 is required. Phosphorylation of Sic1, by 
Clb-CDKs as well as other kinase, results in its degradation by the SCF complex 
(Feldman, Correll et al. 1997, Skowyra, Craig et al. 1997, Verma, Annan et al. 
1997). This promotes the entry of cells into S-phase. Moreover, in order for 
complete Clb-CDK inactivation at the end of mitosis, Sic1 must be 
dephosphorylated by Cdc14 and thus stabilised to enable inhibitory binding of 




1.1.2 The conserved phosphatase Cdc14 
Cdc14 is a dual-sensitivity protein phosphatase with known roles in mitotic CDK 
inactivation (reviewed by Morgan 1999). Whilst Cdc14 homologues have been 
identified in organisms ranging from fission yeast and human cells, its role is 
best understood in budding yeast.  
 
1.1.2.1 Cdc14 is required for mitotic exit via CDK down-regulation  
In budding yeast, Cdc14 is essential for the down-regulation of mitotic CDKs, 
enabling mitotic exit (Jaspersen, Charles et al. 1998, Visintin, Craig et al. 1998, 
Zachariae, Schwab et al. 1998). In temperature-sensitive cdc14 mutants at the 
restrictive temperature, Clb-CDK activity remains high. Furthermore, mitotic 
spindles, which disassemble in low Clb-CDK states, persist in cdc14-1 cells 
indicating that mitotic exit has not occurred (Culotti and Hartwell 1971, Visintin, 
Craig et al. 1998). 
 
Activation of Cdc14 during mitosis brings about Clb-CDK inactivation via 
multiple mechanisms. Firstly, Cdc14 dephosphorylates Cdh1, the late-mitosis 
APC activator, thereby activating it (Visintin, Craig et al. 1998, Zachariae, Schwab 
et al. 1998, Jaspersen, Charles et al. 1999). This results in the proteolysis of B-
type cyclins, antagonising Clb-CDK activity. Cdc14 also dephosphorylates Sic1, 
the mitotic CDK inhibitor, and Swi5, the Sic1 transcription factor. These events 
result in the stabilisation and accumulation of Sic1 in cells, leading to complete 
Clb-CDK inhibition (Knapp, Bhoite et al. 1996, Toyn, Johnson et al. 1997, Verma, 
Annan et al. 1997, Visintin, Craig et al. 1998). Furthermore, Cdc14 opposes Clb-




order to re-set the cell for G1 (Bloom, Cristea et al. 2011, Bremmer, Hall et al. 




1.1.2.2 Cdc14 activation in early anaphase by FEAR 
Cdc14 is tightly regulated throughout mitosis and is only active in anaphase. For 
the majority of the cell cycle, Cdc14 is kept inactive and sequestered in the 
nucleolus, bound to the inhibitor Cfi1/Net1 (Shou, Seol et al. 1999, Visintin, 
Hwang et al. 1999). Upon anaphase onset, Cfi1/Net1becomes phosphorylated 
(Kerr, Sarkar et al. 2011), causing the dissociation of the complex and the 
subsequent release of Cdc14 from the nucleolus. This release is maintained until 
telophase, when Cdc14 is resequestered by its inhibitor (Shou, Seol et al. 1999, 
Visintin, Hwang et al. 1999, Manzoni, Montani et al. 2010). The phosphorylation 
and disassociation of Cfi1/Net1 from Cdc14 is believed to be the work of mitotic 
CDKs, mediated by the Cdc14-Early Anaphase Release (FEAR) network and MEN 
(Fig. 1. 1. 2. 2.) (reviewed by Stegmeier and Amon 2004).  
 
The FEAR network acts in early anaphase, as a consequence of chromosome 
segregation (Stegmeier, Visintin et al. 2002). Activation of APCCdc20 results in the 
destruction of securin and the subsequent activation of separase, a component of 
FEAR (Pereira, Manson et al. 2002, Stegmeier, Visintin et al. 2002, Yoshida and 
Toh-e 2002). Separase activation leads to phosphorylation of Cfi1/Net1 through 
activation of Cdc5, which initiates the transient release of Cdc14 from the 
nucleolus (Visintin, Stegmeier et al. 2003, Azzam, Chen et al. 2004, Queralt, 
Lehane et al. 2006). Separase (Esp1), the polo kinase, Cdc5, kinetochore protein, 
Slk19, and nucleolar protein, Spo12, have all been shown as regulators of Cdc14 






The polo kinase, Cdc5, is essential for Cdc14 release from nucleolar 
sequestration independent of MEN activation (Pereira, Manson et al. 2002, 
Stegmeier, Visintin et al. 2002). However, the role of Cdc5 within FEAR is hard to 
discern due to its function as an activator of MEN (Hu, Wang et al. 2001). Cdc5 
appears to promote the phosphorylation of Cdc14 and Cfi1/Net1 in anaphase 
(Shou, Azzam et al. 2002, Yoshida and Toh-e 2002), although the latter event 
seems to require MEN function (Visintin, Stegmeier et al. 2003). It also appears 
to be the main effector of the FEAR network, as over-expression of Cdc5 
suppresses Cdc14-release defects observed in esp1-1 and slk19Δ FEAR mutants 
(Visintin, Stegmeier et al. 2003). In addition, Cdc5 activity contributes to 
numerous anaphase events. Firstly, Cdc5-dependent phosphorylation of cohesin 
subunit Scc1 facilitates its cleavage by Esp1 (Alexandru, Uhlmann et al. 2001). 
Secondly, Cdc5 kinase induces Swe1 degradation, promoting CDK activity (Liang, 
Jin et al. 2009). Finally, Cdc5-mediated release of Cdc14 plays an important role 
in proper spindle elongation and progression through anaphase (Park, Park et al. 
2008, Roccuzzo, Visintin et al. 2015).  
 
Slk19 and Spo12 also play a role in Cdc14 release, although potentially through 
parallel pathways (Stegmeier, Visintin et al. 2002, Sullivan and Uhlmann 2003, 
Visintin, Stegmeier et al. 2003, Tomson, Rahal et al. 2009). Slk19 is a kinetochore 
protein which forms a complex with Esp1 during anaphase (Fig. 1. 1. 2. 2), the 
association of which is required for localisation of separase to the spindle 
midzone and kinetochores (Sullivan and Uhlmann 2003). However, through use 
of a catalytically inactive separase mutant and a non-cleavable Slk19 mutant, it 




(Sullivan and Uhlmann 2003). The exact mechanism of Slk19-depedent 
regulation of initial Cdc14 release has yet to be determined. More recently, Slk9 
has been implicated in preventing the movement of FEAR released-Cdc14 from 
the nucleus to the cytoplasm (Faust, Wong et al. 2013). A Slk19 triple point 
mutant resulted in the normal release of Cdc14 from the nucleolus into the 
nucleus during early anaphase but, additionally, caused the premature 
appearance of Cdc14 in the cytoplasm prior to spindle disassembly. This early 
movement of Cdc14 to the cytoplasm, which under normal circumstances occurs 
upon MEN activation, enabled spindle disassembly even within MEN-deficient 
cells (Faust, Wong et al. 2013). Expression of SLK19 and slk19Δ in cdc15-2 cells at 
the restrictive temperature does not prevent a delay in spindle disassembly 
observed when MEN in inactivated. However, Slk193R cdc15-2 cells displayed a 
partial rescue of the spindle disassembly arrest defect. This suggests that Slk19 
is required to couple Cdc14 release from the nucleus with spindle disassembly.  
 
The role of Spo12 in the FEAR network has been partially characterised.  
Alongside its homologue, Bns1, Spo12 localises to the nucleolus where it 
interacts with Fob1, a protein required to block replication forks (Stegmeier, 
Huang et al. 2004). Fob1 is also an inhibitor of FEAR, forming a complex with 
Cfi1/Net1 to maintain Cdc14 sequestration during metaphase. Spo12 is 
phosphorylated in anaphase by mitotic CDKs, an event which is dependent on 
Esp1 and Slk19 function (Tomson, Rahal et al. 2009) despite Spo12 appearing to 
act in a parallel pathway to separase (Stegmeier, Visintin et al. 2002, Sullivan and 
Uhlmann 2003, Visintin, Stegmeier et al. 2003). Phosphorylation of Spo12 in 




hinting that the phospho-regulation of Spo12 may play a role in Cdc14 release 
(Fig. 1. 1. 2. 2). Interestingly, Cdc14 was identified as the phosphatase required 
for maintaining Spo12 dephosphorylation prior to anaphase, suggesting that 
Cdc14 may still be active despite sequestration within the nucleolus (Tomson, 
Rahal et al. 2009).   
 
Although FEAR released-Cdc14 is restricted to the cell nucleus (Faust, Wong et 
al. 2013), it is able to regulate a number of anaphase events such as mitotic 
spindle dynamics, correct chromosome structure and segregation, and protein 
localisation (reviewed by D'Amours and Amon 2004, reviewed by Rock and 
Amon 2009, Roccuzzo, Visintin et al. 2015). Cdc14 released by FEAR also 
initiates MEN through dephosphorylation and subsequent activation of Cdc15 
(Fig. 1. 1. 2. 2), as well as through inhibition of the spindle positioning checkpoint 
(SPOC) (Jaspersen and Morgan 2000, Pereira, Manson et al. 2002, Stegmeier, 
Visintin et al. 2002). Although FEAR is not essential for mitotic progression, its 
absence has been associated with a significant loss of viability during anaphase. 
This is indicative of its importance in ensuring accurate separation of rDNA 







1.1.2.3 PP2ACdc55 maintains Cdc14 sequestration in the nucleolus  
The release of Cdc14 in anaphase results from phosphorylation of the Cfi1/Net1 
inhibitor (Queralt, Lehane et al. 2006). In order for Cdc14 resequestration at the 
end of mitosis, this inhibitory phosphorylation must be reversed. Furthermore, 
by maintaining the unphosphorylated form of Cfi1/Net1 during the rest of the 
cell cycle, premature release of Cdc14 is prohibited.   
 
 PP2A is a protein phosphatase that is involved in several aspects of the cell cycle 
(Stark 1996). It can bind to multiple regulatory subunits to enable substrate 
specificity. PP2ACdc55 has been shown to maintain Cdc14 sequestration in the 
nucleolus by preventing early phosphorylation of Cfi1/Net1 in metaphase 
(Queralt, Lehane et al. 2006). Upon anaphase onset, PP2ACdc55 activity is down-
regulated by a separase-dependent pathway (Fig. 1. 1. 2. 2). Cfi1/Net1 is then 
phosphorylated by Clb-CDKs and Cdc5, and Cdc14 is consequently released. Loss 
of Cdc55 in mitosis results in the ectopic release of Cdc14, as a consequence of 




1.1.2.4 Cdc14 activation in late anaphase by MEN 
Whilst FEAR activation is required to couple chromosome segregation to 
initiation of mitotic exit, MEN signalling is essential to trigger the irreversible 
exit of cells from mitosis. MEN activity in late anaphase results in the full 
activation of Cdc14, maintaining its release from nucleolar sequestration and 
enabling Cdc14 accumulation in the cytoplasm (Shou, Seol et al. 1999, Visintin, 
Hwang et al. 1999, Mohl, Huddleston et al. 2009). This sustained release of Cdc14 
enables the phosphatase to access and dephosphorylate a number of mitotic 
substrates, such as Cdh1 and Sic1, which promote the inactivation of Clb-CDKs 
and exit of cells from mitosis (Visintin, Craig et al. 1998, Zachariae, Schwab et al. 
1998, Jaspersen, Charles et al. 1999). 
 
MEN plays an additional role in spindle positioning. Mitotic budding yeast cell 
divide asymmetrically; the daughter cell-derived bud emerges from the mother 
cell (reviewed by Li 2013). Cell polarity is needed to establish this specialised 
budding pattern, and the mitotic spindle aligns along the mother-bud cell 
polarity axis to ensure the proper inheritance of nuclei in dividing cells (Monje-
Casas and Amon 2009). The spindle position checkpoint (SPOC) monitors 
spindle positioning and acts upon MEN component Tem1 to inhibit the signalling 
cascade when spindles are misaligned. Consequently, MEN signalling is regulated 
in a spatial manner (reviewed by Stegmeier and Amon 2004, Caydasi, Ibrahim et 
al. 2010).   
 
MEN is a GTPase-driven signalling pathway (Fig. 1. 1. 2. 2). When active, the G 




Cdc15 (Shirayama, Matsui et al. 1994, Jaspersen, Charles et al. 1998, Lee, Frenz et 
al. 2001, Visintin and Amon 2001). Cdc15 successively activates Dbf2-Mob1. 
Active Dbf2 kinase, alongside its regulatory partner Mob1, is able to enter the 
nucleolus and results in the sustained release of Cdc14 (Mohl, Huddleston et al. 
2009). This has been theorised to be through phosphorylation of Cdc14 itself, as 
well as its inhibitor, to ensure the maintained dissociation of Cdc14 and 
Cfi1/Net1 (Visintin, Stegmeier et al. 2003, Mohl, Huddleston et al. 2009). 
Simultaneous to its role in MEN, Dbf2 also phosphorylates proteins involved in 
cytokinesis, thus linking mitotic exit to onset of cell cleavage in telophase 
(Meitinger, Boehm et al. 2011).   
 
As denoted earlier, MEN activity is driven primarily by temporal and spatial 
changes in its components (Bardin, Visintin et al. 2000, Pereira, Hofken et al. 
2000). The SPB constituent, Nud1, functions as a scaffold for MEN assembly at 
the SPB (Adams and Kilmartin 2000, Bardin, Visintin et al. 2000, Gruneberg, 
Campbell et al. 2000, Pereira, Hofken et al. 2000, Visintin and Amon 2001). 
During mitotic spindle assembly, Tem1 localises preferentially to the daughter 
cell bound-SPB (Fig. 1. 1. 2. 4A). Bub2 and Bfa1 proteins comprise a GTPase-
activating protein complex (GAP), which co-localise with and inhibit Tem1 by 
promoting the hydrolysis of Tem1-GTP to Tem1-GDP (Bardin, Visintin et al. 
2000, Pereira, Hofken et al. 2000). It is believed that, as the mitotic spindle 
grows, the Tem1-associated SPB enters into the bud and comes into close 
proximity with the MEN regulator, Lte1, a guanine-nucleotide exchange factor 
(GEF) (Shirayama, Matsui et al. 1994, Geymonat, Spanos et al. 2009). GEF activity 




Furthermore, phosphorylation of Bfa1-Bub2 by FEAR component, Cdc5, in early 
anaphase alleviates the inhibition of Tem1 by the GAP complex. These two 
regulatory events result in MEN signal cascade activation (Hu, Wang et al. 2001, 
Geymonat, Spanos et al. 2009). PP2ACdc55 has also been implicated in MEN 
activation, through counteracting Bfa1 activity (Baro, Rodriguez-Rodriguez et al. 
2013).   
 
SPOC monitors spindle positioning and can delay MEN activation when the 
mitotic spindle is misaligned (Pereira, Hofken et al. 2000, Pereira, Manson et al. 
2002). This delay provides time for proper spindle realignment along the 
mother-bud cell polarity axis. With correct spindle orientation, Bfa1-Bub2 
localises preferentially to the daughter cell bound-SPB, where Tem1 is also 
asymmetrically localised (Fig. 1. 1. 2. 4A) (Pereira, Hofken et al. 2000, Molk, 
Schuyler et al. 2004). When asymmetrically localised, Bfa1 can achieve maximum 
phosphorylation by Cdc5 and thus GAP activity is inhibited, enabling Tem1 
activation (Hu, Wang et al. 2001, Pereira, Tanaka et al. 2001, Kim, Luo et al. 
2012). 
 
Misalignment of spindles, conversely, results in the mother cortex-associated 
kinase, Kin4, phosphorylating Bfa1 at distinct sites from Cdc5. Kin4-dependent 
phosphorylation of Bfa1 prevents Cdc5-dependent inhibition of Bfa1-Bub2 
(Maekawa, Priest et al. 2007). Therefore, Tem1 inhibition is maintained when 
SPOC is activated (Pereira, Tanaka et al. 2001, Caydasi and Pereira 2009). 
Phosphorylation of Bfa1 by Kin4 also enables Bmh1 docking with the GAP 




promote the symmetric localisation of the GAP complex to SPBs through the 
removal of Bfa1 from the daughter cell bound-SPB (Fig. 1. 1. 2. 4B) (Caydasi and 
Pereira 2009, Monje-Casas and Amon 2009). Decreased residence of Bfa1-Bub2 
at the daughter SPB has been proposed to inhibit Tem1 targeting to SPBs 
(Valerio-Santiago and Monje-Casas 2011, Caydasi, Lohel et al. 2012). Decreased 
Tem1-SPB localisation would inhibit MEN activity, promoting mitotic arrest and 
preventing sustained Cdc14 release.  
 
The protein phosphatase Cdc14 has also been shown to localise asymmetrically 
to SPBs in mitosis, localising preferentially to the MEN-bound SPB. This co-
localisation is dependent on Bfa1-Bub2, and Cdc14 has been shown to 
dephosphorylate and reactivate the GAP complex at mitotic exit (Pereira, 
Manson et al. 2002, Yoshida, Asakawa et al. 2002). Similarly,  Cdc14 is required 
for the dephosphorylation and removal of Cdc15 from SPBs at the time of 
cytokinesis (Cenamor, Jimenez et al. 1999, Jaspersen and Morgan 2000, Xu, 
Huang et al. 2000). As such, Cdc14 appears to play a role in restoring the SPB 
environment to a pre-mitotic state.  
 
Interestingly, the asymmetry of SPOC and MEN components does not appear to 
be a requisite for mitotic exit. It has been reported that a constitutively active 
Tem1 mutant shows increased symetric localisation to SPBs and impairs Bub2 
asymmetry (Scarfone, Venturetti et al. 2015). Despite enhancing Cdc15 loading 
at SPBs, the timing of mitotic exit remains unaffected, suggesting additional 









1.1.2.5 The role of Cdc14 orthologs in other organisms 
Cdc14 in budding yeast (S. cerevisiae), hereafter referred to as ScCdc14, has been 
extensively studied and its role in CDK down-regulation and mitotic exit is well 
documented. However, ScCdc14 is a member of a family of highly conserved 
dual-specificity phosphatases that have been identified in many other organisms.  
Despite sharing sequence similarities, ScCdc14 ortholog in other species do not 
always share a conserved function in cell cycle regulation.  
 
1.1.2.5.1 Fission yeast 
In fission yeast (S. pombe), a non-essential ortholog of Cdc14 was identified, 
termed Clp1/Flp1. SpClp1/Flp1 antagonises mitotic CDK activity, similar to 
ScCdc14, but functions mainly in mitotic entry and coordinating cytokinesis, and 
is not essential for mitotic exit (Cueille, Salimova et al. 2001, Trautmann, Wolfe 
et al. 2001). Whilst ScCdc14 acts mainly through cyclin proteolysis, SpClp1/Flp1 
inhibits mitotic CDKs by promoting the inhibitory phosphorylation of Cdc2, the 
fission yeast homologue to Cdc28 (reviewed by Morgan 1997). SpClp1/Flp1 
dephosphorylates and inactivates Cdc25, a phosphatase required to ensure Cdc2 
is not phosphorylated by the protein kinase Wee1. Once active, Wee1 can 
phosphorylate a highly conserved tyrosine residue (Tyr15) on Cdc2, which 
results in the inactivation of the mitotic CDK (Mueller, Coleman et al. 1995, 
Cueille, Salimova et al. 2001).  
 
SpClp1/Flp1 is predominately sequestered in the nucleolus for the majority of 
the cell cycle (Wolfe, McDonald et al. 2006). However, it is released in early 




mitotic spindle and to the medial ring as well (Cueille, Salimova et al. 2001). The 
co-localisation of SpClp1/Flp1 with SPBs is also observed prior to mitotic release 
of the phosphatase, suggesting that a pool of SpClp1/Flp1 remains associated 
with SPBs throughout the cell cycle.   
 
The mitotic release of SpClp1/Flp1 is promoted through a MEN-like pathway 
involved in septum formation, which contains MEN ortholog (reviewed by 
Bardin and Amon 2001). This so-called septation initiation network (SIN) is 
driven by a GTPase switch, Spg1, and initiates a conserved signalling cascade 
similar to the Tem1-dependent activation of MEN. The SPB acts as a scaffold for 
SIN signalling (Krapp, Schmidt et al. 2001) and inactivation of Cdc2 is sufficient 
to activate SIN (Dischinger, Krapp et al. 2008). SpClp1/Flp1 was found to 
regulate the localisation of SIN components to the SPB following Cdc2 
inactivation, indicating that SpClp1/Flp1 is both an activator and target of SIN 
signalling (Dischinger, Krapp et al. 2008). However, since SpClp1/Flp1 is not 
essential, another phosphatase is likely involved in SIN activation. Interestingly, 
FEAR orthologs are not required for the release of SpClp1/Flp1 from the 
nucleolus (Chen, Peli-Gulli et al. 2006). 
 
In addition to CDK down-regulation, SpClp1/Flp1 appears to regulate the mitotic 
spindle through dephosphorylation of Ase1 and kinesin-6 motor Klp9 to 
promote spindle elongation, analogous to ScCdc14 function (Fu, Ward et al. 
2009, Khmelinskii, Roostalu et al. 2009).  More recently, SpClp1/Flp1 has been 




component Sfi1 after anaphase to enable the re-setting of SPBs for the 
subsequent G1 phase (Bouhlel, Ohta et al. 2015).  
 
These findings suggest that ScCdc14 and SpClp1/Flp1 have similar functions in 
budding yeast and fission yeast respectively. They both promote mitotic CDK 
down-regulation, albeit through differential mechanisms. They are also both 
involved in the stabilisation of mitotic spindles, the re-duplication of SPBs and 
the initiation of cytokinesis events.  However, ScCdc14 and SpClp1/Flp1 release 
from nucleolar sequestration differs in both timing and mechanism, and the role 
of ScCdc14 in mitotic exit appears unique to budding yeast. One proposed reason 
for this is that mitotic CDK activity is high in budding yeast anaphase, unlike in 
other organisms where CDK activity is inhibited upon anaphase onset (Chen, 
Peli-Gulli et al. 2006). This could explain why ScCdc14-dependent 
dephosphorylation of mitotic CDK targets is so crucial in anaphase to ensure that 





1.1.2.5.2 Non-mammalian eukaryotes 
Relatively little is known about Cdc14 function in higher eukaryotes. In C.elegans, 
Cdc14 has been shown to localise to the spindle midzone in anaphase and to the 
midbody of the cell in telophase (Gruneberg, Glotzer et al. 2002), analogous to 
SpClp1/Flp1 localisation. Similarly, CeCdc14 has also been observed at SPBs 
(Saito, Perreault et al. 2004). However, the function of CeCdc14 has not been 
determined, as RNAi experiments in different studies contradict one another 
(Gruneberg, Glotzer et al. 2002, Saito, Perreault et al. 2004). 
 
In Xenopus cells, two isoforms of Cdc14 have been identified; XCdc14A and 
XCdc14B (Kaiser, Nachury et al. 2004, Krasinska, de Bettignies et al. 2007). 
Whilst the role of XCdc14B has yet to be determined, XCdc14A localises to the 
centrosome in interphase and the cell midbody in late mitosis. It appears to be 
involved in cytokinesis and the dephosphorylation of Cdc25, likely resulting in 
the inhibitory tyrosine phosphorylation of Cdc2 by conserved Wee1 (Mueller, 
Coleman et al. 1995, Krasinska, de Bettignies et al. 2007). 
 
A novel function of Cdc14 has also been identified in zebrafish, where it was 
found to regulate ciliogenesis (Clement, Solnica-Krezel et al. 2011). Zebrafish 
have three Cdc14 genes, which are expressed throughout embryogenesis. 
Through inhibition of phosphatase function in a Cdc14B homolog during early 
stage development, it was shown that Cdc14 activity was pivotal to establish left-
right (LR) asymmetry (Clement, Solnica-Krezel et al. 2011). LR asymmetry is 
required for the non-symmetrical placement of internal organs, such as the 




asymmetry defect is unclear, it was observed that several types of cilia were 
affected in a Cdc14B loss of function mutant. Cilia tended to be significantly 
shorter when CDC14B phosphatase activity was abolished, suggesting that 
CDC14B is required to phospho-regulate an as yet unknown substrate in order to 





Human cells contain two orthologs of ScCdc14, hCdc14A and hCdc14B (Li, 
Ernsting et al. 1997). Similar to ScCdc14 and SpClp1/Flp1, hCdc14 can promote 
CDK inactivation (Li, Ljungman et al. 2000, Listovsky, Zor et al. 2000), the 
mechanisms of which appears to be through promoting inhibitory tyrosine 
phosphorylation of Cdk1 (Ovejero, Ayala et al. 2012). Phosphorylation of Cdk1 
on Tyr-15 is catalysed by the kinases Wee1 and Myt1 (reviewed by Marston and 
Amon 2004). 
 
Mammalian Cdc14A localises to centrosomes throughout the majority of the cell 
cycle, similar to SpClp1/Flp1. This localisation is facilitated through active 
nuclear export and is required for accurate centrosome separation and 
subsequent chromosome segregation (Kaiser, Zimmerman et al. 2002, Mailand, 
Lukas et al. 2002). It has also been shown to prevent the premature entry of cells 
into mitosis by inhibiting mitotic CDKs (Sacristan, Ovejero et al. 2011).  
 
hCdc14B function, on the other hand, is tightly regulated via nucleoli 
sequestration and is released in early mitosis with a similar timing to 
SpClp1/Flp1 (Mailand, Lukas et al. 2002, Nalepa and Harper 2004). Once 
released from the nucleoli, hCdc14B localises to the spindle midzone in anaphase 
and later to the cell midbody in telophase. It has been shown to cause the 
bundling and stabilisation of microtubules, suggesting that mammalian Cdc14B 
is important for mitotic spindle assembly and disassembly (Nalepa and Harper 





Many other roles for hCdc14B have been suggested, including centriole 
duplication (Wu, Cho et al. 2008), mitotic exit (Dryden, Nahhas et al. 2003, 
Rodier, Coulombe et al. 2008), nuclear organisation (Nalepa and Harper 2004) 
and regulation of the tumour suppressor p53 (Li, Ljungman et al. 2000). 
However, studies have thus far been carried out using RNAi and over-expression 
of hCdc14, and not knockouts. Inexplicably, deletion of either hCdc14A or 
hCdc14B in human somatic cells appears not to display the same defects 
observed when hCdc14 is depleted (Berdougo, Nachury et al. 2008, Mocciaro, 
Berdougo et al. 2010). Potential substrates of hCdc14 therefore need validated in 
vivo and in vitro to establish if defects observed in RNAi experiments are 




1.2 The meiotic cell cycle 
Unlike in mitosis, meiotic cells undergo two consecutive rounds of chromosome 
segregation. The separation of homologues in meiosis I is a unique event, as it is 
sister chromatids that segregate in both mitosis and meiosis II. Meiosis I, 
therefore, must be differently regulated from mitosis to ensure proper 
chromosome segregation.  
 
Meiosis I differs from mitosis in three key ways. Firstly, homologous 
chromosomes, composed of paired sister chromatids, attach to microtubules 
emanating from opposite SPBs. Kinetochores of sister chromatids, therefore, 
attach to microtubules growing from the same SPB (mono-orientation) instead 
of to microtubules from opposite poles (bi-orientation), as is observed during 
mitosis or meiosis II (reviewed by Duro and Marston 2015). Secondly, these 
homologue pairs must be physically linked to one another by chiasmata, formed 
by reciprocal recombination, to ensure that homologues correctly bi-orientate on 
the meiosis I spindle. Thirdly, cohesin between sister chromatids is maintained 
throughout meiosis I to prevent their premature separation (reviewed by Duro 
and Marston 2015).  
 
The cohesin ring complex, which holds sister chromatids together in mitosis 
until its cleavage in anaphase, is removed from chromosomes in a stepwise 
manner during meiosis (Klein, Mahr et al. 1999). Cohesin is removed by separase 
from chromosome arms in meiosis I but is retained at the area surrounding the 
centromere, termed the pericentromere, until meiosis II (Fig. 1. 2). Protection of 




localisation to this region (Katis, Galova et al. 2004, Kitajima, Kawashima et al. 
2004, Marston, Tham et al. 2004).  
 
Sgo1 is a conserved tension-sensing protein. During metaphase I, bi-orientated 
homologous chromosomes align at the metaphase plate.  Sister chromatids are 
mono-orientated and Sgo1 is retained at the pericentromeres through an as yet 
unidentified mechanism (Nerusheva, Galander et al. 2014). Sgo1 recruits 
PP2ARts1 (Kitajima, Sakuno et al. 2006, Riedel, Katis et al. 2006), which prevents 
the phosphorylation and subsequent cleavage of meiotic cohesin subunit Rec8 
(Brar, Kiburz et al. 2006, Ishiguro, Tanaka et al. 2010, Katis, Lipp et al. 2010). 
Recruitment of PP2A to the pericentromere is sufficient to prevent cleavage of 
Rec8, as was demonstrated through the artificial tethering of PP2A to 
chromosome arms, which resulted in aberrant cohesin protection during meiosis 
I (Riedel, Katis et al. 2006). Since no cohesin protection mechanism is usually 
present at chromosome arms in meiosis I, when separase is released from 
inhibition in anaphase I through APCCdc20 activation, only cohesin at arm sites is 
cleaved. Resolution of chiasmata hence enables the separation of homologous 
chromosomes in meiosis I.  
 
Once meiosis I is completed, cells then progress into meiosis II to separate sister 
chromatids in a mitosis-like segregation step. SPBs require re-duplication, so 
that a total of four SPBs are present in cells to assemble two meiosis II spindles 
(Fig. 1. 2) (Moens and Rapport 1971). At this point, sister chromatids become bi-
oriented and under tension. Tension across sister chromatids likely contributes 




exact mechanism is not yet known (Nerusheva, Galander et al. 2014). Upon 
anaphase I onset, separase is able to degrade pericentromeric cohesin, enabling 
the separation of sister chromatids. Since an intervening S-phase between 
meiosis I and meiosis II is bypassed, these two consecutive rounds of 
chromosome segregations result in the production of four haploid daughter cells 








1.2.1 CDKs in meiosis 
Budding yeast cells undergo meiosis as a response to nutritional stress. As such, 
meiosis can be induced through starvation of cells, grown in the absence of 
glucose and other nutritional factors (reviewed by Honigberg and Purnapatre 
2003). Transcription of the meiotic inducer gene IME1initiates the transcription 
of genes involved in sporulation (Kassir, Granot et al. 1988, reviewed by van 
Werven and Amon 2011), including IME2, which regulates early meiotic genes 
(Smith, Su et al. 1990, Yoshida, Kawaguchi et al. 1990). Ime2 is required for the 
destruction of Sic1, which in turn activates Clb5- and Clb6-CDKs for progression 
through S-phase (Dirick, Goetsch et al. 1998). In combination, Ime1 and Ime2 up-
regulate NDT80 expression, required for the expression of meiotic cyclins Clb1- 
and Clb3-6 (Chu and Herskowitz 1998). As such, CDK activity plays a vital role in 
regulating meiotic progression.  
 
Like in mitosis, Clb-CDK complexes regulate key meiotic events. Clb5- and Clb6-
CDK are essential to initiate S-phase (Dirick, Goetsch et al. 1998, Stuart and 
Wittenberg 1998), with an additional role in triggering homologous 
recombination (Henderson, Kee et al. 2006). Clb1-, Clb3- and Clb4-CDK activities 
are vital during meiosis (Dahmann and Futcher 1995, Benjamin, Zhang et al. 
2003), as they drive cells through two successive meiotic divisions. In contrast to 
mitosis, the major mitotic cyclin, Clb2, is not expressed during meiosis 
(Dahmann and Futcher 1995). 
 
Regulation of Clb-CDK activities during meiosis occurs through a diverse range of 




translational modification other than Clb1 degradation (Carlile and Amon 2008). 
Potential phosphorylation of Clb1, observed as a slower migrating form of Clb1, 
is evident during meiosis I and is associated with Clb1-CDK activity (Carlile and 
Amon 2008, Tibbles, Sarkar et al. 2013). CDK-dependent re-localisation of Clb1 
to the nucleus promotes FEAR activation in anaphase I (Tibbles, Sarkar et al. 
2013), after which the slower migrating form of Clb1 disappears and Clb1-CDK 
becomes inactive (Carlile and Amon 2008).  
 
Clb3 cyclin is expressed only in meiosis II via translational repression during 
meiosis I. This limits Clb3-CDK activity to the second meiotic division (Carlile 
and Amon 2008), where it can regulate late meiotic events such as spore 
morphogenesis. The 5' UTR of CLB3 prevents the accumulation of Clb3 by 
decreasing translational efficiency in meiosis I (Carlile and Amon 2008). This is 
through the association of Rim4, an RNA-binding protein, with the 5'UTR during 
meiosis I. Upon entry into meiosis II, increased Ime2 activity promotes a 
decrease in Rim4 protein levels and thus its inhibitory binding to CLB3 is 
alleviated (Berchowitz, Gajadhar et al. 2013).   
 
Clb4 cyclin is present throughout meiosis and is required after prophase exit to 
initiate spindle assembly (Kim, Meyer et al. 2013), although Clb4-CDK activity is 
down-regulated after metaphase II through an unknown mechanism (Carlile and 
Amon 2008). Clb5, as described earlier, is essential in S-phase. However, Clb5 
protein abundance peaks in metaphase I and then again in metaphase II (Carlile 




suggests that Clb5-CDK may be acting early in meiosis II, although its role has yet 




1.2.2 Regulating CDKs at meiosis I exit 
At the meiosis I to meiosis II transition, meiotic I spindles must disassemble to 
enable the subsequent assembly of spindles in meiosis II (Woodruff, Drubin et al. 
2012). This requires a state of low Clb-CDK activity (Juang, Huang et al. 1997). 
However, to avoid re-duplication of the DNA, origins of replication must not be 
reset, which necessitates the maintenance of high Clb-CDK activity (Elsasser, Lou 
et al. 1996, Nguyen, Co et al. 2001). These opposing requirements hint that 
mitotic CDK activity must be down-regulated to a sufficient level that is 
permissive for meiotic spindle disassembly but is still admissible to restrict the 
formation of the preRC on DNA origins (reviewed by Marston and Amon 2004). 
Partial inactivation of CDKs, as has been observed in frog oocytes at meiosis I 
exit (Furuno, Nishizawa et al. 1994, Iwabuchi, Ohsumi et al. 2000), regulated by 
Cdc14 has been hypothesised (D'Amours and Amon 2004).  
 
In Xenopus, the retention of CDK activity between meiosis I and meiosis II is 
ensured through regulation of cyclin B (reviewed by Marston and Amon 2004).  
After meiosis I, the APC inhibitor Emi1 binds to the APC co-activator Cdc20 to 
prevent complete APC activation and subsequent cyclin B destruction (Reimann 
and Jackson 2002, Schmidt, Rauh et al. 2006). Residual CDK activity is thought to 
inhibit Wee1 activation, whereas the Xenopus polo kinase Plx1 has been 
proposed to inhibit Myt1 kinase activity (Palmer, Gavin et al. 1998), thereby 
preventing Cdc2 inactivation. Since Cdc14 regulates the Wee1 S. cerevisiae 
ortholog Swe1 and the polo kinase S. cerevisiae ortholog Cdc5 regulates Cdc14 
nucleolar release, it is possible Cdc14 does ensure partial down-regulation of 




1.2.3 Cdc14 in meiosis 
Cdc14 is essential for progression of cells from meiosis I to meiosis II (Buonomo, 
Rabitsch et al. 2003, Marston, Lee et al. 2003). It is released from nucleolar 
sequestration twice during meiosis; in anaphase I and, again, in anaphase II after 
its intermediate re-sequestration in metaphase II (Fig. 1. 2). Whilst the FEAR 
network plays a vital role in release of Cdc14 in anaphase I, MEN is dispensable 
(Buonomo, Rabitsch et al. 2003, Marston, Lee et al. 2003, Kamieniecki, Liu et al. 
2005) and does not appear to be active until anaphase II (Attner and Amon 
2012). 
 
Similar to mitosis, PP2ACdc55 is required for maintaining the association of Cdc14 
with Cfi1/Net1. PP2ACdc55-dependent inhibition of Cdc14 activity in early meiosis 
is essential for meiosis I spindle assembly (Bizzari and Marston 2011, Kerr, 
Sarkar et al. 2011). Depletion of Cdc55during meiosis, achieved through putting 
Cdc55 under the control of the mitosis-specific CLB2 promoter (Clift, Bizzari et 
al. 2009), results in impaired nuclear division and prevents the formation of 
meiotic spindles (Bizzari and Marston 2011, Kerr, Sarkar et al. 2011).  
 
Upon activation of the FEAR network during anaphase I, PP2ACdc55 is inhibited, 
enabling the phosphorylation of Cfi1/Net1 and subsequent release of Cdc14 
from the nucleolus (Yellman and Burke 2006, Bizzari and Marston 2011, Kerr, 
Sarkar et al. 2011). When Cdc14 activity is impaired, cells undergo a single 
meiotic division, where a normal reductional division occurs in meiosis I. No 
tetranucleate cells are formed (Sharon and Simchen 1990a, Sharon and Simchen 




progression is similarly affected when Cdc14 release is impaired, as is observed 
in slk19Δ and spo12Δ FEAR mutants (Buonomo, Rabitsch et al. 2003, Marston, 
Lee et al. 2003).  
 
Initially, it was reported that Cdc14 activity was required for meiotic spindle 
disassembly, since meiosis I spindle breakdown appeared delayed in 
temperature-sensitive cdc14-1 cells at the restrictive temperature after the 
separation of homologues (Marston, Lee et al. 2003). However, upon 
visualisation of GFP-tagged tubulin in live cells, it became clear that meiosis I 
spindles do disassemble in cdc14-1 mutants (Marston, Lee et al. 2003, Bizzari 
and Marston 2011). This is in contrast to observations in mitosis. Interestingly, 
10-15% of cdc14-1 cells re-fuse their nuclei upon spindle disassembly and then 
attempt to separate sister chromatids in a following equational segregation step 
but on a single meiosis II spindle (Bizzari and Marston 2011). This explains why 
previous studies believed that meiosis I spindles persist in cells where Cdc14 
activity is impaired, since cell populations and not individual cells were analysed 
(Buonomo, Rabitsch et al. 2003, Marston, Lee et al. 2003). As a result of some 
cells having undergone a meiosis I-like segregation and others having undergone 
a meiosis II-like segregation, analysis of cdc14-1 binucleate cells reveals a mixed 
segregation phenotype (Sharon and Simchen 1990a, Sharon and Simchen 1990b, 
Kamieniecki, Shanks et al. 2000). This mixed segregation phenotype is also 
observed when Cdc14 release is inhibited in anaphase I, as is seen when FEAR 
components SLK19 and SPO12 are deleted (Marston, Lee et al. 2003). Cdc14 
activity, therefore, is essential for the formation of two meiosis II spindles and 




Despite the fact that cdc14-1 mutants form only one meiosis II spindle and 
commit a single nuclear division, several molecular events characteristic of two 
rounds of chromosome segregation are still observed. Securin (Pds1) undergoes 
two rounds of accumulation and degradation, indicative of two FEAR activation 
events (Bizzari and Marston 2011). Furthermore, cohesin (Rec8) is removed 
from chromosomes in a stepwise manner, from chromosome arms in meiosis I 
and from pericentromere during meiosis II when Cdc14 release is impaired 
(Kamieniecki, Shanks et al. 2000).  
 
The role of Cdc14 during the meiosis I to meiosis II transition has yet to be fully 
determined. Preliminary data from an incomplete analysis of CDKs in meiosis 
has suggested that at least a one major cyclin-CDK complex in meiosis is 
normally regulated independently of Cdc14 activity (Bizzari and Marston 2011). 
Clb1 does not appear to be prematurely degraded when Cdc14 is ectopically 
released from inhibition, nor is it stabilised when Cdc14 activity impaired. This 
would appear to contradict the theory that Cdc14 had a CDK-inhibitory role 
during meiosis, as is observed in mitotic exit. However, Clb1 analysis cannot 
disprove the possibility that Cdc14 is required for the down-regulation of other 
mitotic CDKs at the meiosis I-meiosis II transition. Further analysis of Clb-CDKs 





1.3 Aim of this study 
In this study, I will attempt to discern the role of Cdc14 in the meiosis I to 
meiosis II transition using budding yeast as a model organism. To date, how 
meiotic cells are able to undergo two consecutive rounds of chromosome 
segregation without entering an intermediate round of DNA duplication has yet 
to be determined. Understanding the mechanics of meiotic regulation is essential 
to establish how and why chromosome segregation errors occur. Aneuploidy in 
human meiotic cells mostly results in the spontaneous termination of a 
developing foetus, and any offspring that survive until birth often exhibit birth 
defects such as Down Syndrome and Turner syndrome. I hope that my work 
could provide insight into possible causes of infertility, miscarriage and birth 
































2. Materials and Methods 
2.1 General Information 
2.1.1 Supplier information 
Chemicals used in this study were purchased from G.E. Healthcare, Life 
Technologies, Roche, Sigma, Starlab, Thermo Fisher Scientific, Qiagen and VWR 
International, unless stated otherwise. Formedium, Difco and Sigma provided 




Most solutions used were sterilised by filtration using a 0.45 μm bottle top 
(Nalgene) or syringe (Millipore) filters. Growth media was autoclaved at 120°C 
and 15 pounds/inch2 for 15 min. All glassware was sterilised by baking at 250°C 
for 16 h. 
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2.2 Bacterial methods 
2.2.1 E. coli strains  
DH5α electrocompetent cells were used for cloning and propagation of plasmids.  
Strain name Genotype 
DH5α F- φ80lacZ∆M15 ∆(lacZYA-argF)U169 deoR recA1 endA1 
hsdR17(rk-, mk+) phoA supE44 thi-1 gyrA96 relA1 λ 
BL21 (EC76) F- dcm ompT hsdS (rB- mB-) gal [malB+]K-12 (λS) 
EC77 BL21 containing AMp943 (PGK1-GST) 
EC78 BL21 containing AMp945 (PGK1-MBP) 
EC79 BL21 containing AMp949 (KAR2-GST) 
EC80 BL21 containing AMp951 (KAR2-MBP) 
Table 2. 2. 1: E. coli strains used in this study. 
2.2.2 E. coli media 
LB (Luria-Bertani):   1% (w/v) Bactotryptone 
     0.5% (w/v) Bacto-yeast extract 
     0.5% (w/v) NaCl 
     pH adjusted to 7.2 with NaOH 





2.2.3 E. coli growth conditions 
Bacteria were typically grown on solid LB medium at 37°C or in liquid LB at 
37°Cwith shaking. All plasmids used in this study carry an ampicillin resistance 
marker. For plasmid selection and maintenance, Amp was used within medium 
at a final concentration of 100 μg/ml. 
 
2.2.4 Storage of E. coli 
Bacterial cells were typically kept on LB-Amp plates at 4°C for 1-2 weeks. For 
long-term storage, bacterial strains were resuspended in 20% glycerol in 
cyrotubes and frozen at -80°C.  
 
2.2.5 E. coli transformation by electroporation 
Electrocompetent DH5α cells were thawed slowly on ice. 40 μl of cells were 
aliquoted into pre-chilled electroporation curvettes (Cell Projects, 2 mm gap). An 
appropriate amount of plasmid DNA (0.5 – 5 μl depending on plasmid 
concentration) was added to the cells and mixed. Electroporation was performed 
using a Bioread Gene Pulser II at 2.5 V, 200 Ω and 2.5 μF. Immediately following 
electroporation, 1 ml of 37°C LB media was added and transferred with the 
reaction to a glass tube for incubation at 37°C for 1 h. After the incubation, 
cultures were transferred to 1.5 ml eppendorf tubes and spun at 3000 rpm for 3 
mins. The majority of the supernatant was aspirated leaving ~150 μl with which 
to resuspend and plate cells onto pre-warmed LB-Amp solid media. Reactions 
were incubated o/n at 37°C.  
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2.3 Budding yeast methods 
2.3.1 Budding yeast strains 
All yeast strains used in this study were diploid and derived from SK1, unless 
otherwise stated. 


































































































































































































































































































































































































































































Table 2. 3. 1 (Continued): S. cerevisiae strains used in this study. 
 
2.3.1.1 Yeast strain construct and origin 
pCLB2-3HA-CDC55 (cdc55mn) was described in (Clift, Bizzari et al. 2009). CLB1-
9MYC was described in (Buonomo, Rabitsch et al. 2003). cdc20mn was described 
in (Lee and Amon 2003). GAL-NDT80 and pGPD1-GAL4(848).ER were described 
in (Benjamin, Zhang et al. 2003). CLB1-9Myc, cdc14-1, slk19Δ and spo12Δ were 
described in (Marston, Lee et al. 2003). CDC14-GFP, PDS1-tdTomato and GFP-
TUB1 were described in (Matos, Lipp et al. 2008). SPC42-tdTomato was 
described in (Fernius and Hardwick 2007). A one-step PCR method was used to 
generate pCLB2-3HA-SFI1 (sfi1mn) (Lee and Amon, 2003), CDC14-SZZ(TAP), 
SPC42-3FLAG, SPC42-GFP, CDC14-GBP, SFI1-6HA, BFA1-tdTomato, bub2Δ, bfa1Δ, 
kin4Δ, bmh1Δ (Longtine et al., 1998) strains. The SPC42-CFP strain was obtained 








2.3.2 Budding yeast media 
YPDA:      2% (w/v) Bacto-peptone 
     1% (w/v) Bacto-yeast extract 
     2% (w/v) Glucose 
     0.3 mM Adenine 
 
YPG:     2% (w/v) Bacto-peptone 
     1% (w/v) Bacto-yeast extract   
     2.5% (w/v) Glycerol 
 
4%-YPDA:    2% (w/v) Bacto-peptone 
     1% (w/v) Bacto-yeast extract 
     4% (w/v) Glucose 
 
BYTA:     2% (w/v) Bacto-peptone 
     1% (w/v) Bacto-yeast extract 
     1% (w/v) Potassium Acetate 
     50 mM Potassium Phthalate 
 
Sporulation media:   0.3% (w/v) Potassium acetate (pH 7) 
 
For making solid media plates, 2% (w/v) agarose was added to liquid solutions 







Used for KanMX6 selection in solid media. G418 powder was dissolved in sterile 
water, filter sterilised and added to cooled melted agar-media at a final 
concentration of 300 μg/ml.  
 
2.3.3.2 Hygromycin 
Used for HPHMX6 selection in solid media. Hygromycin solution (50 mg/ml) was 
added to cooled melted agar-media at a final concentration of 300 μg/ml. 
 
2.3.3.3 Clonat 
Used for NatMX4 selection in solid media. Clonat stock solution (200 mg/ml) was 
added to cooled melted agar-media at a final concentration of 100 μg/ml.  
 
2.3.4 Budding yeast growth conditions 
Details of individual experiments are given in figure legends.  
 
2.3.4.1 Preparation of cells for sporulation 
For meiotic experiments, diploid strains were removed from -80°C storage onto 
YPG solid media plates and grown overnight (~16 h), The following day, cells 
were patched to 4%YPDA plates. On the third consecutive day, YPDA liquid 
cultures were inoculated with yeast strains and grown overnight. Cells were then 
diluted to OD600 =0.2 in BTYA liquid culture and grown to OD600 = 6-10. On the 
fifth day, cells were washed once in sterile water and resuspended in SPO liquid 
media at OD600 = 1.8-3. Meiosis was performed at 30°C.  
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2.3.4.2 GAL-NDT80 block and release method for synchronous meiosis 
Diploid strains homozygous for GAL-NDT80 and GAL4(848)-ER arrest in 
pachytene (Carlile and Amon 2008). Strains prepared for sporulation are left in 
SPO for 6 h before the addition of 1 μM of β-estradiol to induce transcription of 
NDT80. Samples were taken every 15 mins for 3 h, then every 30 mins for an 
additional 3 h after that. 
 
2.3.4.3 Temperature sensitive alleles 
Cells were G1-arrested at the permissive temperature (25°C) and released at the 
restrictive temperature (30°C).  
 
2.3.4.4 Depletion of proteins in meiosis 
To specifically deplete proteins during meiosis, the native promoter of the 
relevant gene was replaced with pCLB2, a mitosis-specific promoter (Lee and 
Amon 2003). 
 
2.3.5 Budding yeast storage 
For long-term storage of strains, yeast were resuspended in 20% glycerol in 
cryotubes and stored at -80°C.  
 
2.3.6. High efficiency transformation 
LiTE:    0.1 M LiAc 
    10 mM Tris.HCl (pH 7.5) 




40% PEG    0.1 M LiAc 
    40% PEG 4000 
    10 mM Tris.HCl (pH 7.5) 
    1 mM EDTA 
 
50 ml YPDA yeast cultures were grown overnight to OD600 =6. Cultures were 
diluted the following morning to OD600 = 0.2 then grown to OD600 = 0.7-1. Cells 
were spun down at 3000 rpm for 3 mins, washed twice with sterile water and 
transferred to a 1.5 ml eppendorf tube. Cells were washed once in 1 ml LiTE and 
resuspended in 250 μl LiTE. 50 μl of yeast suspension was used per 
transformation reaction and mixed with ~10 μl DNA, 300 μl 40% PEG and 10 μl 
ssDNA. Reactions were incubated at 30°C for ~1 h then heat shocked at 42°C for 
15 mins. Tubes were spun down at 3000 rpm for 3 mins, cell pellets were 
resuspended in 200 μl water and plated out on YPDA solid media.  
 
2.3.7 Crossing strains 
To cross strains, MATa and MATα haploids were mated, and the resulting 
diploids were selected for plating onto sporulation plates. To improve mating 
efficiency, a small amount of one strain containing a unique selectable marker 
was mixed with an excess of another strain of the opposite mating type on YPDA 
solid media and left to mate overnight. The mating was streaked on a selection 
plate and incubated until single colonies appear. The majority of these single 
colonies are diploids, which are picked and patched onto a sporulation plate and 




2.3.8 Tetrad dissection 
Tetrads formed from crosses were checked from sporulation plates using a light 
microscope. A small amount of tetrads were resuspended in 20 μl of zymolase (1 
mg/ml) and incubated for 7-8 mins. 1 ml of sterile water was used to dilute 
zymolase mixture, from which 20 μl were spread on a YPDA solid media plate. 
Tetrads were dissected using a Nikon Eclipse 50i microscope equipped with 




2.4 Microscopy methods 
2.4.1 General Information 
Imaging of fixed cells or live cells at isolated time-points was carried out using a 
Zeiss Axio Imager Z1 and a Photometrics EMCCD camera. Images were taken 
using Micro-Manager 1.4 and processed using ImageJ software. For the 
generation of microfluidics movies, a Deltavision® Elite live cell imaging system 
was utelised with an Olympus IX-71 microscope and a Photometrics EMCCD 
Cascade II camera. Multi-point images were taken using SoftWoRx, movies were 
assembled in Image-Pro Plus and processed further in ImageJ.  For transmission 
EM, images were collected using a Philips CM120 Transmission electron 
microscope and a Gatan Orius CCD camera. 
 
2.4.2 Whole cell Immunofluorescence (IF) for meiotic spindle analysis  
Sorbitol-citrate:    1.2 M Sorbitol 
     0.1 M K2HPO4 
     36 mM Citric acid 
 
PBS-BSA:     1% (w/v) BSA 
     40 mM K2HPO4 
     10 mM KH2PO4 
     0.15 M NaCl 






DAPI mount:     9 mM p-phenylenediamine 
     40 mM K2HPO4 
     10 mM KH2PO4 
     0.15 M NaCl 
     0.1% NaN3 
     50 ng/ml DAPI 
     90% (w/v) Glycerol 
 
200 μl of culture from meiotic cell cycle time-course was spun down at 13000 
rpm for 1 min and the cell pellet was resuspended in 1 ml of 3.7% formaldehyde 
in 0.1 M K Phosphate buffer (pH 6.4). Cells were fixed overnight at 4°C. The 
following day, cells were washed three times in 1 ml 0.1 M K Phosphate buffer 
and once in 1 ml sorbitol-citrate before resuspension in 200 μl sorbitol-citrate 
with 100 μg/ml zymolase 100T and 10% glusulase (Perkin Elmar). Cells were 
digested for 2 h at 37°C, and sufficient digestion was judged using a light 
microscope. Digested cells were then spun at 3000 rpm for 3 mins, washed twice 
in 1 ml sorbitol-citrate and resuspended in ~50 μl of sorbitol citrate. 5 μl of cells 
per well were placed onto multi-well polylysine slides and left for 10 mins. 
Excess liquid was aspirated, cell density per well was checked via light 
microscopy before slides were fixed. Fixation was carried out by submerging 
slides in methanol for 3 mins followed immediately by acetone for 10 secs before 
being left to dry. 5 μl of primary antibody solution (Table 2. 4. 1) was added per 
well and incubated for 2 h at room temperature in a dark moisture chamber. 
After incubation, cells were washed five times with 5 μl PBS-BSA and then 5 μl of 
secondary antibody solution (Table 2. 4. 1) was added per well. Slides were 
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incubated for 2 h in a moisture chamber at room temperature. Cells were 
washed five times with 5 μl PBS-BSA then 3 μl of DAPI-mount was added per 
well. A glass coverslip was placed on top of each slide, which were then sealed 
with clear nail polish and stored long term at -20°C before and after spindle 
analysis.   
Protein Fixation time Primary antibody Secondary antibody 
Tubulin Overnight (4°C) rat α-TUB 1:50 α-rat FITC 1:100 
Table 2. 4. 1: Fixation times and antibody dilutions for whole cell IF. Antibodies 
diluted in PBS-BSA. 
 
2.4.3 Fluorescence analysis of fixed cells  
100 μl of culture from a meiotic cell cycle time-course was added to eppendorf 
tubes containing 10 μl of 37% formaldehyde. Cells were fixed for 8-10 mins at 
room temperature. Tubes were spun down at 13000 rpm for 2 mins, washed 
with 1 ml of 80% ethanol and the cell pellet was resuspended in 20 μl of 1 μg/ml 
DAPI. Typically, 7 μl of cells were placed onto superfrost slides (BDH) and 
covered with a glass coverslip before microscopy. In addition to DAPI staining, 
fluorescently-tagged (-GFP, -tdTomato, -CFP) proteins can also be visualised 
using this method. 
 
2.4.4 Fluorescence analysis of live cells using agarose pads 
A lowered flat surface (~1mm in depth) was created on superfrost slides by 
taping both ends of the slide. 15-20 μl of melted 2% agarose was added to the 
centre of the lowered surface and compressed with a coverslip. Agarose was 
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allowed to cool and solidify before the coverslip was removed. 100 μl of culture 
from a meiotic cell cycle time-course was spun down at 13000 rpm for 2 mins 
and resuspended in 5μl of liquid media. 2-3 μl of cell suspension was added to 
each agarose pad. The slide was covered with a glass coverslip and sealed with a 
molten mixture of vasoline:lamalin:paraffin (1:1:1) before microscopy. 
 
2.4.5 Fluorescence analysis of live cells using Microfluidics 
Live-cell meiotic movies were generated using CellASIC® ONIX Y04D 
Microfluidics plates (Merck Millipore). All chambers on the plate were washed 
three times with 500 μl of sporulation media before 200 μl of sporulation media 
plus 1mM β-estradiol was added to chambers 1-6. Plates were then pre-
incubated at 30  30 mins. After incubation, 200 μl of an individual culture 
of pachytene-arrested cells was loaded into chamber 8.  A total of four different 
strains can be imaged on a single plate. The microfluidics plate was attached via 
a low-profile manifold to the CellASIC® ONIX Microfluidic Platform Control 
System, and the assembly was placed on a Deltavision Elite microscope. Cells 
were loaded, visualised, washed with β-estradiol-containing sporulation media 
and imaged.   
 
2.4.6 Quantification of fluorescence signal 
Quantification of fluorescence signal was performed as described in (Hoffman, 
Pearson et al. 2001) In brief, the following equations were used: 
FBk = (FO – Fi) * (Ai / (AO - Ai))   Fx = Fi - FBk 
O and I represent outer and inner regions respectively. The inner region (I) 
contained ~90% of the signal measured. The outer region (O) was at least twice 
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the area of the inner region, and was used to calculate the surrounding 
background (Bk) signal. F signifies integrated fluorescence signal, calculated 
from Raw Integrated Densities, and A is area of the boxes (Table 2. 4. 6).  
 Area of Inner Box (Ai) Area of Outer Box (AO) 
Single images 16 pixels 64 pixels 
Microfluidics movies 0.000544 inches 0.002 inches 
Table 2. 4. 6: Areas used for quantification of fluorescence signal in this study. 
 
2.4.7 Electron microscopy (EM) 
3 ml of culture from meiotic cell cycle time-course per freezing event was 
vacuum filtered through a 0.45 μm Millipore filter. The cell paste was rapidly 
frozen under high pressure in a Wohlwend Compact 02 High Pressure Freezer 
(Boulder Electron Microscopy Services, University of Colorado, USA). Multiple 
freezing events were performed per time-point, and samples were kept in liquid 
nitrogen until the time-course was completed. Frozen cell pellets were then 
freeze substituted in acetone containing 2% (w/v) osmium tetroxide and 0.1% 
(w/v) uranyl acetate at -80°C. Samples were slowly warmed to room 
temperature over 3 days. After washing cells twice in acetone, samples were 
embedded in Epon 812 resin (Hexion) through multiple changes of diluted resin 
with acetone (1:3, 1:1 and 3:1). Three more changes using undiluted Epon 812 
resin were carried out over 2 days before resin was polymerised at 60-70°C 
overnight. Epon blocks were serially sectioned at a thickness of 70 nm and 
stained with 2% (w/v) uranyl acetate in sterile water for 8 mins then in 
Reynolds’ lead citrate for 3 mins. Sections were viewed on a Philips CM120 
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transmission electron microscope (EM Facility, University of Edinburgh) and 
images were collected with a Gatan Orius CCD camera. Help freezing cells was 
received from Tom Giddings Jr of the University of Colorado (Boulder).  
Sectioning was carried out by Eileen O’Toole, Mary Morphew and Courtney 
Ozzello of the University of Colorado (Boulder), and Stephen Mitchel of the 
University of Edinburgh.  
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2.5 Protein analysis 
2.5.1 TCA protein extraction preparation 
Trichloroacetic acid (TCA) protein extraction method was used for protein 
analysis from cell cycle cultures for rapid protein precipitation and preservation 
of protein phosphorylation. 
TE:      10 mM Tris-HCl (pH 7.5) 
     1 mM EDTA 
 
3x SDS sample buffer:   187 mM Tris (pH 6.8) 
     6% (w/v) β-mercaptoethanol 
     30% (w/v) Glycerol 
     9% (w/v) SDS 
     0.05% (w/v) Bromophenol blue 
 
5 ml of culture from cell cycle time-course was spun down in 15 ml falcon tubes 
at 4000 rpm for 3 mins. Cell pellets were resuspended in 5 ml of 5% TCA and 
incubated on ice for 10 mins. Tubes were spun down at 4000 rpm for 3 mins at 
4°C, the majority of the supernatant was discarded and the pellet was 
transferred to 2 ml Fastprep tubes (MP Biomedicals) using residual supernatant. 
Tubes were spun down briefly at 14000 rpm before complete removal of 
supernatant, and cell pellets were snap-frozen in liquid nitrogen before storage 
at -80°C. Pellets were then resuspended in 1 ml of acetone via vortexing, spun 
down at 14000 rpm for 7 mins and the acetone was removed. Cell pellets were 
air dried in a fume hood for 2-3 h. Dried pellets were then resuspended in 100 μl 
of ice-cold TE with 2.75 μl of 1 M DTT and 1x Roche EDTA-free protease 
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inhibitors and a small quantity of glass beads (Sigma). Cells were disrupted using 
a Fastprep Bio-pulveriser FP120, subjecting tubes to 3 x 45 secs disruption at 
speed 6.0. 50 μl of 3x SDS sample buffer was added and extracts boiled at 100°C 
for 5 mins. Tubes were spun down at 14000 rpm for 5 mins and eluted protein 
was transferred to a new eppendorf before loading onto a gel.   
 
2.5.2 Protein extraction preparation without TCA 
When phosphorylation preservation is not essential, protein preparation 
without TCA was utilised. 10 ml cultures were grown overnight to saturation. 
Cultures were spun down at 4000 rpm for 3 mins, cell pellets were resuspended 
in 1 ml of ice-cold 10 mM Tris (pH 7.5) and transferred to Fastprep tubes. Tubes 
were spun down briefly at 4°C, the supernatant was discarded and cell pellets 
were snap-frozen in liquid nitrogen for storage at -80°C. Thawed pellets were 
then resuspended in 100 μl of ice-cold TE with 2.75 μl of 1 M DTT and 1x Roche 
EDTA-free protease inhibitors and a small quantity of glass beads (Sigma). Cells 
were disrupted using a Fastprep Bio-pulveriser FP120, subjecting tubes to 3 x 45 
secs disruption at speed 6.0. 50 μl of 3x SDS sample buffer was added and 
extracts boiled at 100°C for 5 mins. Tubes were spun down at 14000 rpm for 5 
mins and eluted protein was transferred to a new eppendorf before loading onto 
a gel.   
 
2.5.3 SDS Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
4x Separation buffer:   1.5 M Tris 
     0.4% (w/v) SDS 
     pH adjusted to 8.8 with glacial acetic acid 
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2x Stacking buffer:    0.25 M Tris 
     0.2% (w/v) SDS 
     pH adjusted to 8.8 with glacial acetic acid 
 
Two glass plates were assembled with 1 .5mm gap and the edges sealed with 1% 
agarose. Polyacrylamide separation gels were prepared according to Table 2. 5. 3 
and were poured between the glass plates. The gel was topped with isopropanol 
to level off the gel, which was then allowed to polymerise. After polymerisation, 
the isopropanol was removed, the stacking gel  (Table 2. 5. 3) was poured on top 
and a comb of 20 wells was inserted into the stacking gel for setting. Large gels 
were run using Biometra V15.17 electrophoresis apparatus in 1 x running buffer 
at 65 mA until samples reached the separation gel layer, when they were then 
ran at 12mA overnight. Small gels were run on a Mini Trans-Blot Electrophoretic 
Transfer Cell (Biorad) at 65 mA for ~3 h. A prestained protein marker (GE 





















10ml 6 ml 2 ml 
4 x Separation 
buffer 
7.5 ml 7.5 ml - 
2 x Stacking 
buffer 
- - 7.5 ml 
10% APS 450 μl 450 μl 150 μl 
TEMED 30 μl 30 μl 15 μl 
Water 12.5 ml 16.5 ml 5.3 ml 
Table 2. 5. 3: Polyacrylamide gel recipes (amounts per one large gel). 
 
2.5.4 Western blotting 
Transfer buffer:    25 mM Tris 
     1.5% (w/v) Glycine 
     0.02% (w/v) SDS 
     10% (v/v) Methanol 
 
Ponceau S:     0.47% (w/v) Ponceau S 
     3% (w/v) TCA 
     1% (v/v) Acetic acid) 
 
PBS-T:     0.1% Tween-20 in PBS 
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Following electrophoresis, gels were transferred onto protran BA 85 
nictrocellulous membranes (Whatmann). Large gels were transferred using an 
Amersham TE70 semi-dry transfer unit and small gels were transferred using a 
Mini Trans-Blot Electrophoretic Transfer Cell. The membrane and blotting paper 
(Amersham) were soaked in transfer buffer prior to transfer at 1 mA/cm2 for 2.5 
h. After transfer, membranes were stained with Ponceau S then blocked with 2% 
dry milk in PBS-T. Membranes were incubated with primary antibody (Table 2. 
5. 4) overnight at 4°C. Membranes were then washed three times for 15 mins in 
PBS-T and incubated with secondary antibody (Table 2. 5. 4). After final 
incubation, membranes were washed twice with PBS-T for 15 mins then a final 
time with PBS for ~1 h before developing.  
 Primary antibody Secondary 
antibody for ECL 
Secondary 
antibody for LiCor 






1:10000        
(LiCor® 
Bioscience) -9Myc mouse α-9E10 (Roche) 
1:1000 
-SZZ(TAP) mouse α-PAP (Thermo Fisher) 1:1000 - 







1:10000         
(LiCor® 
Bioscience) 
PGK1 rabbit α-PGK1 
(laboratory stock) 
1:10000 
Table 2. 5. 4: Antibodies used for western blots in this study. Antibodies were 
diluted with 2% milk in PBS-T.  
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2.5.4.1 Western blot analysis using ECl 
The ECL detection method was utilised to analyse faint protein signals since ECL 
offers increased sensitivity. Membranes were subjected to chemiluminescence 
using the SuperSignal West Pico chemiluminescent kit (Thermo scientific) 
according to manufactorers instructions. For Sfi1-6HA analysis, SuperSignal 
West Femto chemiluminescent kit was additionally used. Membranes were 
wrapped in Saran wrap and exposed to Kodak Bio-Max light film and developed 
using a Konica-Minolta SRX-101A developer.    
 
2.5.4.2 Western blot analysis using LiCor® 
LiCor was utilised for quantification of protein signal. LiCor IRDyes® secondary 
antibodies are labelled with fluorescent dyes which can be visualised under 
different wavelengths. The LiCor Odyssey® Quantitative Fluorescence Imager 
was used to scan membranes at 700nm and 800nm wavelengths. Odyssey® 
Infrared Imaging software was used to quantify protein signal.  
 
2.5.5 Immunoprecipitation 
Hyman buffer:   50 mM Bis-Tris propane (pH 7) 
     100 mM KCl 
     5 mM EGTA 
     10% (v/v) Glycerol 
 
SPB buffer:     20 mM Na-Hepes (pH 7.4) 




Meiotic cells were harvested and washed with sterile water by centrigation at 
4000 rpm for 6 mins. Cells were resuspended in 0.2x cell volume of sterile water 
before drop-freezing in liquid nitrogen. Cells were ground five times in a Retsch 
Mixer Mill MM400. The yeast lysate were then thawed in Hyman or SPB buffer 
plus inhibitors (Table 2. 5. 5), depending on pulldown experiment. Hyman buffer 
was used for Cdc14-TAP immunoprecipitations, whereas SPB buffer was used 
for Spc42-3FLAG IPs and was adapted from (Niepel, Strambio-de-Castillia et al. 
2005). Triton X-100 was added to a final concentration of 1% (w/v) before 
sonication at 39% amplitude for 1 x 30 secs per 10 ml of lysate.   Lysates were 
centrifuged at 4000 rpm for 5 mins at 4°C and supernatant was transferred to a 
new 50 ml falcon tube. Immunoprecipitation was performed by adding 5 mg of 
rabbit IgG-coupled Dynabeads or 18 mg of M2 αFLAG-coupled Dynabeads per 30 
g lysed yeast, and rotating at 4°C for 2 h. Lysates were then washed five times in 
cold buffer without inhibitors and then transferred to a 1.5 ml eppendorf tube 
with 1ml buffer. Residual buffer was removed and 25 μl of 1x NuPAGE® LDS 
sample buffer was added to tubes before boiling at 100°C for 5 mins. Samples 
were transferred to new eppendorfs, removing the Dynabeads. 5 µl of β-
mercaptoethanol was added to samples, boiled for another 5 mins then spun 
down at 13000 rpm for 5 mins before loading onto a precast NuPAGE® 8-12% 







Inhibitor Final concentration Notes 
CLAAPE 1x From 2000x CLAAPE: 
Chymostatin, Leupeptin, 
Antipain, Pepstatin A, E-
64 Protease inhibitor 
(all 10 mg/ml) 
AEBSF (Pefabloc) 4 mM  
Benzamidine 2 mM  
PMSF 2 mM  
LR microcystin 0.4 μM  
N-ethylmaleimide 
(NEM) 
2 mM  
Sodium orthovanadate 0.8 mM  
 
From 20x phosphatase 
inhibitor solution 
β-glycerophosphate 8 mM 
Sodium pyrosphosphate 4 mM 
Sodium fluoride 20 mM 
Table 2. 5. 5: Protease and phosphatase inhibitors used in immunoprecipitations. 
 
2.5.5.1 Silver Staining 
Silver staining was performed using a Silver Staining kit (Thermo Scientific) 





2.5.5.2 Coomassie Staining 
Coomassie staining was performed using a Colloidal Blue Staining kit (Novex) 
according to manufacturer's instructions. 
 
2.5.5.3 In-gel tryptic digestion of proteins 
Protein bands were excised from Coomassie-stained NuPAGE® 8-12% Bis-Tris 
gels and washed alternatingly with 50 mM ammonium bicarbonate and 
acetonitrile solutions until Coomassie staining was removed. Gel pieces were 
treated with 10 mM DTT in 50 mM ammonium bicarbonate for 30 mins at 37°C 
then DTT was removed and samples were washed with acetonitrile. 55 mM 
iodoacetamide in 50 mM ammonium bicarbonate was added to gel slices and 
incubated at room temperature in the dark for 20 mins. After washing again with 
50 mM ammounium bicarbonate and acetonitrile, gel pieces were incubated with 
trypsin for 15 mins on ice then samples were transferred to 37°C for overnight 
digestion. The following morning, digestion reactions were treated with 0.1% 
(w/v) trifluoroacetic acid and left for 15 mins to allow peptides to diffuse from 
the gel. Samples were then passed through an equilibrated StageTip consisting of 
two layers of Empore Disks C18 within a pipette tip. A single StageTip was used 
per sample, as peptides within samples bind to StageTips. Peptides were later 
eluted for analysis via Mass Spectrometry. 
 
2.5.5.4 Mass Spectrometry (MS) 
Mass Spectrometry was performed by Flavia Alves and Juan Zao in the Juri 
Rappsilber lab (University of Edinburgh). MS data was compiled in MaxQuant 
1.4.1.2 and quantitative analysis was performed using Perseus 1.5.1.6 software.  
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2.5.6 Production of polyclonal antibodies 
2.5.6.1 Protein expression 
 E. coli strains EC77-80 were streaked on LB with ampicillin solid media and 
single colonies selected to inoculate 5 ml LB with ampicillin starter culture, 
grown overnight at 37°C. The next day, cells were diluted 1:100 in LB with 
ampicillin and grown again overnight. The following morning, cells were diluted 
1:100 in LB with ampicillin in a 1 L volume and grown to OD = 0.4-0.8. A 5 ml 
sample was removed as a non-induced control before IPTG was added to the 
culture at a final concentration of 1 mM to induce protein expression. Cells were 
grown for 4 h at 37°C before harvesting via ultracentrifugation at 4°C for 10 mins 
at 3500 rpm.  
 
2.5.6.2 Preparation of inclusion bodies 
Lysis buffer:     20 mM Tris (pH 8.0) 
     1 mM EDTA 
     5 mM MgCl2 
     0.3 mM PMSF 
     8 U/ml Benzonase 
     400 μg/ml lysozyme 
 
 Resuspension buffer:   50 mM Tris (pH 8.0) 
     300 mM NaCl 
     1 mM EDTA 




Cells were resuspended in ~9 cell volumes of lysis buffer, ensuring that lumps 
are removed. Reactions were incubated for 20 mins at room temperature to 
enable Benzonase activity then reactions were ran through a Constant system 
1.1 kW TS cell disruptor (EPPF, University of Edinburgh) on 39kPSI. The 
disruptor was washed through between samples with ddH2O, 10% Deacon and 
HCl. A total cell extract was removed from samples for later comparison. 300 mM 
of NaCl and 1% (w/v) of Triton X-100 was added to protein samples, and 
resuspension buffer of an equal volume to that of the sample was also added. 
Reactions were vortexed briefly and spun down at 4°C for 20 mins at 10000 rpm. 
A soluble sample was taken from the supernatant and the rest was discarded. 
Cell pellets were washed three times in 10-20 cell volumes of resuspension 
buffer before finally resuspension in 1 ml resuspension buffer. 100 μl sample 
was removed to test the inclusion body fraction, and the rest of the sample was 
snap-frozen in liquid nitrogen for long-term storage. 3x SDS sample buffer was 
added to non-induced (NI), total cell extract (TCE), soluble (SOL) and inclusion 
body (IB) samples, boiled at 100°C for 5 mins and spun down at 14000 rpm for 5 
mins. The eluted protein was transferred to a new eppendorf before loading onto 
a 10% SDS gel (Section 2. 5. 3) alongside BSA standards to visualise protein 










Name Description Origin 
AMp195 pFA6a-kanMX6 Described in (Longtine, 





Described in (Longtine, 





Described in (Longtine, 
McKenzie et al. 1998) 
Mark 
Longtine 
AMp267 PXH133/Spc42-CFP Described in (He, Asthana 




AMp197 GFP gene 
mutated to F64L and S65T 





Described in (Lee and 
Amon 2003) 
Brian Lee 
AMp495 pFA6a-6HA-kanMX6 6HA cloned into AMp195 Brian Lee 
AMp636 pFA6a-SZZ(TAP)-
kanMX6 
SZZ(TAP) cloned into 
AMp195 
 
AMp683 pFA6a-NAT Described in (Hentges, 
Van Driessche et al. 2005) 
Kevin 
Hardwick 










Name Description Origin 
AMp751 pFA6a-tdTomato-
NAT 
Described in (Taxis, 
Maeder et al. 2006) 
 
AMp795 pDONR201  Invitrogen 
AMp796 pDEST-GST  Invitrogen 
AMp797 pDEST-INT  Invitrogen 
AMp798 pDEST-MBP  Invitrogen 
AMp894 pFA6a-3FLAG-
kanMX6 
3FLAG cloned into 
AMp195 
Robin Allshire 
AMp934 pCUP1-GBP-mRFP  Peter Thorpe 
AMp935 pDONR201-PGK1 PGK1 cloned into AMp795 This study 
AMp942 pDONR201-KAR2 KAR2 cloned into AMp795 This study 
AMp943 pDEST-PGK1-GST PGK1 from AMp935 
cloned into AMp796 
This study 
AMp944 pDEST-PGK1-INT PGK1 from AMp935 
cloned into AMp797 
This study 
AMp945 pDEST-PGK1-MBP PGK1 from AMp935 
cloned into AMp798 
This study 
AMp949 pDEST-KAR2-GST KAR2 from AMp942 
cloned into AMp796 
This study 






Name Description Origin 
AMp950 pDEST-KAR2-INT KAR2 from AMp942 
cloned into AMp797 
This study 
AMp951 pDEST-KAR2-MBP KAR2 from AMp942 




GBP-mRFP amplified from 
AMp934 and cloned into 




Table 2. 6. 1 (Continued): Plasmids used in this study. 
 
2.6.2 E. coli plasmid mini-prep 
GTE solution:    50 mM glucose 
     10 mM EDTA 
     25 mM Tris (pH 7.5) 
 
Alkaline SDS:    200 mM NaOH 
     1 % (w/v) SDS 
 
High salt buffer:    2.5 M potassium acetate (pH 4.8) 
 
2 ml of LB-Amp was inoculated with E. coli and incubated at 37°C overnight. The 
cells were then spun down at 3000 rpm for 3 mins in a 1.5 ml eppendorf tube 
and the pellet was resuspended in 100 μl of GTE by vortexing. 150 μl of alkaline 
SDS was added and mixed via inversion. 150 μl of cold high salt buffer was then 
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added and mixed via inversion before incubation on ice for 15 mins. The reaction 
was then spun down at 14000 rpm for 5 mins and the supernatant was 
transferred to a new eppendorf containing 900 μl of cold ethanol. The reaction 
was then spun down at 14000 rpm for 5 mins, the pellet was washed with 200 μl 
of 70% ethanol, air dried then resuspended in 50 μl of TE. 
 
2.6.3 Genomic DNA extraction from yeast 
DNA breakage buffer:  2% (w/v) Triton X-100 
     1% (w/v) SDS 
     100 mM NaCl 
     10 mM Tris.HCl (pH 8.0) 
     1 mM EDTA  
 
A toothpick of yeast cells from a solid media plate was suspended in 200 μl of 
DNA breakage buffer in an eppendorf tube, along with a scoop of glass beads and 
200 μl phenol chloroform. The mixture was vortexed for 1-2 min and then spun 
down at 14000 rpm for 5 mins. The upper aqueous layer was transferred to a 
new eppendorf containing 1 ml of cold ethanol. The reaction was mixed via 
inversion then spun down at 14000 rpm for 5 mins. The supernatant was 
discarded and the pellet was air dried then suspended in 50 μl of TE.   
 
2.6.4 Agarose gel electrophoresis 
TAE buffer:     40 mM Tris 
     1 mM EDTA 
     0.11% (v/v) acetic acid 
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1% (w/v) agarose gels were used to analyse DNA with ethidium bromide 
staining.  Agarose was dissolved in TAE buffer by microwaving. After cooling, 
ethidium bromide was added to the gel at a final concentration of 0.5 μg/ml. DNA 
samples were mixed with 1 x Orange G DNA loading buffer (NEB) and run at a 
voltage of 90-140 V. 1 kb DNA ladder (NEB) was ran alongside samples to 
determine band sizes. DNA was visualised using a UV transilluminator system.  
 
2.6.5 PCR 
PCR was performed using a Bio-Rad DNAEngine Thermal Cycler. 
 
2.6.5.1 Polymerase Chain Reaction 
10x PCR buffer:    100 mM Tris-HCl (pH 8.3) 
     500 mM KCl  
     20 mM MgCl2 
     0.1% (w/v) gelatin 
 
PCR reaction:    10-500 ng template DNA 
     1 μM of each oligonucleotide primer 
     0.2 mM dNTPs  
     1x PCR buffer 
     DNA polymerase 
     Sterile distilled water   
   
For most applications, Taq polymerase purified in the lab was used. For 
reactions where sequence fidelity was essential, ExTaq DNA polymerase 
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(TaKaRa) was used with 10x PCR buffer and dNTPs provided by the 
manufacturer. PCR programmes varied depending on the size of the expected 
product and the annealing temperature of primers used (Fig. 2. 6. 5. 1). 
Segment Cycles Temperature Time 





95°C 30 secs 
55°C 30 secs 
72°C 1 min/kb 
3 1 72°C 5 mins 
4 1 10°C forever 
Table 2. 6. 5. 1: Template PCR programme.  
 
2.6.5.2 Yeast colony PCR 
A fraction of yeast colony DNA was added to 0.2 ml PCR tubes containing 20 µl of 
PCR reaction. PCR programmes varied depending on the annealing temperature 








Segment Cycles Temperature Time 





95°C 30 secs 
55°C 30 secs 
72°C 1 min 
3 1 72°C 5 mins 
4 1 10°C forever 
Table 2. 6. 5. 2: Colony PCR programme.  
 
2.6.6 Cloning 
2.6.6.1 Restriction digest 
Restriction digests were performed using NEB restriction enzymes and buffers 
according to manufacturer's instructions. Digests were subject to agarose gel 
electrophoresis to quickly confirm the identity of plasmids.  
 
2.6.6.2 Gateway® cloning 
Genes desired for cloning were amplified using PCR with primers to introduce 
attB flanking regions (Section 2. 6. 5. 1). PCR products were inserted into Donor 
Vector AMp795 using Gateway® Cloning kit containing BP ClonaseTM following 
manufacturer's instructions. BP reactions were transformed into DH5α cells via 
electroporation (Section 2. 2. 5). Entry clones were isolated from E. coli via mini-
prep reactions (Section 2. 6. 2). Genes were transferred into destination vectors 
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AMp796-798 containing epitope tags using LR ClonaseTM following 
manufacturer's instructions. 
 
2.6.6.3 Sequencing  
Sequencing reaction:   1-2 µl mini-prep DNA 
     2 µl Big Dye v3.1   
     0.5 µl primer (5 μM) 
     2 µl 5x Big Dye buffer 
     3.5-4.5 μl sterile water  
DNA samples were sequenced using the Big Dye Terminator kit v3.1 (Applied 
Biosystems; Table 2. 6. 6. 3) and analysed by GenePool (Edinburgh Genomics 
Sequencing Service, University of Edinburgh) on a ABI 3730 DNA analyser.  
Segment Cycles Temperature Time 





95°C 30 secs 
55°C 15 secs 
60°C 4 mins 
3 1 72°C 5 mins 
4 1 10°C forever 
















Cdc14 is not essential for cyclin 










3. Cdc14 is not essential for cyclin degradation during meiosis I 
3.1 Introduction 
Key eukaryotic cell cycle events, such as DNA replication and chromosome segregation, 
are driven by cyclin-dependent kinases (CDKs) (reviewed by Morgan 1997).  In budding 
yeast, a single CDK, Cdc28, is activated through binding to different stage-specific 
cyclins. Progression of cells through S-phase and M-phase requires activation of Cdc28 
by Clb1-Clb6 cyclins (Richardson, Lew et al. 1992, Schwob and Nasmyth 1993) whereas 
in G1 phase Cdc28 associates with Cln1-3 cyclins (Richardson, Wittenberg et al. 1989). 
Exit from mitosis is achieved through the inactivation of Clb-CDKs, creating permissive 
conditions for Cln-CDK activities and enabling cells to enter G1 (Amon, Irniger et al. 
1994).  
 
 The protein phosphatase Cdc14 is essential for mitotic exit in budding yeast (Visintin, 
Craig et al. 1998). Cdc14 accomplishes mitotic CDK down-regulation through Clb 
proteolysis and activation of the CDK inhibitor, Sic1 (Jaspersen, Charles et al. 1998, 
Visintin, Craig et al. 1998, Zachariae, Schwab et al. 1998). It also reverses CDK-
dependent phosphorylation (Bremmer, Hall et al. 2012), thus resetting the cell for the 
next round of DNA duplication. 
 
One hallmark of CDK inactivation is spindle disassembly (Woodruff, Drubin et al. 2012). 
Cdc14 activates the anaphase-promoting complex (APC) through dephosphorylation of 
the regulatory subunit, Cdh1. In addition to initiating cyclin proteolysis, APC-dependent 
degradation of microtubule-stabilising proteins occurs. Degradation of spindle 
regulators, such as Ase1 (Juang, Huang et al. 1997), Fin1 (Woodbury and Morgan 2007)  
and Cin8 (Hildebrandt and Hoyt 2001, Roccuzzo, Visintin et al. 2015),  results in 
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microtubule depolymerisation and disassembly of the mitotic spindle . Incomplete 
spindle disassembly in mitosis inhibits the subsequent assembly of spindles in the 
following cell cycle (Woodruff, Drubin et al. 2012).   
 
The activity of protein phosphatase Cdc14 is tightly regulated during mitosis through 
differential subcellular localisation (Shou, Seol et al. 1999, Visintin, Hwang et al. 1999). 
During prophase and metaphase, Cdc14 is rendered inactive through binding to the 
inhibitor Cfi1/Net1 in the nucleolus. Upon anaphase onset, Cdc14 is released from 
nucleolar sequestration allowing it to dephosphorylate substrates and thereby enable 
mitotic progression. This nucleolar release is achieved through the phosphorylation of 
Cfi1/Net1 (Shou, Azzam et al. 2002, Yoshida and Toh-e 2002), which reduces its affinity 
for Cdc14.  
 
Two distinct but interacting pathways regulate the release of Cdc14 in anaphase; the 
Cdc14 early anaphase release (FEAR) network and the Mitotic Exit Network (MEN). 
FEAR promotes the transient release of Cdc14 in early anaphase, promoting spindle 
stability, spindle elongation and activation of MEN (Pereira, Manson et al. 2002, 
Stegmeier, Visintin et al. 2002, Marston, Lee et al. 2003, Higuchi and Uhlmann 2005, 
Mohl, Huddleston et al. 2009). In late anaphase, MEN activation provides a complete 
and sustained release of Cdc14 that drives mitotic exit (Jaspersen, Charles et al. 1998, 
Shou, Seol et al. 1999, Azzam, Chen et al. 2004, Queralt, Lehane et al. 2006).    
 
 During meiosis, Cdc14 is released from nucleolar sequestration in anaphase I through 
activation of FEAR but not MEN (Kamieniecki, Liu et al. 2005, Attner and Amon 2012).  
MEN is in fact dispensable for meiosis I exit, suggesting that FEAR alone is sufficient for 
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anaphase I spindle disassembly (Marston, Lee et al. 2003). CDK activity must be 
reduced to a sufficient level to allow meiosis I spindles to disassemble. However, 
complete CDK inactivation would be expected to cause relicensing of DNA origins of 
replication. It is believed that meiotic CDKs are only partially down-regulated to prevent 
an intervening S-phase from occurring between meiosis I and meiosis II (Bizzari and 
Marston 2011). After meiosis I spindle breakdown, Cdc14 is then re-sequestered in 
metaphase II before a second release occurs in anaphase II (Bizzari and Marston 2011). 
Both FEAR and MEN activity in anaphase II ensures the complete inactivation of meiotic 
cyclin-CDKs and exit of cells from meiosis II (Attner and Amon 2012).    
 
In a cdc14-1 mutant at the restrictive temperature, Cdc14 is present in cells but the 
phosphatase allele is largely inactive (Marston, Lee et al. 2003).  Impairment of Cdc14 
activity during meiosis results in cells undergoing a single meiotic division, where 
homologous chromosomes are segregated normally on an anaphase I spindle (Sharon 
and Simchen 1990, Bizzari and Marston 2011). Tetranucleate cells are not formed. 
Initial analysis of fixed cells from poorly synchronised populations observed an 
increased fraction of cells with long spindles resembling anaphase I (Marston, Lee et al. 
2003), suggesting a problem with anaphase I spindle breakdown. Later, live cell 
imagining revealed that anaphase I spindles do disassemble in cdc14-1 mutants but 10-
15% of cells then re-fuse nuclei and segregate sister chromatids on a single anaphase II 
spindle (Marston, Lee et al. 2003, Bizzari and Marston 2011). This leads to production 
of binucleate cdc14-1 cells where some chromosomes have undergone a meiosis I-like 
segregation and others have undergone a meiosis II-like segregation.  This mixed 
segregation phenotype is also observed when Cdc14 release is inhibited in anaphase I, 
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as is seen when FEAR components SLK19 and SPO12 are deleted (Marston, Lee et al. 
2003). 
 
Even though cdc14-1 mutants are unable to assemble two meiosis II spindles and 
commit only a single nuclear division, a number of molecular events indicative of two 
rounds of chromosome segregation still occur. Pds1, the inhibitor of separase, 
undergoes two rounds of accumulation and degradation (Bizzari and Marston 2011). 
Cohesin subunit Rec8 is also lost from chromosomes in a stepwise manner 
(Kamieniecki, Shanks et al. 2000). It is therefore unclear what role Cdc14 plays in the 
transition between meiosis I and meiosis II. I set out to address this question, taking 
cues from what is known of Cdc14 function during mitosis. 
 
I hypothesise that Cdc14 enables the partial down-regulation of meiotic CDK activity 
during the meiosis I-meiosis II transition. This hypothesis predicts that during late 
meiosis I, inactivation of Cdc14 would prevent CDK inactivation. The effect of Cdc14 on 
CDK down-regulation can be monitored through cyclin proteolysis. Inactivation of 
Cdc14 would lead to stabilisation of cyclins whereas early activation of Cdc14 would 
result in premature cyclin degradation. Spindle disassembly would also be affected if 
CDK inactivation were inhibited. Whilst Cdc14 is not required for spindle breakdown in 
meiosis (Bizzari and Marston 2011), a delay in anaphase I spindle disassembly could 
affect the subsequent assembly of a second meiosis II spindle perhaps through 
sequestration of tubulin monomers or by throwing meiosis out of synchrony.  This 
could perhaps explain why a fraction of cdc14-1 cells separate sister chromatids on a 




3.2 Results  
3.2.1 Rate of spindle disassembly is significantly affected when Cdc14 activity is 
impaired 
To ascertain whether Cdc14 is required for timely breakdown of anaphase I spindles, I 
monitored spindle disassembly in live cells during meiosis. Pds1 degradation was used 
as a marker for entry into anaphase I. The time taken for the meiosis I spindle to 
completely disassemble after Pds1 proteolysis was measured in individual cells. In the 
wild type example (Fig. 3. 2. 1A), meiotic spindles break down 40 mins after entry into 
anaphase I. Following this, metaphase II spindles assemble. Pds1-tomato does not 
accumulate in live cells during prophase II. This observation is consistent with findings 
made previously using Pds1-tdTomato and Pds1-RFP constructs, and is believed to be 
due to a delay in fluorophore maturation (Katis, Lipp et al. 2010, Miller, Unal et al. 2012, 
Nerusheva, Galander et al. 2014).   
 
 In ~82% of cdc14-1 cells, anaphase I spindles break down and a new spindle does not 
assemble (Fig. 3. 2. 1A). Similarly, slk19Δ and spo12Δ cells, which retain Cdc14 in the 
nucleolus (Stegmeier, Visintin et al. 2002, Marston, Lee et al. 2003), disassemble 
anaphase I spindles with a timing comparable to wild type cells. The individual rates of 
spindle disassembly for >67 cells were compiled to calculate a mean rate for all four 
strains (Fig. 3. 2. 1B). On average, wild type cells took 45.7 ± 2.32 mins to completely 
disassemble anaphase I spindles. In cdc14-1 cells, a modest increase in the time taken to 
disassemble spindles (52.2 ± 1.97 mins) is observed. This increase is statistically 
significant (p=0.04). However, deletion of SLK19 and SPO12 also do not affect spindle 
breakdown timing, with mean rates of 43.8 ± 4.06 mins and 41.9 ± 2.86 mins 
respectively. These rates are not statistically significant from wild type cells (p=0.73 
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and 0.41).  Taken together, this data suggests that the release of active Cdc14 may play a 
role in the timely disassembly of meiosis I spindles but by a FEAR-independent 






3.2.2 Aberrant spindle dynamics observed upon deletion of FEAR components 
From the quantification of spindle disassembly in live cells, a number of outliers were 
present in both slk19Δ and spo12Δ cell populations. This is reflective of the dynamic 
nature of the meiotic spindle in FEAR mutants. The cells that entered meiosis were 
further categorised. As noted earlier, many cdc14-1, slk19Δ and spo12Δ mutants (82%, 
57% and 39% respectively) disassemble anaphase I spindles, leaving two Tub1-GFP foci 
that do not extend microtubules (Fig. 3. 2. 2). However, 14% of cdc14-1 cells do extend 
microtubules and elongate a second meiosis I-like spindle. This phenotype is 
emphasized further in the FEAR mutants, with 27% and 53% of cells respectively 
reassembling spindles after the initial anaphase I spindle breakdown (Fig. 3. 2. 1A & Fig. 
3. 2. 2). A further 4-16% of FEAR mutants display multiple rounds of microtubule 
elongation and collapse on the same spindle before spindle disassembly.    
 
The fact that microtubules undergo several round of elongation then collapse in FEAR 
mutants prior to spindle disassembly indicates that Cdc14 may be required for 
stablilisation of meiotic spindles. This is concurrent with mitotic data, where Cdc14 has 
been shown to dephosphorylate the kinetochore component Ask1 in anaphase, which 
contributes to the silencing of microtubule turnover (Higuchi and Uhlmann 2005). 
However, since spindle disassembly is only slightly delayed upon Cdc14 inactivation, it 















3.2.3 Cyclin proteolysis in meiosis is not dependent on Cdc14 activity  
To determine whether Cdc14 is required for CDK down-regulation at the meiosis I-
meiosis II transition, cyclin protein levels were measured throughout meiosis. During 
meiosis, Cdc28 is activated through binding to several different meiotic cyclins (Fig. 3. 2. 
3). These different CDK complexes are regulated either by protein degradation or 
posttranslational mechanisms, which confine their activity to specific stages in meiosis 
(Bloom and Cross 2007, Carlile and Amon 2008). 
 
Clb1-CDK activity is restricted to meiosis I, despite Clb1 protein persisting in cells until 
exit from meiosis II (Fig. 3. 2. 3). A slower migrating form of Clb1, believed to be 
phosphorylated Clb1 (Tibbles, Sarkar et al. 2013), is associated with Clb1-CDK activity 
and is evident in meiosis I indicating that a posttranslational modification other than 
protein degradation inhibits Clb1-CDK activity (Carlile and Amon 2008). Clb3-CDK 
activity is meiosis II-specific. Clb3 protein is confined to meiosis II through translational 
control (Carlile and Amon 2008). Clb4-CDK activity is down-regulated after metaphase 
II through an unknown mechanism, whilst Clb5-CDK activity is correlated to Clb5 
protein abundance (Carlile and Amon 2008). 
 
If Cdc14 phosphatase is required for partial down-regulation of CDKs at the meiosis I to 
meiosis II transition, its inactivation would lead to stabilisation of meiotic cyclins. I 
decided to analyse the levels of each individual cyclin throughout meiosis in wild type 












3.2.3.1 Production of polyclonal antibodies for Pgk1 and Kar2 loading controls to 
allow quantification of target protein levels  
Accurate quantification of cyclin protein levels required a new approach for Western 
blot analysis. Enhanced chemiluminescence (ECL) is a common technique used for the 
detection of biomolecules on Western blots. A protein of interest is identified through 
labelling an immunoglobin, which specifically recognizes the molecule, with 
horseradish peroxidase (HRP) (Towbin, Staehelin et al. 1979). The enzyme complex 
catalyzes the oxidation of a commercially available enhanced chemiluminescent 
substrate. This reaction emits a light that is detectable by exposure of photographic film, 
the intensity of which is indicative of HRP activity and therefore protein abundance.   
 
Whilst ECL can enable the generation of clear and reliable data, the technique has a 
number of drawbacks (LiCor Biosciences 2015). Firstly, numerous exposures are 
typically required to capture optimal protein signals and avoid saturation to film. For 
multiplex detection, where multiple protein targets are detected, the membrane must 
be stripped and re-probed. Quantification and direct comparison of biomolecules is 
consequently imprecise. Finally, signal stability is usually restricted to ~30 minutes, 
after which time the signal begins to fade. This short duration can make comparisons 
between multiple membranes processed consecutively less accurate.  
 
LiCor® has developed the Odyssey Sa system, which utilizes fluorescence detection of 
biomolecules (LiCor Biosciences 2015). The secondary antibody is labelled with a near-
infrared (NIR) fluorescent dye. Membranes are scanned using Odyssey software to 
detect fluorescent molecules bound to the target. Signal intensity is indicative of protein 
abundance. NIR - fluorescence detection is preferable to ECL for a number of reasons. It 
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is cheaper, gives greater signal sensitivity, allows for both weak and strong signals to be 
detected on the same membrane with minimized saturation and is a direct detection of 
target proteins instead of the HRP signal from which depends on enzyme activity. The 
greatest benefit of fluorescence over chemiluminescence is the ability to detect two 
target proteins simultaneously on the same membrane, eliminating the need to strip 
and re-probe. This provides increased accuracy of quantification and comparison.  
 
Loading controls are essential for correct Western blot analysis. By measuring the level 
of protein loading, the abundance of a target protein can be calibrated. If both protein of 
interest and loading control are detected on the same membrane, this normalization can 
be more precise.  In order to employ multiplex detection and quantification, target 
protein and loading control must be recognized by primary antibodies that have been 
produced from different organisms. LiCor® secondary antibodies labelled with 
divergent fluorescent dyes can then be used to identify the different proteins via two-
colour detection.  Since the majority of target proteins regularly used in the laboratory 
are recognized by mouse-generated antibodies, the antibodies specific to loading 
controls need to be generated from a different organisms. 
 
I set out to generate polyclonal antibodies specific for Pgk1 and Kar2 in rabbits. These 
loading controls were chosen as previous experiments have shown that their levels do 
not change significantly during the cell cycle or meiosis (Clift, Bizzari et al. 2009, Bizzari 
and Marston 2011).  
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3.2.3.1.1 Cloning and expression of tagged recombinant Pgk1 and Kar2 in E. coli 
derivative BL21 cells 
I tagged Pgk1 and Kar2 with a number of different affinity tags in order to determine 
which clone would give optimal expression and purification levels. Glutathione-S-
transferase (-GST), Intein (-INT) and Maltose binding protein (-MBP) tags were 
attached to the C-termini of Pgk1 and Kar2 through Gateway Cloning. Clones were 
sequenced, to confirm no mutations had been introduced into the genes, and 
transformed into BL21 cells. Since recombinant proteins often show large variability in 
expression levels and solubility, a small-scale expression test was carried out to 
determine which derivative clone should be purified (Fig. 3. 2. 3. 1. 1). Protein 
expression was induced by addition of 1mM IPTG, and cells were lysed with benzonase 
to degrade nucleic acids in purified protein samples. Soluble and insoluble fractions 
were run against a non-induced fraction to compare protein expression levels.  
 
Over-expression of Pgk1-GST (~71kDa), Pgk1-MBP (~87kDa), Kar2-GST (~100kDa) 
and Kar2-MBP (~116kDa) was evident predominately in the insoluble fraction lanes 
(Fig. 3. 2. 3. 1. 1). INT-fusion proteins achieved poor levels of expression and so were 















3.2.3.1.2 Purification of Inclusion Bodies 
Inclusion bodies (IB) are in vivo protein aggregates formed during protein folding, 
commonly associated with over-expression of recombinant proteins (Fink 1998). It is 
unclear whether the proteins contained within IBs resemble native forms or are the 
result of mis-folding. There is evidence to suggest that proteins may partially retain 
their native structures (Tsumoto, Umetsu et al. 2003, Umetsu, Tsumoto et al. 2005). 
However, since the recombinant proteins are only required as antigens for the 
generation of polyclonal antibodies, protein solubility and correct protein folding are 
not essential.   
 
I prepared IBs from the bacterial strains containing Pgk1-GST, Pgk1-MBP, Kar2-GST and 
Kar2-MBP. Dilutions of IB samples were compared to known BSA standards in order to 
determine protein concentration (Fig. 3. 2. 3. 1. 2).  Results suggest that total Pgk1-GST 
and Kar2-GST purified in IB fractions were ~ 70mg and ~ 18mg respectively. Both 
















3.2.3.1.3 Generation of Pgk1 and Kar2 polyclonal antibodies 
Purified Pgk1-GST and Ka2-GST antigens were injected into pre-screen rabbits R3285-
R3288 (Fig. 3. 2. 3. 1. 3A). Production of Pgk1 and Kar2 antibodies by host rabbits were 
monitored in sera isolated from animals prior to each immunization. Final 
exsanguinations of rabbit revealed each antiserum contained polyclonal antibodies 
specific to Pgk1 and Kar2 loading controls (Fig. 3. 2. 3. 1. 3A).   
 
Simultaneous detection of two targets is now achievable. Mps3-6HA and loading 
controls are recognised by primary antibodies isolated from mice and rabbits, 
respectively. Secondary LiCor® antibodies labelled with spectrally distinct IRDye 
fluorescent dyes specifically bind to these antigens and are detected in independent 
fluorescent channels 700nm and 800nm (Fig. 3. 2. 3. 1. 3B).  αMouse secondary and 
αKar2 shows a slight cross-reactive band of the expected size for Kar2 but in the 800nm 
channel. However, this is extremely faint with respect to the band observed in the 
700nm channel. Ultimately, Pgk1 and Kar2 antibodies proved successful for utilisation 






3.2.3.2 Analysis of cyclin degradation in meiosis using multiplex Western blotting 
To investigate the role of Cdc14 in meiotic cylin degradation, the protein levels of each 
Clb was analysed individually during meiosis. The role of Cdc14 in Clb1 degradation had 
previously been reported by (Bizzari and Marston 2011). Their findings indicate that 
ectopic release of Cdc14 does not lead to premature degradation of Clb1. Furthermore, 
they showed that the slower migrating form of Clb1, observed only in meiosis I and 
associated with Clb1-CDK activity (Carlile and Amon 2008),  correlated with nuclear 
localisation of Clb1.  Localisation of Clb1 was unaffected when Cdc14 activity was 
impaired, suggesting that the posttranslational mechanism regulating Clb1-CDK activity 
was not dependent of Cdc14 function.  
 
I repeated this experiment and validated these findings. Cdc14 is not required for the 
formation of a slower migrating form of Clb1 in meiosis I. As metaphase I spindles form 
in both wild type and cdc14-1 cells, unmodified Clb1 is detected. The appearance of the 
slower migrating form of Clb1 correlates with the appearance of anaphase I spindles in 
both strains. Cdc14 activity is also not a requisite for proteolysis of Clb1, which occurs 
in both wild type and cdc14-1 cells when meiotic spindles disassemble (Fig. 3. 2. 3. 2A). 
Similarly, early release of Cdc14 in cdc55mn cells does not result in premature 
degradation of Clb1. Instead, accumulation of the slow migrating form of Clb1 is 
observed. As meiotic spindles do not assemble in cdc55mn cells, the timing of Clb1 
appearance is difficult to determine. However, early release of Cdc14 does not appear to 
inactivate nor degrade Clb1 as is predicted by my earlier hypothesis. 
 
Clb3-CDK activity is restricted to meiosis II through translational control of CLB3 
transcription (Carlile and Amon 2008). I confirmed that Clb3 is only observed in wild 
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type cells during meiosis II. Clb3 is then degraded when cells exit meiosis II (Fig. 3. 2. 3. 
2B). When Cdc14 activity is impaired, the timing of Clb3 accumulation and degradation 
appears unaffected. Early activation of Cdc14 in cdc55mn cells also does not elicit 
premature Clb3 degradation, excluding the probability that Cdc14 is required for Clb3 
proteolysis. 
  
Clb4 and Clb5 protein degradation during spindle disassembly appears unaffected by 
inactivation of Cdc14 (Fig. 3. 2. 3. 2C-D). Likewise, neither Clb4 nor Clb5 is degraded 
early when Cdc14 is released prematurely from the nucleolus. Thus, Cdc14 activity is 
not essential for Clb4 and Clb5 degradation. 
 
This data suggests that the main role of Cdc14 at the meiosis I- meiosis II transition is 
not to regulate cyclin proteolysis. However, western blot analysis of cdc14-1 mutants 
does seem to show evidence of Clb1 and Clb 3 proteins persisting in cells later than is 
observed in wild type cells, albeit at greatly reduced levels. Cdc14 may, therefore, be 












3.2.3.2.1 Quantification of meiotic cyclin levels 
To further assess degradation of cyclins in meiosis, the immunoblots generated in Fig. 3. 
2. 3. 2A-D can be analysed through quantification of protein signal. Relative meiotic 
cyclin levels were determined through quantification of each Clb signal, normalising 
these values against the respective loading control signal. The proteolysis of cyclins in 
wild type and cdc14-1 cells can be compared to identify if inactivation of Cdc14 prevents 
the complete destruction of cyclins. 
 
From qualitative western blot analysis alone, Clb1 and Clb3 proteins appear to persist 
in cdc14-1 cells longer than is observed in wild type cells (Fig. 3. 2. 3. 2A,C). However, 
when the relative abundances of meiotic cyclins were plotted, it is clear that Clb1, Clb3, 
Clb4 and Clb5 values all decrease in cdc14-1 mutants to levels comparable to wild type 
cells (Fig. 3. 2. 3. 2. 1).  The timing of Clb1 and Clb3 proteolysis appears delayed by 
~30mins when Cdc14 activity is impaired. However, delayed entry of these cells into 
meiosis, as is illustrated by cdc14-1 spindle morphology (Fig. 3. 2. 3. 2A-B), could 
explain this postponement in cyclin degradation. Clb4 abundance may be reduced when 
Cdc14 is inactivated but the pattern of Clb4 quantification does not seem affected (Fig. 
3. 2. 3. 2. 1). Cdc14 is, therefore, unlikely to be involved in cyclin degradation.  
 
To further test whether Cdc14 is required for cyclin degradation, the abundance of 
meiotic cyclins in cdc55mn cells were quantified. If Cdc14 were required for cyclin 
proteolysis in meiosis, early release of Cdc14 would lead to premature degradation of 




Clb1, Clb3 Clb4 and Clb5 proteins are not reduced ahead of wild type cells when Cdc14 
is released from inhibition early (Fig. 3. 2. 3. 2. 1). On the contrary, cyclin levels appear 
increased in cdc55mn mutants with respect to wild type and cdc14-1 cells late in 
meiosis. This finding is consistent with previous data (Bizzari and Marston 2011).  
There is a slight delay in the appearance of Clb1 and Clb3 protein in cdc55mn cells with 
respect to wild type and cdc14-1 cells. However, as noted previously, due to a lack of 
meiotic spindle formation it is difficult to accurately determine the timing of meiosis in 
these mutants. Since cyclin levels are not prematurely degraded, it is likely that the 
spindle assembly defect observed in cdc55mn mutants is not due to failure of cells to 










In mitosis, differential binding of the ubiquitin ligase to two activators regulates 
APC-dependent proteolysis of cyclins, Cdc20 and Cdh1. APCCdc20 is active when 
mitotic CDK activity is high in early anaphase (Yeong, Lim et al. 2000). Upon 
initial cyclin degradation and subsequent CDK down-regulation, APCCdh1 
becomes activated in late anaphase to carry out complete cyclin degradation 
(Visintin, Prinz et al. 1997). Cdh1 activation is believed to be a result of MEN-
mediated release of Cdc14 (Jaspersen, Charles et al. 1998, Visintin, Craig et al. 
1998). Since MEN is not active during the meiosis I-meiosis II transition 
(Kamieniecki, Lu et al. 2005), I hypothesised that Cdc14 activation in anaphase I 
enabled the partial but not complete down-regulation of meiotic CDK activity.    
 
To test this theory, I investigated the role of Cdc14 on timely spindle 
disassembly, a marker of CDK down-regulation, and on cyclin proteolysis. I 
discovered that Cdc14 activity did have a minor effect on the timely breakdown 
of the anaphase I spindle. However, cyclin degradation occurred independent of 
Cdc14 activity. These observations led me to reject the initial hypothesis. 
Instead, Cdc14 must play another role in regulating the meiosis I-meiosis II 
transition.      
 
Whilst it is possible that Cdc14 may down-regulate CDK activity through another 
mechanism other than cyclin degradation, it is doubtful. Clb3-CDK and Clb5-CDK 
activities correlate to cyclin protein abundance (Carlile and Amon 2008) and 
neither is greatly affected by Cdc14 inactivation. Clb1-CDK activity is associated 
with the slow migrating form of the cyclin (Carlile and Amon 2008, Bizzari and 
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Marston 2011). This modified form of Clb1 is still present in cdc14-1 cells during 
meiosis I. Finally, although the mechanism that regulates Clb4-CDK activity has 
yet to be identified (Carlile and Amon 2008), Clb4-CDK down-regulation occurs 
during meiosis II. It is, therefore, unlikely that Cdc14 is essential for Clb4-CDK 
inhibition at meiosis I exit.   
 
Surprisingly, ectopic release of Cdc14 led to stabilisation, not premature 
degradation, of meiotic cyclins. This is further evidence against the hypothesis 
that Cdc14 is required for cyclin proteolysis.  Since spindle assembly is inhibited 
when Cdc14 is active early in meiosis, the majority of kinetochores are not 
attached to microtubules in cdc55mn cells. As a result, the spindle assembly 
checkpoint (SAC) is likely activated. SAC activation blocks anaphase entry 
through inhibition of the APC. Cyclins degradation is inhibited to prevent further 
progression through meiosis (Musacchio and Hardwick 2002). Deletion of a SAC 
component, such as Mad1 or Mad2, could help investigate this further.    
 
An alternative mechanism proposed for uncoupling DNA replication and spindle 
formation events in meiosis, other than Cdc14-dependent partial down-
regulation of CDKs, is through the activity of an auxiliary kinase. Ime2 has been 
shown to phosphorylate CDK substrates, including Cdh1 and CDK inhibitor Sic1, 
but at distinct sites that are resistant to Cdc14-dependent dephosphorylation 
(Holt, Hutti et al. 2007). Ime2 activity may consequently prevent DNA re-
replication and complete cyclin degradation during meiosis independent of 
Cdc14 activity. This could explain why impairment of Cdc14 activity showed 




If Cdc14 does not regulate the meiosis I-meiosis II transition through cyclin 
degradation, it may be required to dephosphorylate CDK-dependent substrates. 
Reversal of CDK-dependent phosphorylation is necessary to reset the cell for a 
new round of nuclear division (Manzoni, Montani et al. 2010). Potential meiotic 
substrates of Cdc14 need to be identified in order to discern why impairment of 
















Cdc14 is required for re-












4. Cdc14 is required for reduplication of SPBs after meiosis I  
4.1 Introduction 
Since Cdc14 does not appear to regulate the meiosis I to meiosis II transition 
through degradation of meiotic cyclins, it may be required for the reversal of 
CDK-dependent phosphorylation. In mitosis, Cdc14 dephosphorylates CDK 
substrates to reset the cell in preparation for the following round of cell division 
(Visintin, Craig et al. 1998). Upon completion of meiosis I, meiotic CDK targets 
will presumably also need resetting to restore them to their initial 
phosphorylation states, enabling cells to enter a second meiotic division. The 
phosphatase Cdc14 may be acting likewise during meiosis to oppose CDK 
phosphorylation. 
 
Global analysis of Cdc14 targets in mitotic cells identified several SPB 
components as Cdc14 associated proteins (Bloom, Cristea et al. 2011, Kao, Wang 
et al. 2014). Following meiosis I, SPBs must be re-duplicated to undergo a second 
meiotic division. In this chapter, I hypothesise that Cdc14 acts on the SPBs to 
allow the assembly of duplicated meiosis II spindles, thereby ensuring the 
production of tetranucleate cells.   
 
The spindle pole body (SPB) is the microtubule organising centre in budding 
yeast, functionally comparable to the centrosome in higher eukaryotes (Moens 
and Rapport 1971, Byers and Goetsch 1974). It consists of at least 19 different 
components assembled into an organised structure, which is embedded in the 
nuclear envelope and interacts with cytoplasmic and nuclear microtubules via 
the γ-tubulin complex (Jaspersen and Winey 2004). The SPB is highly 
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phosphorylated (Wigge, Jensen et al. 1998), and a number of its components 
contain multiple consensus Cdc28-phosphoryltaion sites (Ubersax, Woodbury et 
al. 2003). Phospho-regulation of the SPB has been shown to affect SPB assembly 
(Adams and Kilmartin 1999),  microtubule nucleation (Vogel, Drapkin et al. 
2001) and SPB duplication (Vallen, Ho et al. 1994, Kilmartin 2003, Avena, Burns 
et al. 2014, Elserafy, Saric et al. 2014).  
 
I hypothesise that, upon release from nucleolar sequestration in anaphase I, 
Cdc14 is required to dephosphorylate SPBs. This dephosphorylation enables re-
duplication of SPBs to allow for the proper segregation of sister chromatids in 
meiosis II. Impairment of Cdc14 activity would therefore result in hyper-
phosphorylated SPBs that are unable to re-duplicate after meiosis I. This could 
explain why cdc14-1 mutants are unable to properly assemble two meiosis II 





4.2.1 Cdc14 interacts with SPBs when released from the nucleolus 
To understand how Cdc14 regulates the meiosis I to meiosis II transition, I 
sought to identify its substrates during meiosis. I decided to IP Cdc14 from 
meiotic cells. Since Cdc14 is bound to its inhibitor, Cfi1, in the nucleolus for the 
majority of the cell cycle, I also performed the IP in cdc55mn cells. Upon 
depletion of Cdc55 from cells, the Cdc14-Cfi1/Net1 association is inhibited and 
Cdc14 is ectopically released from the nucleolus (Bizzari and Marston 2011, 
Kerr, Sarkar et al. 2011). Therefore, I anticipated that Cdc14 substrates would be 
enriched in this IP. 
131 
 
4.2.1.1 Cdc14 immunoprecipitates with all SPB components when released 
for Cfi1/Net1 
I immunoprecipitated Cdc14-TAP (tandem affinity purification tag) (Rigaut, 
Shevchenko et al. 1999) in wild type and cdc55mn cells harvested in anaphase I. 
Meiotic progression was monitored by counting binucleate and tetranucleate cell 
populations (Fig. 4. 2. 1. 1A). Cells were harvested~ 4h after induction in 
sporulation media, where binucleate but not tetranucleate cells were present in 
wild type samples. This ensures that cells have progressed into meiosis I but 
have not completed meiosis II.  The Cdc14-TAP fusion protein retains the meiotic 
functions of the endogenous protein, since there was no dramatic change in 
nuclear division efficiency or timing during meiosis (Fig. 4. 2. 1. 1A).   
 
SDS-PAGE analysis and silver staining of immunoprecipitates (Fig. 4. 2. 1. 1B) 
reveals a band corresponding to Cdc14-TAP (~82kDa) in both tagged-strain 
lanes but, crucially, was absent from both no-tag control lanes. This indicates 
that Cdc14-TAP is enriched in these lanes.  Another band, approximately the 
expected height for Cfi1/Net1 (129~kDa), was present in the wild type IP 
sample. Cfi1/Net1 band intensity was greatly reduced in cdc55mn cells. This 
observation is in agreement with the phenotype of cdc55mn mutants, where 
Cdc14-Cfi1/Net1 binding is inhibited (Kerr, Sarkar et al. 2011).  
 
 IP samples were digested with trypsin and mass spectrometry (MS) was 
performed by our collaborators, Flavia Alves and Juri Rappsilber. MaxQuant 
software was used to identify peptides pulled-down with Cdc14.  Compiled MS 
data was sorted by total peptide number. Proteins recognized by comparison to 
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a data set of routinely occurring contaminants were disregarded, as were 
proteins that appeared with high peptide numbers in the no tag control samples 
(Table A1- page 223). 
 
As expected, both Cdc14 and Cfi1 were identified in Cdc14-TAP pulldowns from 
wild type and cdc55mn cells (Fig. 4. 2. 1. 1C). Interestingly, the number of Cfi1 
peptides was reduced in cdc55mn cells compared to wild type, from 43 to 29 
peptides. Although this is not quantitative, it is consistent with the fact that 
Cdc14 tends to reside outside the nucleolus in cdc55mn cells, as shown by 
imaging methods. 
 
Components of the SPB were highly abundant in both wild type and cdc55mn 
Cdc14-TAP IP samples. This was expected, since greater numbers of Cdc14 
proteins are released from Cfi1/Net1-dependent nucleolar sequestration. In 
depth analysis of SPB constituents confirmed the presence of all proteins from 
the SPB core, the SPB periphery, the half-bridge and γ-tubulin complex (Fig. 4. 2. 
1. 1D). This data suggests that Cdc14 associates with the SPB when released 
from nucleolar sequestration.   
 
During meiosis II, the SPB is modified through replacement of the outer plaque 
component Spc72 with Mpc52, and later Spo21, to initiate spore formation 
(Knop and Strasser 2000). A small number of Mpc52 peptides were identified in 
wild type but not cdc55mn cells, whilst Spo21was not identified in either IP (Fig. 
4. 2. 1. 1D). Cells harvested for use in the IP experiment were not synchronous so 
it is possible that a small fraction of wild type cells entered meiosis II. However, 
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the lack of Mpc52 in cdc55mn mutants suggests that the ectopic release of Cdc14 
may prevent meiosis II-specific modification of the SPB. 
 
Another meiotic specific SPB-associated protein, Ndj1, was identified in both 
wild type and cdc55mn pulldowns (Table A1). Ndj1 has recently been identified 
as a regulator of SPB separation during meiosis, and is absent from SPBs in 
mitosis (Li, Shao et al. 2015). The presence of this protein in cdc55mn samples 



















4.2.1.2 Retention of Cdc14 in the nucleolus reduces Cdc14-SPB interactions 
The association of Cdc14 with the SPB complex in Fig. 4. 2. 1. 1D appears to correlate 
with Cdc14 release from nucleolar sequestration. Retention of Cdc14 by Cfi1/Net1 
should consequently inhibit Cdc14-SPB interactions.     
 
To test this theory, I pulled down Cdc14-TAP in metaphase-arrested cells. During 
metaphase I, Cdc14 is bound to Cfi1/Net1, thus the association of Cdc14 with SPB 
components should be impaired. The metaphase arrest was achieved through 
construction of a Cdc20 meiotic-depletion strain. Cdc20 is an activator of the APC 
(Visintin, Prinz et al. 1997). Depletion of Cdc20 hence results in inhibition of anaphase I 
entry.  
 
Metaphase-arrested Cdc14-TAP IP samples were processed, sent for MS and compiled 
in MaxQuant (Table A2.1 – page 230).  Peptide numbers identified for SPB subunits 
were compared to those observed in the previous IP, where cells were allowed to 
progress in meiosis (Fig. 4. 2. 1. 2). These are termed as "metaphase I" and "meiosis I" 
cells respectively. 
 
 Cdc14 peptide numbers recovered in both wild type samples were comparable 
between the two experiments (Fig. 4. 2. 1. 2). An increase in Cfi1/Net1 peptide numbers 
in the "metaphase I" cells from 43 to 54 peptides may fit well with the idea that Cdc14 
was retained in the nucleolus when entry into anaphase I was prohibited. A clear 
reduction in SPB-Cdc14 association was also evident in these cells, suggesting that 




The number of Cdc14 peptides identified in cdc55mn "metaphase I" cells was slightly 
reduced compared to the wild type situation in the same experiment. Because of this, 
SPB peptide values were normalised in each IP with respect to Cdc14 peptide numbers 
to better compare all the samples across both experiments (Table A2.2). These 
normalised values were then further analysed. 
 
 Ratios of wild type/cdc55mn normalised peptides values showed that a greater number 
of SPB components were enriched in cdc55mn samples when cells were arrested in 
metaphase I than when meiotic progression was permitted (Fig. 4. 2. 1. 2). This hints 
that release of Cdc14 from inhibition is conducive to SPB interaction.  However, the 
total number of SPB peptides pulled-down in cdc55mn cdc20mn cells was considerably 
reduced when compared to those achieved in "meiosis I". This is unanticipated, as the 
metaphase-arrest should not affect early release of Cdc14 from the nucleolus in 
cdc55mn cells.  
 
It is unclear why SPB and Cfi1/Net1 peptide numbers are so diminished in the 
"metaphase I" cdc55mn sample compared to the "meiosis I" IP. One possible explanation 
is that Cdc14 failed to pull-down interactors as effectively in this IP. If that were the 
case, far greater values of SPB peptides would be expected. As a consequence, the 
enrichment of SPB peptides in the cdc55mn sample observed would be further 
emphasised.  
 
Both Cdc14-TAP IP experiments, using metaphase-arrested cells and meiotic-
progressing cells, were performed only once. As such, the MS data generated are not 
quantitative. Furthermore, some SPB peptides are identified in metaphase-arrested 
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wild type cells, where Cdc14 is retained in the nucleolus. However, the data imply that 
enrichment of Cdc14-SPB association likely requires the release of Cdc14 from 









4.2.1.3 Cdc14 localises asymmetrically to SPBs in anaphase I  
Since Cdc14 appears to associate with the SPB when released from inhibitory binding to 
Cfi1/Net1, it is reasonable to expect that Cdc14 localises to SPBs in anaphase I. To 
investigate the localisation of Cdc14 during meiosis, I visualised wild type cells 
undergoing synchronous meiosis after release from prophase I arrest, where Cdc14 was 
tagged with GFP (Cdc14-GFP) and the core SPB component, Spc42, was tagged with 
tdTomato (Spc42-tdTomato). To measure Cdc14 association with the SPB, I quantified 
the amount of Cdc14-GFP signal, normalising Cdc14-GFP signal intensity at the SPB to 
that of Spc42-tdTomato.  Average relative intensity of Cdc14 per SPB was calculated for 
50 cells in each meiotic phase. The meiotic cell cycle stage was determined by the 
analysis of the number and positioning of SPBs, and the nucleolar sequestration state of 
Cdc14. 
 
This analysis showed that, in anaphase I, Cdc14 is significantly enriched at SPBs with 
respect to metaphase I, increasing from 0.08 arbitrary units (a.u) to 0.37 a.u. (Fig. 4. 2. 1. 
3A). This confirms that Cdc14 co-localises with SPBs when released from nucleolar 
sequestration in meiosis I. The SPB-associated pool of Cdc14 observed in anaphase I is 
not detected in metaphase II, and Cdc14-GFP signal reappears in the nucleolus. This 
suggests that Cdc14 at SPBs may be re-sequestered in the nucleolus upon meiosis II 
entry, as evident from the restoration of metaphase I-like Cdc14/SPB relative 
intensities (0.06 a.u.).  
 
Upon anaphase II entry, there is a modest increase in Cdc14-SPB co-localisation during 
this second wave of Cdc14 release. However, the increase observed is not statistically 
significant (p =0.67). This suggests that simply the release of Cdc14 from nucleolar 
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sequestration is not the only mechanisms regulating Cdc14-SPB localisation. As it is the 
meiosis I-meiosis II transitional role of Cdc14 that is of interest, I decided to focus on 
this aspect of Cdc14 localisation and function, and did not further analyse meiosis II.  
 
The images of meiosis I cells were examined further to analyse the localisation of Cdc14 
at the SPB. Cells were categorised as either metaphase I or anaphase I based upon 
release of Cdc14 from the nucleolus and SPB positioning.  The co-localisation of Cdc14 
with SPBs was scored, discriminating between no SPB localisation, localisation to one 
SPB (asymmetric) and localisation to both SPBs (symmetric).         
 
During metaphase I, when Cdc14 is retained in the nucleolus, 98.5% of cells exhibited 
no detectable co-localisation of Cdc14 with SPBs (Fig. 4. 2. 1. 3B). As expected, when 
Cdc14 is released from inhibition, a pool of Cdc14 is evident at SPBs in 97% of anaphase 
I cells.  This is in accord with the Cdc14-SPB quantification data. Strikingly, this 
localisation is predominately asymmetric (Fig. 4. 2. 1. 3B).  
 
Using the same Cdc14-GFP strain, I released cells into a synchronous meiosis and 
imaged the live cells on a microfluidics plate to follow the same cell throughout meiosis. 
It is apparent that the asymmetric localisation of Cdc14 is maintained throughout 
anaphase I (Fig. 4. 2. 1. 3C). The pool of SPB-associated Cdc14 remains only at one SPB 
and there is no evidence of Cdc14 transitioning between the two poles.  
 
It is unclear whether the pool of Cdc14 observed at SPBs is active. However, since Cdc14 







4.2.1.4 Cdc14 localises to SPBs in cdc55mn mononucleate cells 
To determine whether ectopically released Cdc14 prematurely associates with the SPB, 
I analysed Cdc14-GFP localisation in cdc55mn mutants. In meiotic wild type cells, Cdc14 
is released from nucleolar sequestration in anaphase I (Fig. 4. 2. 1. 3A). When Cdc55 is 
depleted in meiosis, Cdc14 prematurely exits the nucleolus prior to SPB separation in 
metaphase I. After 3h in meiosis, 52% of Cdc55-depleted cells show partial or complete 
release of Cdc14 from the nucleolus (Fig. 4. 2. 1. 4A-B).  
 
Cells were grouped into three distinct categories based on their Cdc14 localisation 
phenotype. Group 1 cells retain Cdc14 within the nucleolus and display no detectable 
co-localisation of Cdc14 with SPBs (Fig. 4. 2. 1. 4C). Group 2 cells exhibit a partial 
release of Cdc14. Whilst a portion of the GFP signal is retained in the nucleolus, a diffuse 
cloud of Cdc14 is observed emerging from the nucleolar spot. This released Cdc14 cloud 
co-localises with SPBs in 69% of group 2 cells, although the intensity with which Cdc14 
signal localises to the SPB ranges from a mild to strong association. In group 3 cells, 
Cdc14-GFP signal completely dissipates from the nucleolus. 95% of these cells exhibit 
strong Cdc14-SPB co-localisation (Fig. 4. 2. 1. 4C), indicating that release of Cdc14 from 
the nucleolus correlates with SPB co-localisation.   
 
These findings confirm that the early release of Cdc14 in cdc55mn mutants results in the 
premature localisation of Cdc14 to SPBs, prior to meiosis I.  This is consistent with MS 








4.2.2 Cdc14 plays a role in regulating the SPB duplication pathway 
For cells to properly assemble meiosis II spindles, a total of four SPBs are required. If 
inactivation of Cdc14 prevents or impairs SPB duplication, cdc14-1 cells would not 
contain the appropriate number of SPBs necessary for nuclear division in meiosis II. 
This could explain the mixed segregation phenotype observed when Cdc14 activity is 
inhibited. cdc14-1 mutants might be unable to properly duplicate the machinery 
required for a second chromosome segregation step, and so attempt an equational 
segregation but on a single anaphase I spindle. 
 
To test this hypothesis, the role of Cdc14 in SPB duplication in meiotic cells needed to 








4.2.2.1 Investigating SPB duplication by SPB focus analysis 
To investigate the role of Cdc14 on SPB duplication, I analysed wild type, cdc14-1, 
cdc55mn, slk19Δ, spo12Δ and cdc14-1 cdc55mn cells containing SPC42-tdTomato. Spc42 
is an essential component of the SPB complex (Donaldson and Kilmartin 1996) and, 
consequently, the tomato-tagged construct can be used as a marker for presence of the 
SPB, as was utilised in the Cdc14-SPB localisation experiment (Fig. 4. 2. 1. 3A-C).  I 
released the cells into a synchronous meiosis and counted the percentages of 
binucleates and tetranucleates at regular time intervals to monitor cell cycle 
progression. The number of SPB foci per cell was also scored.  
 
Anaphase I and anaphase II entry is indicated by the appearance of binucleate and 
tetranucleate cells respectively. In wild type cells, the appearance of two or four SPB 
foci precedes each chromosome segregation steps by ~15 mins (Fig. 4. 2. 2. 1), 
corresponding to the timing of metaphase I and metaphase II respectively. When Cdc14 
activity is impaired, binucleate cells accumulate and persist. Tetranucleate cells are not 
produced. The same phenotype is observed when Cdc14 is restricted to the nucleolus in 
slk19Δ and spo12Δ mutants. These binucleates contains only two SPB foci, suggesting 
that Cdc14 activity is required for the production of four distinct SPBs. 
 
Early activation of Cdc14 in cdc55mn mutants prevents meiosis I nuclear division, 
resulting in mononucleate cells with ~90% containing a single SPB focus (Fig. 4. 2. 2. 1). 
A further ~10% of cdc55mn mononucleates contain two SPBs. These SPB foci are 
usually in close proximity to one another, suggesting that SPB separation is impaired 
through ectopic release of Cdc14.  When the prematurely released Cdc14 is inactive in a 
cdc14-1 cdc55mn mutant, SPB separation is partially rescued and two SPBs are 
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observed, as is seen in a cdc14-1 single mutant (Fig. 4. 2. 2. 1). This confirms that it is the 
early activity of Cdc14 in meiosis that impedes proper regulation of the SPB duplication 
pathway. 
 
Due to the limitations in resolution of conventional light microscopy, it is unclear 
whether a singular SPB focus observed in cells is an unduplicated SPB or two SPBs that 
are duplicated but unable to separate from one another, remaining in close association. 
This distinction must be made in order to identify the stage of SPB duplication that 







4.2.2.2 Investigating SPB duplication by quantification of total SPB fluorescence 
Total SPB fluorescence can be used to determine the quantity of Spc42 protein in cells. 
As SPBs duplicate, the fluorescence signal of the SPB focus increases two-fold. I 
measured Fi (integrated fluorescence intensity minus background) of individual SPBs 
using a method previously described by Hoffman, Pearson et al., 2001, following SPB 
duplication in individual cells during meiosis. Fi values for cells of each strain were 
aligned in time with respect to entry into metaphase I (appearance of two SPBs). The 
mean total Fi per cell was calculated for each strain and plotted. 
 
Wild type cells initially contain one SPB focus. After the SPB focus splits in metaphase I 
to two foci, the mean total Fi increases slightly from 3.4 to 3.8 a.u. (Fig. 4. 2. 2. 2A). This 
is consistent with the expectation that SPBs have already undergo the first round of 
duplication at the start of the experiment, when cells are arrested in prophase I. On 
entry into meiosis II, SPBs duplicate and separate into four SPBs with a total Fi of 6.9 a.u. 
per cell. This value corresponding to four SPBs is approximately double the Fi of two 
SPBs, indicating that the second round of SPB duplication can be detected using this 
method. I conclude that quantification of Spc42-tomato signal can be used as an 
indicator of SPB duplication and separation.     
 
In cdc14-1 cells, when Cdc14 activity is impaired, four SPBs are not observed. 
Quantification of the two SPB foci seen in cells show that total SPB Fi is 3.4 a.u. (Fig. 4. 2. 
2. 2A-B). This value is close to the 3.9 a.u. measured when wild type cells contain only 
two SPBs. If SPBs were duplicated but unable to separate from one another in cdc14-1 
mutants, this value should be approximately 6.9 a.u. Therefore, it would appear 
inactivation of Cdc14 prevents re-duplication of SPBs after meiosis I.  
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When Cdc14 is prematurely released from nucleolar sequestration, ~90% of 
mononucleates contain one SPB (Fig. 4. 2. 2. 1). This single SPB focus has a mean Fi of 
2.9 a.u. throughout the time course (Fig. 4. 2. 2. 2A-B), reflective of the value observed in 
both wild type and cdc14-1 cells prior to entry into metaphase I. It is, therefore, 
probable that the single focus observed in cdc55mn cells after prophase I is actually two 
adjacent SPBs duplicated side-by-side, since SPBs are known to duplicate after mitosis 
in G1/S-phase (Jaspersen, Giddings et al. 2002). 
 
To confirm that SPBs are duplicated prior to the prophase I arrest stage, wild type, 
cdc14-1 and cdc55mn cells were induced to sporulate but were maintained in the GAL-
NDT80 block arrest for 6h (Fig. 4. 2. 2. 2C). Mean SPB intensities were quantified for 100 
cells per strain. Total Fi per cell increases in all strains from ~180 to ~290 a.u. These 
results suggest that Spc42 protein abundance almost doubles before cells arrest in 
prophase I, implying that SPB duplication occurs and that cdc55mn cells contain two 
duplicated but un-separated SPBs during meiosis. 







4.2.2.3 Investigating SPB duplication by EM analysis 
Quantification of SPBs using fluorescence microscopy suggests that Cdc14 activity is 
required for the re-duplication of SPBs after meiosis I, and that early release of Cdc14 
prevents initial SPB separation in metaphase I. However, to unequivocally establish the 
stage at which the SPB cycle is blocked, it is necessary to observe their ultrastructure 
using electron microscopy (EM).   
 
I used cryo-immobilisation, via high pressure freezing (HPF), freeze substitution and 
subsequent embedding of cdc14-1 and cdc55mn cells to fix mutant meiotic cells for 
visualisation. Epon blocks were sectioned, stained and serial sections were analysed by 
transmission EM.  
 
When Cdc14 activity is impaired in meiosis, only two SPB foci are observed in 
binucleate cells using fluorescence microscopy (Fig. 4. 2. 2. 1). As a result, binucleate 
cdc14-1 cells were specifically targeted for analysis via EM. In all cases where SPBs were 
observed in cdc14-1 binucleates (n = 7), two SPBs are embedded in the nuclear 
envelope at polar opposite ends of the cell with a long bipolar spindle assembled 
between them (Fig. 4. 2. 2. 3A). The SPB structures appear completely unduplicated, as 
there is no evidence of half bridge elongation or outer plaque assembly at either SPB.  
 
Despite the fact that Cdc14 activity is required for the production of four SPBs in 
meiosis II, cdc14-1 mutants are still able to modify their unduplicated SPBs in a meiosis 
II-specific manner. The meiotic plaque components Mpc54 and Spo21 replace Spc72 
during meiosis II, enabling vesicle docking and pro-spore membrane formation (Knop 
and Strasser 2000). In wild type cells, diffuse Spo21 signal starts to weakly associate 
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with SPBs in late meiosis I. This signal becomes more pronounced at all four SPBs in the 
late stages of meiosis II (Marston, Lee et al. 2003). When Cdc14 activity is impaired, 
cells enter a sustained anaphase I-arrest. At early time points, Spo21 signal appears 
unaltered from wild type localisation in meiosis I. However, at later time points, Spo21 
signal accumulates at SPBs in a meiosis II-like manner. (Marston, Lee et al. 2003). 
 
I show that in cdc14-1 mutants, a double-membrane sheet, termed the pro-spore 
membrane (Moens and Rapport 1971), is clearly visible around SPBs (Fig. 4. 2. 2. 3A-B). 
Serial section images reveal vesicle recruitment to the cytoplasmic side of the SPB, 
coalescing into the pro-spore membrane (Fig. 4. 2. 2. 3A). This membrane then expands 
during meiosis II to completely enclose the nucleus anchored to the SPB (Fig. 4. 2. 2. 
3B). Pro-spore membrane formation at SPBs appears to be asymmetric, assembling and 
expanding at one SPB prior to assembly at the other SPB (n = 3). Cdc14, therefore, is not 
required for meiosis II-specific SPB modification or pro-spore membrane formation.   
 
Ectopic release of Cdc14 results in mononucleate cells containing predominately one 
SPB focus (Fig. 4. 2. 2. 1). Quantitative fluorescence analysis suggests that this single 
focus is actually two un-separated SPBs. EM analysis of cdc55mn mutants confirms this 
theory. Two SPBs are visible, embedded into the nuclear envelope in cdc55mn cells (Fig. 
4. 2. 2. 3C). These SPBs are physically connected to one another by a bridge structure 
emanating from the central plaque of each SPB (n = 6), visible on both sides of the 
nuclear envelope. Short nuclear and cytoplasmic microtubules assemble at both SPBs  
but, since SPBs do not separate and migrate to opposite poles of the cell, are unable to 
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4.2.3 Bfa1-Bub2-dependent location of Cdc14 to SPBs is important for timely SPB 
re-duplication in meiosis 
During mitosis, budding yeast cells divide asymmetrically. To ensure proper 
segregation of sister chromatids in anaphase, the mitotic spindle must align correctly on 
the mother-bud cell polarity axis, enabling spindle elongation and insertion into the 
budding daughter cell. Failure to properly align spindles results in activation of the 
spindle position checkpoint (SPOC) (Pereira, Hofken et al. 2000, Pereira, Manson et al. 
2002, Kim, Luo et al. 2012) and delayed mitotic exit. The SPB acts as a scaffold for MEN 
signalling (Bardin, Visintin et al. 2000, Visintin and Amon 2001, Pereira, Manson et al. 
2002), components of which assemble preferentially at the daughter cell-bound SPB 
(Menssen, Neutzner et al. 2001, Valerio-Santiago and Monje-Casas 2011, Kim, Luo et al. 
2012).  
 
Bfa1-Bub2 form a GTPase activating protein (GAP) complex that activates Tem1 and 
initiates MEN signalling (Bardin, Visintin et al. 2000, Pereira, Hofken et al. 2000). Bfa1-
Bub2 localisation is regulated by SPOC components Kin4 and Bmh1, which ensures that 
GAP activity is restricted to daughter SPB when mitotic spindles are correctly aligned. In 
contrast, spindle misalignment results in activation of SPOC and symmetric localisation 
of Bfa1-Bub2 (Caydasi, Micoogullari et al. 2014).  Asymmetric localisation of MEN is 
required for timely mitotic exit (Kim, Luo et al. 2012). Cdc14 has also been show to 
localise asymmetrically to the daughter pole in a Bub2-dependent manner (Yoshida, 
Asakawa et al. 2002). 
 
Meiosis is a symmetric division and MEN is not active in anaphase I (Jaspersen, Charles 
et al. 1998, Shou, Seol et al. 1999, Azzam, Chen et al. 2004, Queralt, Lehane et al. 2006). 
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Therefore, it is unclear why asymmetrical localisation of Cdc14 to SPBs is observed (Fig. 
4. 2. 1. 3B-C). To determine whether this localisation is important for the role of Cdc14 




4.2.3.1 Localisation of Cdc14 to SPBs is Bfa1-Bub2-dependent 
I monitored Cdc14-GFP localisation in cells where SPOC components BUB2, BFA1, KIN4 
and BMH1 were deleted. Cdc14 co-localisation with SPB signal was quantified, using 
SPB number and positioning, and Cdc14 nucleolar release as a marker for anaphase I. 
The average relative intensity of Cdc14 per SPB was calculated for each SPOC mutant, as 
was previously described in Fig. 4. 2. 1. 3A. 
 
Cdc14-SPB association is significantly reduced in bfa1Δ and bub2 Δ mutants relativet to 
wild type cells during anaphase I (Fig. 4. 2. 3. 1A). However, deletion of upstream SPOC 
components KIN4 and BMH1 has no effect on Cdc14 abundance at SPBs (p = 0.53 and p 
= 0.37 respectively). Furthermore, the asymmetric localisation of Cdc14 to SPBs 
observed in wild type anaphase I cells is unchanged in kin4Δ and bmh1Δ mutants. 
Consistent with Cdc14-SPB quantification data, deletion of BUB2 and BFA1 results in 
faint or non-detectable localisation of Cdc14 to SPBs.   
 
These findings are surprising, since Kin4 and Bmh1 control the localisation of Bfa1-
Bub2 in mitosis (Caydasi, Micoogullari et al. 2014). If deletion of KIN4 and BMH1 affect 
Bfa1-Bub2 localisation similarly in meiosis, these results would suggests that the 
activity but not necessarily the localisation of Bfa1-Bub2 affects Cdc14 localisation to 
SPBs. However, it is also possible that Bfa1-Bub2 localisation is regulated independently 






4.2.3.2 Loss of Cdc14-SPB co-localisation prevents the timely duplication of SPBs 
Since Cdc14 localisation to SPBs is significantly reduced when BFA1 and BUB2 are 
deleted in meiosis, bfa1Δ and bub2Δ mutants can be utilised to investigate the role of 
Cdc14-SPB co-localisation on the re-duplication of SPBs. 
 
I monitored SPB duplication during meiosis, as was described in Fig. 4. 2. 2. 1. In bfa1Δ 
and bub2Δ mutants, the efficiency of tetranucleate cell formation is greatly decreased. 
After 6h in meiosis, 90% of wild type cells are tetranucleate whereas only 36% and 
~57% of bfa1Δ and bub2Δ cells respectively contain four nuclei (Fig. 4. 2. 3. 2). A delay 
in the appearance of bfa1Δ tetranucleates is also observed. On average, cells lacking 
Bfa1 take ~1h longer to enter anaphase II despite the fact that timing of anaphase I 
entry, indicated by the appearance of binucleate cells, is unaffected.  
 
Deletion of BFA1 and BUB2 during meiosis also appears to result in the accumulation of 
binucleate cells, as has been observed when Cdc14 activity is impaired. These 
binucleates persist in cell populations >4 hours longer than is observed in wild type 
cells (Fig. 4. 2. 3. 2). In bfa1Δ and bub2Δ mutants, ~54% and ~22% of cells respectively 
contain two nuclei after 6 hours in meiosis. This is compared to only ~3% observed in 
wild type cells. From this, it would appear that Bfa1 and Bub2 may be important for the 
timely and efficient transition of cells from meiosis I to meiosis II.  
 
SPB duplication is likewise affected in the SPOC mutants. The timing of SPB re-
duplication after meiosis I is delayed in bfa1Δ cells. Four distinct SPB foci are not 
observed in meiotic cells until ~30 mins after they are seen in wild type cells (Fig. 4. 2. 
3. 2). This suggests that Bfa1 may be required for timely re-duplication of SPBs. Whilst 
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the timing of SPB duplication does not appear to be affected in bub2Δ mutants, the 
efficiency of re-duplication is. Only 58% of bub2Δ cells contain four SPBs compared to 
~90% observed in the wild type situation. Taken together, these results imply that 
Bfa1-Bub2-dependent localisation of Cdc14 to SPBs may be required to ensure the 
proper re-duplication of SPBs for meiosis II. However, further investigation is needed to 








4.2.3.3 Bfa1 localises symmetrically to SPBs during meiosis I 
Deletion of BUB2 and BFA1 results in the abolishment of Cdc14 asymmetric localisation 
at SPBs and delayed re-duplication of SPBs after meiosis I. This suggests that, whilst 
MEN in not active during meiosis I (Attner and Amon 2012), SPOC may play a role in 
regulating the meiosis I to meiosis II transition. During mitosis, the asymmetric 
localisation of Bfa1-Bub2 to SPBs indicates that mitotic spindles are correctly aligned 
and that SPOC is inactive. Symmetric localisation therefore correlates with SPOC 
activation. To investigate whether SPOC is active during meiosis, I monitored the 
localisation of Bfa1 within cells.  
 
During metaphase I and anaphase I, Bfa1-tdTomato signal is evident at both SPBs in 
~99% of cells (Fig. 4. 2. 3. 3A-B). This suggests that SPOC may be active during meiosis 
I.  Since deletion of BUB2 and BFA1 leads to a delay in exit from meiosis I, it is possible 
that Bfa1-Bub2 may be required at SPBs to enable re-duplication via a MEN-
independent mechanism. However, how and why symmetrically localised Bfa1 results 
in the asymmetric localisation of Cdc14 in anaphase I remains unclear. 
 
When cells enter metaphase II, SPBs re-duplicate but Bfa1 signal is retained at only one 
of these duplicated SPBs in ~93% of cells. Upon entry into anaphase II, Bfa1-SPB co-
localisation is undetectable (Fig. 4. 2. 3. 3A-B). From this observation, it could be 
inferred that SPOC becomes inactivated during meiosis II. This is consistent with the 
known role of MEN during meiosis II. Meiotic MEN signalling occurs independent of the 
SPB scaffold protein, Nud1 (Attner and Amon 2012). In addition, the MEN component, 
Cdc15, does not localise to SPBs during meiosis, implying that the pathway occurs off 
the SPB (Attner and Amon 2012). Bfa1-Bub2 signalling is therefore not required at the 
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SPB, perhaps explaining why Bfa1-tdTomato signal does not co-localise with SPBs 






4.2.3.4 Artificial tethering of Cdc14 to SPBs is lethal 
To determine whether the localisation of Cdc14 to SPBs during anaphase I is essential 
for SPB re-duplication, I attempted to artificially tether Cdc14 to SPBs. GFP-fused 
proteins can be mislocalised to specific locations within the cell by coupling a GFP-
binding protein (GBP) to a protein within the desired sub-cellular compartment or 
organelle (Rothbauer, Zolghadr et al. 2006).  
 
I constructed Cdc14-GBP and Spc42-GFP strains. However, when I attempted to cross 
haploids of opposite mating types containing the two constructs, I observed that 
inheritance of both fusion proteins resulted in cell death (Fig. 4. 2. 3. 4). This suggests 
that sustained localisation of Cdc14 to SPBs is lethal during mitosis. Furthermore, the 
heterozygous diploids formed during the crossing displayed poor sporulation efficiency 
on SPO plates, indicating that regulation of Cdc14 localisation to SPBs is important for 








One role of Cdc14 in mitotic exit is to reverse CDK-dependent phosphorylation 
(Pereira and Schiebel 2003, Higuchi and Uhlmann 2005, Woodbury and Morgan 
2007, Jin, Liu et al. 2008). Dephosphorylation of multiple mitotic CDK-substrates 
by Cdc14 is required to enable the re-setting of cells for the next round of cell 
division. Similarly, for cells to exit meiosis I and transition into meiosis II, the 
molecular machinery within cells must be re-set in order for the proper 
execution of two consecutive rounds of chromosome segregation. For this 
reason, it is possible that Cdc14 regulates the meiosis I- meiosis II transition 
through reversal of CDK-phosphorylation events.    
 
The SPB is a highly phosphorylated organelle (Wigge, Jensen et al. 1998) that has 
previously been identified as a target of CDK phospho-regulation (Adams and 
Kilmartin 1999, Kilmartin 2003, Ubersax, Woodbury et al. 2003, Jaspersen, 
Huneycutt et al. 2004). In meiosis I, two SPBs organise and assemble a meiosis I 
spindle, enabling the segregation of homologous chromosomes in anaphase I. 
For the segregation of sister chromatids in anaphase II, a total of four SPBs are 
required to assemble two meiosis II spindles. Since the SPB duplication pathway 
is regulated by Cdc28 (Byers and Goetsch 1974), Cdc14 may be required to 
oppose CDK phosphorylation to ensure proper SPB duplication and function.     
 
I hypothesised that Cdc14 activity is required in anaphase I to dephosphorylate 
and re-set the SPB complex for meiosis II.   When Cdc14 activity is impaired, I 
predicted that cells were unable to properly re-duplicate their SPBs and, 
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consequently, attempted to segregate sister chromatids but on a single meiosis II 
spindle. 
 
To test this theory, I investigated the role of Cdc14 in SPB duplication.  I found 
that Cdc14 associated with and localised to SPBs when released from nucleolar 
sequestration in anaphase I. Through quantitative fluorescence and transmission 
EM, I confirmed that Cdc14 is in fact required for the re-duplication of SPBs after 
meiosis I. As a result, cdc14-1 cells are unable to assemble two meiosis II spindles 
due to an insufficient number of SPBs present in cells. Furthermore, I discovered 
that the early activation of Cdc14 in cdc55mn mutants prevents duplicated SPBs 
from separating in metaphase I. Since the SPBs are unable to move apart and, 
accordingly, migrate to opposite poles of the cell, meiotic spindle assembly is 
prohibited.  
 
Interestingly, despite the fact that Cdc14 must enable re-duplication of both SPBs 
after meiosis I, Cdc14 localises asymmetrically to SPBs in anaphase I. Whilst 
during mitotic anaphase Cdc14 localises preferentially to the daughter cell-
bound SPB, this localisation is linked to SPOC and MEN signalling. Active Bfa1-
Bub2, part of the SPOC signalling pathway, inhibits MEN. Inhibitory 
phosphorylation of Bfa1-Bub2 by Cdc5 enables MEN activation and promotes 
mitotic exit. Bfa1-Bub2 and MEN components assemble asymmetrically on the 
daughter SPB, which acts as a scaffold for MEN signalling (Adams and Kilmartin 
1999, Visintin and Amon 2001, Valerio-Santiago and Monje-Casas 2011), and 
Bub2 is required for the asymmetric localisation of Cdc14 to SPBs (Yoshida, 
Asakawa et al. 2002). However, in meiosis I MEN is not active (Kamieniecki, Liu 
170 
 
et al. 2005). Moreover, MEN signalling in meiosis II occurs off the SPB (Attner 
and Amon 2012). Therefore, preferential localisation of Cdc14 to one SPB is 
unexpected during meiosis. Currently, it is unclear which SPB Cdc14 localises to 
in anaphase I. 
 
The dependency of Cdc14-SPB co-localisation on Bfa1-Bub2, despite a lack of 
MEN signalling in meiosis I, is surprising. One could argue that persistent SPOC 
activity prevents MEN activation during anaphase I. This is consistent with the 
finding that Bfa1 is symmetrically localised to SPBs during meiosis I. In mitosis, 
Cdc14 dephosphorylates Bfa1in late mitosis to re-activate the GAP following its 
inhibition by Cdc5 (Pereira, Manson et al. 2002). This hypophosphorylation of 
Bfa1 enables Tem1 inactivation and "switching off" of MEN signalling at the end 
of mitosis. Cdc14, therefore, may be required in anaphase I to ensure Bfa1-Bub2 
remains active by opposing Cdc5-depedent phosphorylation. This would ensure 
MEN inactivation throughout meiosis I despite FEAR activation in anaphase I.   
 
Another possible interpretation is that Bfa1-Bub2 is required to recruit Cdc14 to 
SPBs to ensure the timely re-duplication of SPBs. Deletion of BUB2 and BFA1 
results in undetectable localisation of Cdc14 to SPBs and delays SPB re-
duplication after meiosis I. Deletion of upstream SPOC regulators KIN4 and 
BMH1 had no effect on Cdc14-SPB association. Whilst Kin4 and Bmh1 play a role 
during mitosis in maintaining Bfa1-Bub2 activity, there is no evidence to suggest 
that they are required for Bfa1-Bub2 localisation to SPBs. Therefore, it is likely 
that in kin4Δ and bmh1Δ mutants, Bfa1 is able to recruit Cdc14 to SPBs. However, 
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5. Phospho-regulation of Sfi1 by Cdc14 enables SPB re-
duplication during meiosis  
5.1 Introduction 
The SPB duplication pathway has been studied in detail using EM analysis of 
mitotic yeast cells. In G1, the half-bridge structure attached to one side of the 
core SPB elongates along the inner and outer faces of the nuclear envelope 
(Byers and Goetsch 1974, Adams and Kilmartin 1999). Central SPB components 
are recruited to the distal, cytoplasmic tip of the fully elongated bridge to form a 
small satellite, which then expands into a completely duplicated outer plaque 
(Adams and Kilmartin 1999).  The duplicated plaque is then inserted into the 
nuclear envelope, after which nuclear SPB components assemble (Byers and 
Goetsch 1974, Winey, Goetsch et al. 1991, Winey, Hoyt et al. 1993, Schutz and 
Winey 1998). The result is side-by-side duplication of SPBs connected by an 
intact bridge.  Following G1, the bridge structure is severed thus enabling SPBs 
to separate and form the poles of the mitotic spindle. 
 
Daughter SPB assembly is initiated by half-bridge elongation. Whilst the half-
bridge comprises of Kar1, Mps3, Cdc31 and Sfi1 proteins (Baum, Furlong et al. 
1986, Rose and Fink 1987, Spang, Courtney et al. 1993, Jaspersen, Giddings et al. 
2002), it is Sfi1 duplication and assembly that is the key player in bridge 
elongation (Li, Sandercock et al. 2006). Sfi1 molecules are attached to existing 
SPBs via their N-terminus. C-terminal end-to-end interactions with other Sfi1 
proteins enables doubling of the half-bridge, elongating away from the 
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unduplicated SPB. The N-terminus of this Sfi1-dimerised bridge acts as the site 
for new outer plaque assembly (Li, Sandercock et al. 2006, Anderson, Prudden et 
al. 2007).  Bridge integrity is maintained through the centrin homologue Cdc31 
(Byers and Goetsch 1974, Baum, Furlong et al. 1986), which binds to Sfi1 at 
multiple sites and is required for the assembly of Sfi1 parallel arrays (Li, 
Sandercock et al. 2006, Bouhlel, Ohta et al. 2015).  
 
Recent studies have shown that CDKs and Cdc14 regulate half -bridge elongation 
and fission in mitosis through phospho-regulation of the Sfi1 C-terminus (Avena, 
Burns et al. 2014, Elserafy, Saric et al. 2014, Bouhlel, Ohta et al. 2015). CDK-
dependent phosphorylation of Sfi1 prevents C-terminal end-to-end dimerization, 
inhibiting half-bridge elongation. In anaphase, Cdc14 activity results in the 
dephosphorylation of Sfi1, which promotes half-bridge duplication. Following 
SPB duplication, phosphorylation of Sfi1 by CDKs enables the severing of the 
complete bridge structure and separation of adjacent SPBs (Avena, Burns et al. 
2014, Elserafy, Saric et al. 2014, Bouhlel, Ohta et al. 2015).   
 
I hypothesise that Cdc14 is required during meiosis for the phospho-regulation 
of Sfi1. This theory predicts that impairment of Cdc14 activity would result in 
sustained Sfi1 phosphorylation. This would prevent Sfi1 dimerization after 
meiosis I, which would explain why cdc14-1 mutants display no evidence of half-
bridge elongation in EM images. Furthermore, the early activation of Cdc14 in 
cdc55mn cells would result in premature Sfi1 dephosphorylation, impeding 
fission of the bridge and separation of SPBs.
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5.2 Results  
5.2.1 LFQ proteomic analysis of Spc42-3FLAG reveals reduced Sfi1 
abundance at cdc14-1 SPBs 
Since half-bridge elongation initiates SPB duplication in mitosis, it is probable 
that accumulation and assembly of half-bridge components at the SPB is also 
required for re-duplication of SPBs after meiosis I. To determine whether Cdc14 
activity was required for proper elongation of the half-bridge structure, I 
compared the protein abundance of SPB components in wild type and cdc14-1 
cells using a Spc42-FLAG construct to immunoprecipitate Spc42, harvesting cells 
after 4h in sporulation media. IP samples were digested with trypsin and MS was 
subsequently utilised to identify peptides pulled-down with Spc42 (Fig. 5. 2. 1A.). 
Each protein preparation and IP was performed in triplicate, resulting in a total 
of six data sets. Our collaborators, Juan Zou and Juri Rappsilber, using MaxQuant 
software, performed MS analysis. Label-Free Quantification (LFQ) intensities 
were calculated via spectral counting.   
 
I normalised LFQ intensities to Spc42 and statistically analysed the MaxQuant 
output using Perseus software. Data sets were filtered for contaminants, 
logarithmised to log2(x) and grouped to compare proteins identified at SPBs in 
wild type and cdc14-1 conditions. Numerical venn diagrams show the total 
number of proteins quantitatively identified in each sample (Fig. 5. 2. 1B-C). 
From the collated six data sets (Fig. 5. 2. 1B), only one protein was identified in 
all three wild type samples but was absent from cdc14-1 SPBs (Leu1). Likewise, 
two proteins were found only in cdc14-1 IPs (Gln1 and Pup3). These proteins are 
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all involved in metabolite biosynthesis and so are not relevant for investigating 
SPB changes when Cdc14 activity is impaired and are likely contaminants.   
 
Since SPB structures are still present in cdc14-1 cells, it is likely that any change 
to SPB composition and environment will be subtle. All 46 existing combinations 
of valid values identified in each sample are indicated in Fig. 5. 2. 1B. Reduction 
of the data matrix by filtering for valid values in at least 5 out of 6 columns, 
highlighted in grey in Fig. 5. 2. 1B-C, ensures that only proteins identified at SPBs 
in the majority of IPs were considered. 202 proteins were identified in all six 
samples, and a further 52 were present in 5 out of 6 samples (Fig. 5. 2. 1B-C). 
This filtering step reduces the total number of proteins analysed further from 
740 to 254. Missing values were replaced by imputation from normal 
distribution.  
 
Multi-scatter plots enabled the visual comparison of one replicate relative to 
another (Fig. 5. 2. 1D). SPB components are highlighted in red, Cdc14 in blue and 
Bfa1/Bub2 in green. The intensity distributions plotted for each data set 
comparison shows typically a non-uniform spread, which is slightly wider at 
lower intensities than at high intensities. In the majority of scatter plots, proteins 
plotted lie predominately on an x=y axis. This shows that protein abundances 
quantified in all replicates correlate well with one another. The average Pearson 
correlation coefficient for wild type samples is 0.73 and for cdc14-1 is 0.90. The 
greater variation in relative LQF protein intensities between wild type replicates 
is due to greater SPB component enrichment in the first wild type sample 
(WT_1). This suggests that cells harvested in the first replicate experiment may 
176 
 
have already re-duplicated their SPBs, whereas SPBs in the other replicates, as 
well as in cdc14-1 cells, are unduplicated.  
 
Changes in SPB composition between all data sets can be quickly identified using 
volcano plots (Fig.5. 2. 1E). Significance (-log of pValue) is plotted against protein 
fold change between wild type and cdc14-1 groups on the y- and x-axes 
respectively. False discovery rate (FDR) is set at 5% and s0 = 1. Whilst none of 
the data points are statistically divergent between wild type and cdc14-1 
grouped data sets, Cdc14 is greatly reduced at SPBs when Cdc14 activity is 
impaired. In addition, a number of SPB components are also reduced at cdc14-1 
SPBs. These proteins include all half-bridge and SPB peripheral components. 
Since half-bridge elongation initiates SPB duplication, the unduplicated SPBs in 
cdc14-1 cells would likely have fewer half-bridge constituents than re-
duplicating wild type SPBs.   
 
The lack of significance in protein fold change may result from several factors.  
Firstly, wild type cells duplicate their SPBs from two to four poles in total. This 2-
fold change may not be great enough to be detected with significance. Secondly, 
the variation in wild type LFQ intensities negatively affects reproducibility. 
Cultures grown for protein preparation are non-synchronous and, therefore, the 
timing of SPB re-duplication in wild type cells varies. As stated above, WT_1 cells 
may contain re-duplicating SPBs, whereas WT_2 and WT_3 intensity 
distributions are similar to those of cdc14-1, where SPBs are unduplicated (Fig. 







5.2.2 Reduced Sfi1 in meiosis prevents SPB re-duplication 
Since Cdc14 activity is required for Sfi1-dependent half-bridge elongation, it is 
possible that depletion of Sfi1 during meiosis would result in a cdc14-1-like 
phenotype. Without the accumulation of Sfi1 in prophase II, SPB re-duplication 
would not be initiated. To test this hypothesis, I constructed an Sfi1 meiotic null 
strain by putting SFI1 under the control of the Clb2 promoter. CLB2 is not 
expressed in meiosis, and this mechanism has been used previously for cdc55mn 
and cdc20mn strains.  
 
I analysed SPB duplication in meiotic wild type and sfi1mn cells by counting 
Spc42-tdTomato foci per cell. The depletion of Sfi1 during meiosis was 
confirmed via western blotting of 3HA-Sfi1. After 1h in sporulation media, Sfi1 is 
reduced ~46% and, by 3h in meiosis, it is completely undetectable (Fig. 5. 2. 2A). 
The percentages of binucleates and tetranucleates recorded at regular time 
points enabled monitoring of cell cycle progression. When Sfi1 is depleted, 
~35% of cells arrest after meiosis I as binucleates (Fig. 5. 2. 2B). A further 9% of 
cells progress through meiosis II to form tetranucleates. The efficiency of 
tetranucleate formation is drastically impaired when compared to the wild type 
situation, which contain >82% tetranucleates after 10h in meiosis. Furthermore, 
tetranucleate production is severely delayed in sfi1mn cells, as they are only 
observed from 8h compared to ~4.5h in wild type cells.  
 
 The binucleates formed by sfi1mn cells contain two SPB foci (Fig. 5. 2. 2B). When 
these foci observed in binucleate sfi1mn cells were quantified, the total SPB Fi in 
cells is ~3.5 a.u. (Fig. 5. 2. 2C). This corresponds to the 3.9 a.u Fi observed in wild 
180 
 
type cells when two SPBs are present (Fig. 4. 2. 2. 2). This value is also roughly 
half the total quantitative SPB intensity per cell measured when four SPB foci are 
within wild type cells (~6.9 a.u.). Taken together, this data strongly suggests that 






5.2.3 Cdc14 activity is required for the phospho-regulation of Sfi1 
The abundance of Sfi1 fails to increase at SPBs following meiosis I when Cdc14 
activity is impaired. This suggests that Cdc14 may be required to 
dephosphorylate Sfi1 in late anaphase I, thus relicensing SPBs for the next round 
of SPB duplication by enabling the assembly of the full-bridge structure. This 
theory would predict that Sfi1 is hyperphosphorylated in cdc14-1 cells, when 
Cdc14 activity is impaired. Conversely, Sfi1 might be hypophosphorylated when 
Cdc14 is ectopically released in cdc55mn cells.  
 
To investigate the phosphorylation state of Sfi1, I tagged the half-bridge 
component and monitored it throughout meiosis. Protein samples were run on a 
6% SDS gel to better resolve any motility shift in Sfi1, which is characteristic of 
phospho-regulation. ECL development of western blots was used in preference 
to LiCor® due to the low abundance of Sfi1 in cells. Despite the numerous 
advantages of LiCor® over ECL, the latter is more sensitive and so better for 
detection of faint protein signal. 
 
In wild type cells, Sfi1-6HA (~120 kDa) is present at low levels throughout 
meiosis (Fig. 5. 2. 3). Multiple migration bands are observed at 0.45 h after 
release from GAL-NDT80 block, which corresponds to the appearance of 
metaphase I spindles.  Since SPBs separate prior to metaphase I, this observation 
is consistent with the idea that Sfi1 phosphorylation is required for cleavage of 
the full-bridge structure between SPBs. Sfi1 then accumulates in cells after exit 
from meiosis at 3 h, which is indicated by the disassembly of anaphase II 
spindles.   
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When Cdc14 activity is impaired, the protein bands observed for Sfi1 appear 
distinctly thicker from 1.45 h compared to those seen on the wild type protein 
gel (Fig. 5. 2. 3). This is likely due to the appearance of phosphorylated Sfi1, 
which migrates slower in the SDS gel. The timing of this detectable shift 
corresponds with the appearance of anaphase I spindles, suggesting that Sfi1 is 
hyperphosphorylated in cdc14-1 cells from anaphase I onwards. Additionally, 
upward smearing of Sfi1 is prominent from 3 h, further arguing that impairment 
of Cdc14 activity prevents the dephosphorylation of Sfi1 during meiosis. 
 
In cdc55mn cells, Sfi1 band thickness appears comparable to the wild type 
situation. There is no evidence of Sfi1 band shifting upwards, nor are there 
phosphorylation smears above the proteins bands, except perhaps at 5.30 h. It 
therefore seems that the early release of Cdc14 from inhibition prevents the 
hyperphosphorylation of Sfi1 seen in cdc14-1 cells. 
 
Whilst it is possible that the motility shift detected in cdc14-1 is due to a 
posttranslational modification other than phosphorylation, the fact that it 
appears as a consequence of phosphatase inactivation strongly implies a role for 






I had previously verified that Cdc14 is required for re-duplication of SPBs after 
meiosis I (Section 4. 2. 2). However, the exact mechanism of SPB regulation had 
yet to be determined. The mitotic SPB duplication pathway is regulated at many 
stages by CDKs (reviewed by Jaspersen and Winey 2004), and therefore it is 
plausible that Cdc14 is required to counteract CDK phosphorylation after 
meiosis I in order for progression through a second meiotic SPB duplication 
event.  EM analysis of SPBs gave no indication of half-bridge elongation in cdc14-
1 cells after anaphase I (Fig. 4. 2. 2. 3A-B). It is therefore likely that the initiation 
of SPB re-duplication via half-bridge extension is a target of Cdc14 regulation.  
 
 
I hypothesised that Cdc14 was required for the phospho-regulation of Sfi1 
during meiosis. When Cdc14 activity is impaired, I predicted that Sfi1 became 
hyperphosphorylated. Since phosphorylated Sfi1 is unable to correctly dimerise 
during mitosis (Avena, Burns et al. 2014, Elserafy, Saric et al. 2014), this 
hyperphosphorylated form of meiotic Sfi1 could prevent half-bridge elongation 
after meiosis I and therefore inhibit SPB re-duplication. Conversely, since 
dephosphorylation of Sfi1 is vital for full-bridge cleavage in mitosis (Avena, 
Burns et al. 2014, Elserafy, Saric et al. 2014), I anticipated that ectopic release of 
Cdc14 lead to hypophosphorylation of Sfi1. This could perhaps explain why 
duplicated but unseparated SPBs are observed in cdc55mn cells. 
 
To test this theory, I investigated the role of Cdc14 on SPB half-bridge extension 
during meiosis.  Using LFQ proteomics, I identified a number of proteins that 
were reduced at SPBs when Cdc14 activity was impaired. These included all SPB 
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half-bridge components and SPB periphery proteins, suggesting that cdc14-1 
cells are unable to initiate SPB re-duplication via half-bridge elongation. I 
demonstrated that reduced Sfi1 protein abundance within cells prevents the re-
duplication of SPBs during meiosis. Additionally, I investigated the effect of 
Cdc14 on Sfi1 phosphorylation. I found that impairment of Cdc14 activity 
resulted in multiple migrating forms of Sfi1, which is likely due to 
hyperphosphorylation. Furthermore, I observed that this posttranslational 
modification of Sfi1 is absent in cells when Cdc14 is active early. These data 
indicate that Cdc14 is required for the phospho-regulation of Sfi1, and suggests 
that this regulation is what enables re-duplication of SPBs after meiosis I and 
SPB separation prior to metaphase I.   
 
This analysis of SPB duplication in cdc14-1 and cdc55mn cells is currently 
incomplete. Without phosphatase treatment of protein samples, I cannot rule of 
the possibility that the motility shift observed for Sfi1 in cdc14-1 cells is due to 
phosphorylation and not another type of posttranslational modification. 
However, the fact that the shift is only observed when Cdc14 activity is impaired 
and not in either wild type or cdc55mn situations strongly implies phospho-
regulation. I attempted to address this issue by immunoprecipitating Sfi1 in wild 
type and cdc14-1 cells, and treating IPs with phosphatase. Unfortunately, the low 
abundance of Sfi1 within cells proved to make this experiment difficult. Since 
Cdc14 has been shown in mitosis to regulate the phosphorylation state of Sfi1 
(Avena, Burns et al. 2014, Elserafy, Saric et al. 2014), I am fairly confident to 
conclude that the modification made to Sfi1 is phosphorylation.  
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Within this study, I have not shown a direct link between Sfi1 phospho-
regulation and SPB duplication/separation during meiosis. Whilst I have 
indicated that cdc55mn cells contain SPBs that are unable to cleave their full-
bridge structures and that ectopic release of Cdc14 prevents 
hyperphosphorylation of Sfi1, I have not shown that hypophosphorylation of Sfi1 
prevents SPB separation. This connection has been drawn from the data and 
from work carried out in mitotic cells. I am currently in the process of carrying 




















6. Final Discussion  
As discussed previously in this work, meiosis is the process through which four haploid 
gametes are formed from a diploid progenitor cell (reviewed by Marston and Amon 
2004). It consists of one round of DNA duplication followed by two consecutive rounds 
of chromosome segregation, where homologous chromosomes and then sister 
chromatids segregate in meiosis I and meiosis II respectively. Unlike in mitosis, where 
each round of chromosome segregation is preceded by a DNA replication phase, an 
intervening round of S-phase does not occur between meiosis I and meiosis II. As a 
result, daughter cells exhibit a reduction in chromosome number with respect to the 
parental cell. The meiosis I to meiosis II transition is therefore a unique event that must 
be properly regulated to ensure the accurate segregation of chromosomes during 
meiosis.  
 
Despite a lack of DNA re-replication between meiosis I and meiosis II, the molecular 
machinery required for chromosome segregation must be re-duplicated within cells. A 
single meiosis I spindle is needed to segregate homologous chromosomes in anaphase I. 
This spindle must then disassemble before the formation of two meiosis II spindles in 
metaphase II for the accurate segregation of sister chromatids. Both DNA replication 
and microtubule dynamics are regulated by cyclin-CDK activity (Ubersax, Woodbury et 
al. 2003, Loog and Morgan 2005). CDKs must be down-regulated at meiosis I exit to 
enable the disassembly of anaphase I spindles. On the other hand, some maintained CDK 
activity is required to prevent the re-firing of DNA origins of replication. These 
combined observations hint towards the need for partial down-regulation of CDKs at 
the meiosis I to meiosis II transition, sufficient enough to be permissive for spindle 




The protein phosphatase, Cdc14, has been implicated in the meiosis I to meiosis II 
transition (Buonomo, Rabitsch et al. 2003, Marston, Lee et al. 2003). Cdc14 activity is 
required for the assembly of two meiosis II spindles despite the unhindered 
disassembly of meiosis I spindles (Bizzari and Marston 2011). Additionally, Cdc14 plays 
a role in CDK inactivation during mitotic exit. This CDK down-regulation is achieved 
through the degradation of cyclins and the stabilisation of the CDK inhibitor, Sic1 
(Knapp, Bhoite et al. 1996, Toyn, Johnson et al. 1997, Verma, Annan et al. 1997, Visintin, 
Craig et al. 1998, Zachariae, Schwab et al. 1998, Jaspersen, Charles et al. 1999). Cdc14 
has also been shown to reverse CDK-dependent phosphorylation events (Bloom, Cristea 
et al. 2011, Bremmer, Hall et al. 2012, Avena, Burns et al. 2014).  
 
In the first part of this study, I aimed to determine the role of Cdc14 in meiosis I to 
meiosis II transition, attempting initially to address whether it was involved in the 
partial down-regulation of CDKs. I showed that Cdc14 is not required for cyclin 
degradation during meiosis. Clb1, Clb3, Clb4 and Clb5 cyclin proteolysis is unaffected 
when Cdc14 activity is impaired (Fig. 3. 2. 3. 2A-D). Furthermore, the early activation of 
Cdc14 in cdc55mn mutants does not result in the premature degradation of meiotic 
cyclins. This suggests that, if Cdc14 is required to regulate CDK activity, it is not via 
cyclin proteolysis. Since Clb3 and Clb5-CDK activity correlates to protein abundance 
(Carlile and Amon 2008), it would appear that Cdc14 does not regulate either of these 
CDKs. Clb1 and Clb4-CDK activities are regulated by mechanisms distinct from cyclin 
degradation.  The posttranslational modification of Clb1, believed to be an active 
phosphorylated form, is observed in cdc14-1 cells (Fig. 3. 2. 3. 1A) indicating that the 
phosphatase likely is not regulating Clb1-CDK either. The mechanism for Clb4-CDK 
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down-regulation has yet to be determined but since Clb4-CDK is active in meiosis II, it is 
probable that Cdc14 is not essential for its regulation at meiosis I exit. I therefore 
concluded that Cdc14 was not required for the down-regulation of CDKs at the meiosis I 
to meiosis II transition.      
 
Next, I set out to identify potential substrates of Cdc14 during meiosis I exit. I used a 
non-biased approach where I pulled down Cdc14 in meiotic cells. Cells were staged so 
that binucleates but not tetranucleates were present in harvested populations (Fig. 4. 2. 
1. 1A). The IP revealed that Cdc14 interacts with SPB components when it is not bound 
to its inhibitor, Cfi1/Net1 (Fig. 4. 2. 1. 1D). I further showed that Cdc14 localises to SPBs 
in anaphase I (Fig. 4. 2. 1. 3), and that impairment of Cdc14 activity or release prevents 
the appearance of four SPBs during meiosis (Fig. 4. 2. 2. 1). Through quantitative 
fluorescence (Fig. 4. 2. 2. 2A-B) and EM analysis (Fig. 4. 2. 2. 3A-B), I determined that 
cdc14-1 mutants are unable to re-duplicate their SPBs after meiosis I. In contrast, the 
early activation of Cdc14 impedes SPB separation prior to metaphase I in cdc55mn cells 
(Fig. 4. 2. 2. 3C). These results suggested a role for Cdc14 in the SPB duplication 
pathway.    
 
In order to build a molecular mechanism for Cdc14-dependent regulation of the SPB 
duplication pathway, I used LFQ proteomics to pinpoint the precise stage of SPB 
duplication affected in cdc14-1 mutants. Through comparison of wild type and cdc14-1 
samples, I identified half-bridge components, Sfi1, Mps3, Cdc31 and Kar2, and SPB 
periphery proteins, Mps2, Ndc1 and Bbp1, as reduced at SPBs when Cdc14 activity is 
impaired (Fig. 5. 2. 1. 1E). Furthermore, I found that reduced Sfi1 protein abundance 
prevented the re-duplication of SPBs during meiosis (Fig. 5. 2. 2A-C). Through western 
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blot analysis, I determined that Cdc14 is required for the phospho-regulation of Sfi1. A 
putative hyperphosphorylated form of Sfi1 accumulates in cdc14-1 cells (Fig. 5. 2. 3). 
This form is not observed when Cdc14 is active, either in wild type or cdc55mn cells. I 
speculated that Cdc14 is required during the meiosis I to meiosis II transition to 
dephosphorylate Sfi1, so that cells can initiate SPB re-duplication in meiosis II via half 
bridge elongation. Additionally, the activity of Cdc14 must be tightly regulated in early 
meiosis. Ectopic release of Cdc14 in cdc55mn mutants prevents the phosphorylation of 
Sfi1, which appears to be required for SPB separation via half-bridge cleavage.   
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6.1 Future Plans 
6.1.1 Does phospho-regulation of Sfi1 affect SPB duplication/separation in 
meiosis? 
The phospho-regulation of Sfi1 by Cdc14 appears to be vital for control of the SPB 
duplication pathway. However, a direct link between SPB duplication/separation and 
Sfi1 phosphorylation has yet to be shown in meiosis. A number of phospho-mimetic and 
phospho-null forms of Sfi1 were generated by (Avena, Burns et al. 2014) for SPB 
analysis during mitosis. To fully confirm that the SPB duplication defect observed in 
Cdc14-impaired cells was the result of Sfi1 hyperphosphorylation, I would need to 
investigate the affect of introducing an unphosphorylatable Sfi1 mutant into cdc14-1 
cells. Similarly, the integration of hyperphosphorylated form of Sfi1 in cdc55mn cells 
could help determine if Sfi1 phosphorylation is vital for SPB half-bridge cleavage. These 
Sfi1 phospho-forms were received from Mark Winey and could be transformed into 
wild type and mutant diploids containing the SPB marker, Spc42-tdTomato, to monitor 
their effect of SPB duplication throughout meiosis. 
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6.1.2 Why is Cdc14 asymmetrically localised during anaphase I? 
The localisation of Cdc14 to SPBs appears to play a role in the timing of SPB duplication 
(Fig. 4. 2. 3. 2). However, why this localisation is asymmetric in anaphase I is unclear. 
The GTPase activating protein, Bfa1-Bub2, has been identified as important for Cdc14-
SPB co-localisation (Fig. 4. 2. 3. 1A-B) despite Bfa1 localising to SPBs symmetrically in 
anaphase I (Fig. 4. 2. 3. 3A-B). Since the localisation of Bfa1 is not asymmetric, perhaps 
GAP activity is distinctly regulated at different poles. To gain a better understanding of 
the role of GAP activity on Cdc14 localisation, a GAP inactive Bub2 variant (Bub2-
Q123L) (Scarfone, Venturetti et al. 2015) received from Simonetta Piatti could be 




The aim of this study was to determine the role of Cdc14 during the meiosis I to meiosis 
II transition. My findings suggest that Cdc14 may be required to phospho-regulate the 
SPB half bridge, Sfi1 (Fig. 6. 2). When Cdc14 activity is impaired, SPBs are unable to re-
duplicate. Sfi1 appears to be hyper-phosphorylated in cdc14-1 cells, which could 
perhaps prevent the elongation of the half-bridge structure since phosphorylate Sfi1 is 
unable to dimerise in mitosis (Avena, Burns et al. 2014). Premature activation of Cdc14 
prevents the separation of SPBs prior to metaphase I. Sfi1 appears unphosphorylated. 
Since Sfi1 phosphorylation is required to cleave the assembled full-bridge between 
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Appendix 1: Mass Spectrometry results for Cdc14-TAP IP in meiosis 
 Wild Type cdc55mn 
Name No tag Cdc14-TAP No tag Cdc14-TAP 
SPC110  73 33 89 
CNM67  45 14 53 
ACS1 18 33 21 32 
POM152  52  51 
EFT1 20 33 13 32 
TDH3 20 30 19 28 
ATP1 20 28 22 26 
SPC42  36 19 40 
PGK1 21 26 17 29 
PCK1 21 27 15 30 
CDC19 20 27 15 31 
FAS1 8 32 13 36 
NET1  43 15 29 
BFA1  42 8 37 
FOX2 9 33 8 37 
CDC14 12 30 16 28 
SSA1 18 25 14 28 
URA2 13 29 13 29 
ALD4 18 25 15 22 
PET9 19 25 13 22 
TEF1 18 21 19 19 
FAS2 8 27 10 29 
ENO2 16 22 13 21 
MLS1 12 20 9 30 
SSB1 16 27  25 
SPC97  28  38 
QCR2 13 19 7 22 
GUT2 12 19 11 18 
ACH1 11 20 10 19 
SPC29  20 8 31 
ICL1 16 17 10 15 
SPC72  27  30 
ADH1 11 18 12 15 
PDC1 11 17 8 20 
SPC98  25  30 
GDH2 12 20  23 
FAA2  21  33 
ACC1  23 7 22 
IDP2 9 17 6 19 




 Wild Type cdc55mn 
Name No tag Cdc14-TAP No tag Cdc14-TAP 
MPS3  26 4 20 
PMA2 10 15 8 17 
ADH2 7 18 10 14 
SFC1 11 15 6 17 
MPS2  19 3 26 
HSL7  25  23 
RPL3 7 15 7 18 
POR1 12 14 7 14 
CAT2 6 12 6 21 
COR1 10 14 9 11 
HSP60 10 17 5 12 
BBP1  22 3 18 
RPS3 7 12 10 14 
HSP82  20  23 
YEF3 12 11 4 16 
ADY3  18  24 
SIK1 16 11  15 
NOP58 9 14 8 10 
BUB2  16 7 17 
GPH1 4 20  16 
KGD1 8 14 7 10 
FBA1 10 13 5 11 
GFA1  14 7 17 
TPI1 7 13 6 11 
CIT1 11 10 6 10 
PFK2 8 15  14 
ACO1 8 13  16 
RPS1A 3 19 12 2 
SDH1 7 15 4 10 
MIR1 5 14 4 13 
NDC1  18  18 
PFK1  13 6 16 
ACT1 3 9 9 14 
RPS5 10 10 5 10 
KAR1  17  18 
NDI1 9 10 4 12 
ERG6 6 12 5 11 
RPS18A 7 9 6 11 
RPP0 8 10 5 10 
CDC31  12 5 15 
CDC48  14 5 12 
CIT2  11 2 18 
ATP5 8 10 4 9 
SFI1  15  16 




 Wild Type cdc55mn 
Name No tag Cdc14-TAP No tag Cdc14-TAP 
RPL8A 7 12 1 11 
SSC1 11 19   
HSC82 14 3 11 2 
FAA1  11 4 15 
IDH1 7 8 6 9 
ENO1 7 11 3 9 
TUB4  14  16 
PDH1  14 5 10 
RPL4A  11 6 12 
PEP4 5 8 8 8 
VMA2  16  13 
CAR2  11 5 12 
TUB2  9 6 13 
RPS6A 6 10 4 8 
TIF1 5 10 4 9 
RPS1B 10 3 1 14 
GPM1 7 13 7  
ILV5 9 12 6  
NOP1 12 8 7  
CHC1  14  13 
PGI1 7 8 3 9 
KAR2  13 4 9 
ASC1 3 12 5 6 
RPL10 7 9  10 
LPD1 5 14 6  
CIT3  11 4 10 
TDH1 3 9 7 6 
TEF4 6 7 6 6 
FBP1  14  11 
FMP13 7 10  8 
ATP3 8 9  8 
TUB1  10 3 10 
RPL7A 8  4 11 
TOF2  22   
DNM1  11  10 
LSC2  11  10 
LSP1 7 10 3  
RPL23A 5 10 5  
RPS13 5 8 7  
SPS19  9  11 
DLD1 5 14   
PRP43 10  9  
RPL1A  8 3 8 
IPP1  9 2 8 




 Wild Type cdc55mn 
Name No tag Cdc14-TAP No tag Cdc14-TAP 
HTB1 3 5 4 7 
YEL020C  8  11 
RPL19A 5  5 9 
OM45 7 11   
SEC53 6 7 5  
BMH1 8  5 5 
ATP4 3 8  7 
RPL20A 5 8 4  
RPS14A 6 8 3  
TSA1 5 6 6  
RPL14A 4 6 2 5 
CMD1  9  8 
NDJ1  8  9 
NUD1  8  9 
RPS22A 3  6 8 
PYC1 5  4 8 
HXK1 5 8 3  
RPL27A 5 6 4  
RPL30  6 4 5 
TDH2 3 6 2 4 
RPS17A 4  3 8 
IDP3  4  11 
IDH2 5  2 8 
GLK1   3 12 
PSA1 4 5  6 
RPL6A 6   9 
ARO1    15 
CST9    15 
MDH1 3 11   
MET6  14   
RPL6B  8 6  
DMC1  9  5 
PIL1 4   10 
MDH3    14 
PDB1 3 8 2  
HHF1 4 6  3 
NCP1   4 9 
ARF2 5 3  5 
CTA1    13 
POX1    13 
NBP1  12   
QCR7 6 6   
RPL2A 7  5  
SSB2   12  
RIP1  5  7 




 Wild Type cdc55mn 
Name No tag Cdc14-TAP No tag Cdc14-TAP 
SSA3 2  1 9 
RPS11A 6  5  
RPS4A 11    
SSA2 1 6 1 3 
PEX11   4 7 
PCS60    11 
MDH2  10   
RPL28 6  4  
SNU13 5  5  
BGL2 3   7 
HMG1    10 
ARF1  5 4  
KGD2 5 4   
RPS12 5 4   
RPS24A 5  4  
RPS25A 5  4  
RPS31 5  4  
SAH1 6  3  
STE23    9 
UGP1    9 
ARG1  8   
DED81  8   
HYP2  5 3  
MCR1  8   
MPC54  8   
PAB1 4  4  
SAR1 8    
RPL8B  1 6 1 
RPS8A 2   6 
PGM2    8 
COX2  4 3  
DPS1  7   
MKT1 7    
RPL13A 7    
RPL18A 7    
RPL5 7    
VPH1  7   
ERG10   3 4 
RNQ1   3 4 
RPS2    7 
ATP7 4  2  
DEF1 6    
RPL12A   6  
AAT2    6 
PMU1    6 




 Wild Type cdc55mn 
Name No tag Cdc14-TAP No tag Cdc14-TAP 
RPN1    6 
RPT3    6 
VPS1    6 
HXK2  5   
IDP1  5   
RPL17A 2  3  
RPS20 5    
GLC7    5 
RVB2    5 
COX5A 4    
DPM1   4  
FUM1   4  
GND1   4  
GSF2   4  
PET10 4    
RAS2  4   
RIM4 4    
RPL24A   4  
RPL36A 4    
RPS0A   4  
RPS19A 4    
RPS9A   4  
SAM2   4  
SIS1   4  
ERV25    4 
GPD1   3  
OM14 3    
PPN1   3  
RPL17B  3   
RPL21A 3    
RPL9A 3    
RPL9B   3  
SOD2 3    
SSA4  2  1 
POT1    3 
DED1   2  
FUR1   2  
RFS1   2  
RPL38 2    
TUB3  2   
YCP4 2    
YHM2   2  
AAC1    2 
ADY2   1  
BMH2 1    




 Wild Type cdc55mn 
Name No tag Cdc14-TAP No tag Cdc14-TAP 
COX1   1  
GAS5   1  
YJL045W  1   
Table A1 (Continued): All protein identified by Mass Spectrometry. 





Appendix 2: Cdc14-TAP IP interactions in metaphase-arrested cells 
A2.1: Mass Spectrometry results for Cdc14-TAP IP in metaphase I 
 Wild Type cdc55mn  Wild Type cdc55mn 
Name Cdc14-TAP Cdc14-TAP  Name Cdc14-TAP Cdc14-TAP 
SPC110 35 45 RPS4A 7 16 
CNM67 24 45 ACO1 8 15 
ACS1 26 39 GFA1 8 15 
NET1 54 6 PMA2 9 14 
SPC42 27 31 NDI1 12 11 
FAS1 19 35 MPS2 7 15 
HSP82 22 32 BFA1 8 14 
ATP1 25 29 PIL1 8 14 
CDC19 17 34 IDP2 7 14 
CDC14 27 23 ADH2 6 14 
ENO1 18 31 FBA1 7 13 
SSA1 20 29 TPI1 7 13 
TEF1 21 28 OM45 8 12 
EFT1 20 28 RPS6A 8 12 
FOX2 16 31 RPS5 9 11 
TDH3 19 28 KAR2 5 14 
PET9 20 27 CIT1 8 11 
PGK1 14 29 HSP60 10 9 
ALD4 17 24 HSP104 4 14 
FAS2 12 26 MDH1 5 13 
MLS1 8 28 ACT1 7 11 
ADH1 15 21 MIR1 8 10 
TOF2 35  SSB1  17 
PCK1 15 19 ACC1 4 13 
QCR2 15 17 CDC48 5 12 
PDC1 9 22 CHC1 5 12 
POR1 13 18 RPL4A 5 12 
RPS3 11 19 CAR2 6 11 
SPC29 13 16 HHF1 6 11 
SSC1 14 14 RPL26A 6 11 
URA2 7 20 KGD1 9 8 
COR1 9 18 RPL8B  16 
RPS1B 11 15 UGP1 1 15 
ICL1 6 19 RPS11A 5 11 
GPM1 8 17 SDH1 5 11 
GUT2 13 12 ILV5 6 10 
GDH2 3 21 PGI1 6 10 
ACH1 4 20 RPL2A 6 10 
FAA1 9 15 RPP0 7 9 
GPH1 5 18 SFC1 7 9 
RPL7A 7 16 PFK1 1 14 




 Wild Type cdc55mn  Wild Type cdc55mn 
Name Cdc14-TAP Cdc14-TAP  Name Cdc14-TAP Cdc14-TAP 
RPL3 3 12 RPS14A 5 7 
SPS2 3 12 SPC72 5 7 
IDH1 5 10 TDH1 5 7 
RPS17A 5 10 IDH2 7 5 
BUB2 6 9 SIR2 12  
RPS16A 6 9 RPN2 1 10 
FAA2 2 12 SSE1 1 10 
HXK1 2 12 CAT2 2 9 
PGM2 2 12 LPD1 2 9 
FBP1 3 11 CAR1 3 8 
GLK1 3 11 CIT2 3 8 
TSA1 3 11 IPP1 3 8 
VMA2 3 11 RPL18A 3 8 
ENO2 4 10 TUB1 3 8 
RPL1A 4 10 ATP4 4 7 
RPL19A 5 9 RPL24B 4 7 
TUB2 5 9 RPS13 4 7 
RPL23A 6 8 TEF4 4 7 
LEU1 10 4 ATP7 5 6 
SSB2 14  RPL21A 5 6 
BMH1  13 RPL33A 5 6 
SPO21  13 SEC53 5 6 
POX1 1 12 RPL6B  10 
GND1 3 10 YSW1  10 
MDH2 3 10 RPN1 2 8 
ADY3 4 9 RPL5 3 7 
RPS18A 4 9 RPS12 3 7 
RPS25A 4 9 RPS19A 3 7 
TKL1 4 9 TIF1 3 7 
ATP5 5 8 ARF1 4 6 
RPS8A 6 7 ATP3 4 6 
ERG6 7 6 MRP8 4 6 
HEF3  12 RPL27A 4 6 
LSP1 2 10 RPS20 4 6 
PAB1 2 10 RPS31 4 6 
RPL16B 2 10 CIT3 6 4 
WTM1 2 10 RPL8A 7 3 
FMP13 3 9 BFR1  9 
PES4 3 9 ETR1  9 
DPM1 4 8 HTB2  9 
RPL10 4 8 LSC2  9 
RPS0B 4 8 PCS60  9 
RPS24A 4 8 RPL13B  9 
RPS9A 4 8 TAL1  9 
SDH2 4 8 CLU1 1 8 




 Wild Type cdc55mn  Wild Type cdc55mn 
Name Cdc14-TAP Cdc14-TAP  Name Cdc14-TAP Cdc14-TAP 
GUS1 1 8 PET10 3 5 
POT1 1 8 PYC1 3 5 
RPL15A 1 8 RPL14A 3 5 
DNM1 2 7 RPL35A 3 5 
DPS1 2 7 SSA2 3 5 
FUM1 2 7 COX6 4 4 
MIP6 2 7 RIP1 4 4 
RPL36B 2 7 RPS15 4 4 
VPH1 2 7 HTB1 7 1 
BBP1 3 6 ABF2  7 
CDC31 3 6 NQM1  7 
DAK1 3 6 PDB1  7 
DMC1 3 6 RPL9B  7 
ERG10 3 6 RPS2  7 
PDH1 3 6 SHM2  7 
QCR7 3 6 TOM70  7 
RPL11B 3 6 AAT2 1 6 
RPL17A 3 6 CDC5 1 6 
RPL20A 3 6 CRC1 1 6 
RPT1 3 6 GLC3 1 6 
RTN1 3 6 PSA1 1 6 
YDJ1 3 6 RPS7A 1 6 
COX2 4 5 SPS19 1 6 
FAA4 4 5 SUB2 1 6 
KGD2 4 5 UBA1 1 6 
OLA1 4 5 BGL2 2 5 
RPS1A 4 5 CCT8 2 5 
ODC1 6 3 CWP1 2 5 
APE2  8 GAS1 2 5 
CYS4  8 HXK2 2 5 
EMI2  8 PEX11 2 5 
MDH3  8 PST2 2 5 
MET6  8 RPL38 2 5 
CPR1 1 7 SAM2 2 5 
ERG13 1 7 TPS1 2 5 
BAT2 2 6 YAT2 2 5 
RPL12A 2 6 GPD1 3 4 
RPL30 2 6 LSC1 3 4 
RVB2 2 6 NCE102 3 4 
SAH1 2 6 NDC1 3 4 
SEC14 2 6 RPT3 3 4 
TMA19 2 6 SIK1 3 4 
YAL018C 2 6 VTC4 3 4 
CYT1 3 5 HYP2 4 3 
PDI1 3 5 MPS3 4 3 




 Wild Type cdc55mn  Wild Type cdc55mn 
Name Cdc14-TAP Cdc14-TAP  Name Cdc14-TAP Cdc14-TAP 
ADE17  6 RPS23A 1 4 
CAM1  6 RPT4 1 4 
GDB1  6 RVB1 1 4 
RPN8  6 SPO74 1 4 
SEC24  6 YAT1 1 4 
AMS1 1 5 ASC1 2 3 
PEP4 1 5 AYR1 2 3 
PFK2 1 5 DED1 2 3 
SSA4 1 5 ERG20 2 3 
THS1 1 5 GSP1 2 3 
TMA29 1 5 GVP36 2 3 
URA1 1 5 LEU4 2 3 
YCP4 1 5 PHB2 2 3 
YNK1 1 5 RPL31A 2 3 
DON1 2 4 SOD2 2 3 
RPL25 2 4 SSO1 2 3 
RPS10A 2 4 RPA190 3 2 
SEC4 2 4 RPS7B 3 2 
SSA3 2 4 SAR1 3 2 
TFP1 2 4 BMH2 4 1 
YFR032C 2 4 RPL13A 5  
ARG1 3 3 ADE13  4 
MCR1 3 3 ADE16  4 
PHB1 3 3 ADE2  4 
RNR4 3 3 ADK1  4 
RPS27A 3 3 APE3  4 
ADE6  5 ARP2  4 
COF1  5 GUA1  4 
CTA1  5 HMG1  4 
CYS3  5 LAP3  4 
FRS1  5 LAP4  4 
KAP123  5 LAT1  4 
NCP1  5 MBF1  4 
SCP160  5 PRS3  4 
SER1  5 RPL28  4 
SMC3  5 RPN5  4 
THR4  5 SEC61  4 
ARP3 1 4 SUC2  4 
CDC60 1 4 TCB3  4 
HFD1 1 4 TUF1  4 
HHT1 1 4 VMA13  4 
HSC82 1 4 YEF3  4 
NPL3 1 4 YEL020C  4 
PUP2 1 4 ADE52C7 1 3 
RPG1 1 4 ARC35 1 3 




 Wild Type cdc55mn  Wild Type cdc55mn 
Name Cdc14-TAP Cdc14-TAP  Name Cdc14-TAP Cdc14-TAP 
COX5A 1 3 IDP3  3 
CYB2 1 3 IMD4  3 
HOM2 1 3 MET17  3 
MSC1 1 3 MUC1  3 
PHO88 1 3 PHO86  3 
PRX1 1 3 POL30  3 
RPN10 1 3 PRE5  3 
RPN11 1 3 PRE6  3 
RPN9 1 3 PRE7  3 
RPT5 1 3 PTC3  3 
SES1 1 3 PUP3  3 
SOD1 1 3 QRI1  3 
SPR1 1 3 RIB4  3 
STO1 1 3 RIM1  3 
SUI2 1 3 RPL32  3 
TDH2 1 3 RPN13  3 
TUB4 1 3 RPN7  3 
VPS1 1 3 RPS26A  3 
IME2 2 2 RPT2  3 
INO1 2 2 RPT6  3 
NUD1 2 2 SEC23  3 
PDA1 2 2 SER3  3 
RHO1 2 2 SPR3  3 
RPS22A 2 2 SPS22  3 
SPC97 2 2 SSZ1  3 
YMR031C 2 2 STI1  3 
YOP1 2 2 UGA1  3 
RPL9A 3 1 WBP1  3 
ALA1  3 YET3  3 
ARB1  3 YHR202W  3 
ARO9  3 YNR034W  3 
CCT3  3 YPT7  3 
CCT4  3 ADE4 1 2 
CDC28  3 ADH3 1 2 
CDC3  3 CDC10 1 2 
CDC33  3 CMD1 1 2 
CPR6  3 HSP42 1 2 
CYC1  3 KRS1 1 2 
DHH1  3 LSB3 1 2 
DUG1  3 LYS20 1 2 
FDH1  3 NAP1 1 2 
FET5  3 PRO3 1 2 
GRE3  3 RAS2 1 2 
GRX2  3 RPL43A 1 2 
HOM6  3 RTN2 1 2 




 Wild Type cdc55mn  Wild Type cdc55mn 
Name Cdc14-TAP Cdc14-TAP  Name Cdc14-TAP Cdc14-TAP 
SAC6 1 2 EMP24  2 
SBP1 1 2 ERG26  2 
SDH3 1 2 ERG9  2 
TRP5 1 2 ERV25  2 
YOR285W 1 2 FPR3  2 
YPT1 1 2 GAD1  2 
ACS2 2 1 GCD11  2 
ARG4 2 1 GCV1  2 
DEF1 2 1 GET3  2 
DLD1 2 1 GND2  2 
NBP1 2 1 GSF2  2 
PMT1 2 1 GSY2  2 
RHO3 2 1 HEM2  2 
RIM4 2 1 HHO1  2 
RPS29A 2 1 HMG2  2 
YRA1 2 1 HRR25  2 
NDE2 3  HSP12  2 
AAC1  2 HTA1  2 
ADE3  2 HTS1  2 
AGX1  2 HTZ1  2 
AHP1  2 ICL2  2 
ALD2  2 IFA38  2 
ARA1  2 KAP95  2 
ARC1  2 LYS1  2 
ARO1  2 MCK1  2 
ARO8  2 MPC54  2 
BAT1  2 NHP6B  2 
BCY1  2 NIP1  2 
CCC1  2 NUG1  2 
CCT2  2 NUS1  2 
CCT6  2 OST1  2 
CCT7  2 OYE2  2 
CDA2  2 PBI2  2 
CDC12  2 PCM1  2 
COP1  2 PDS5  2 
COX7  2 PFS1  2 
COX9  2 PHO8  2 
CPR3  2 PMC1  2 
DBP1  2 PMT4  2 
DCS1  2 PRE1  2 
DED81  2 PRE4  2 
ECM4  2 PRP43  2 
EFB1  2 PRS2  2 
EGD2  2 PUB1  2 
EHD3  2 QCR8  2 




 Wild Type cdc55mn  Wild Type cdc55mn 
Name Cdc14-TAP Cdc14-TAP  Name Cdc14-TAP Cdc14-TAP 
RFA1  2 YKT6  2 
RHR2  2 YMR099C  2 
RKI1  2 YMR196W  2 
RPL33B  2 YNL045W  2 
RPL34A  2 YNL134C  2 
RPL39  2 YOR251C  2 
RPS28A  2 YPL225W  2 
RPS30A  2 YPT31  2 
RRP5  2 ZUO1  2 
RSP5  2 ZWF1   2 
SAC1  2 ADH5 1 1 
SAM4  2 ADY2 1 1 
SCL1  2 CDA1 1 1 
SDS23  2 COX1 1 1 
SEC21  2 COX4 1 1 
SEC26  2 FMP10 1 1 
SEC31  2 FMP45 1 1 
SHE10  2 FPR1 1 1 
SIS1  2 GCD6 1 1 
SOL4  2 GSY1 1 1 
SPC98  2 HSL7 1 1 
SPR28  2 HYR1 1 1 
SSD1  2 ILV2 1 1 
SSP1  2 NHP2 1 1 
STE23  2 NOP58 1 1 
STE24  2 OM14 1 1 
STT3  2 RPL17B 1 1 
SUI3  2 RPL6A 1 1 
SYP1  2 RPN6 1 1 
TGL4  2 RPP1B 1 1 
TIF5  2 RPP2A 1 1 
TOM22  2 SRP1 1 1 
TPD3  2 SUP45 1 1 
TPK1  2 TIM11 1 1 
TRR1  2 TOM40 1 1 
TSL1  2 VMA6 1 1 
TYS1  2 VMA8 1 1 
VAC8  2 YHB1 1 1 
VMA4  2 YPL260W 1 1 
VPS21  2 ALO1 2  
YCK2  2 ATP17 2  
YET1  2 ILV3 2  
YHR113W  2 MDJ1 2  
YIL108W  2 PAA1 2  
YKR018C  2 RPS26B 2  




 Wild Type cdc55mn  Wild Type cdc55mn 
Name Cdc14-TAP Cdc14-TAP  Name Cdc14-TAP Cdc14-TAP 
ACB1  1 GLC7  1 
ADO1  1 GLO1  1 
AFG3  1 GNA1  1 
AHA1  1 GOR1  1 
AIP1  1 GPT2  1 
ALG12  1 GRS1  1 
APT1  1 GRX4  1 
ARC18  1 GUK1  1 
ARE2  1 HEK2  1 
ARF2  1 HIM1  1 
ATG8  1 HOP1  1 
ATO3  1 HSP26  1 
ATP16  1 IDI1  1 
BDH1  1 IDP1  1 
BNA4  1 ILV6  1 
CAP2  1 IRC24  1 
CBF5  1 IST2  1 
COX13  1 KAP120  1 
CRG1  1 KAR1  1 
CRP1  1 LSM1  1 
CST9  1 LYS12  1 
DBP5  1 MAM3  1 
DBP9  1 MAM33  1 
DOP1  1 MCA1  1 
DPB11  1 MCM7  1 
DPL1  1 MEF1  1 
ECM11  1 MEK1  1 
ECM33  1 MET12  1 
ECM38  1 MGM101  1 
EGD1  1 MKT1  1 
ELP2  1 MLC1  1 
ENT3  1 MMF1  1 
ERV14  1 MNN10  1 
ERV29  1 MNN9  1 
FES1  1 MPD1  1 
FMP26  1 MSR1  1 
FPR2  1 MSS4  1 
GAS4  1 MSS51  1 
GAS5  1 MTD1  1 
GCV3  1 MVD1  1 
GCY1  1 NAT1  1 
GET1  1 NDE1  1 
GGC1  1 NDJ1  1 
GID7  1 NSP1  1 
GIP4  1 NTF2  1 




 Wild Type cdc55mn  Wild Type cdc55mn 
Name Cdc14-TAP Cdc14-TAP  Name Cdc14-TAP Cdc14-TAP 
NUP120  1 SPE3  1 
OST3  1 SPO73  1 
PBP2  1 SPS4  1 
PDR11  1 SSE2  1 
PET100  1 SSH1  1 
PEX8  1 SSO2  1 
PFY1  1 SSS1  1 
PIC2  1 STN1  1 
PIR3  1 STU2  1 
PMI40  1 SUP35  1 
PNC1  1 SVF1  1 
PPN1  1 SVP26  1 
PRE3  1 TFP3  1 
PRE8  1 TFS1  1 
PRE9  1 TGL1  1 
PRP19  1 THI20  1 
PRS5  1 THR1  1 
PRT1  1 TIF4631  1 
PXA2  1 TKL2  1 
REC8  1 TMA17  1 
RET2  1 TOM20  1 
RFS1  1 TOP2  1 
RLI1  1 TPK2  1 
RMD1  1 TRP3  1 
RNQ1  1 TRX1  1 
RNR2  1 UBP6  1 
ROK1  1 UTR2  1 
RPB4  1 VAS1  1 
RPC40  1 VMA5  1 
RPL24A  1 YBL029CA  1 
RPN12  1 YBR285W  1 
RPS30B  1 YCL057C-A  1 
SBH2  1 YDL086W  1 
SDH4  1 YDL144C  1 
SEC17  1 YDL237W  1 
SEC27  1 YGR054W  1 
SEC62  1 YGR130C  1 
SEC63  1 YGR250C  1 
SEC66  1 YHR087W  1 
SFT2  1 YLR225C  1 
SGT2  1 YMR148W  1 
SMC1  1 YNL115C  1 
SMK1  1 YNL208W  1 
SNA2  1 YNR021W  1 
SNF4  1 YOR152C  1 




 Wild Type cdc55mn 
Name Cdc14-TAP Cdc14-TAP 
YOR289W  1 
YPL009C  1 
YPR004C  1 
YPR172W  1 
YPT52  1 
YSA1  1 
ZSP1  1 
ALT1 1  
ARG5%2C6 1  
ATP18 1  
ATP20 1  
ATP6 1  
BSC1 1  
CAF16 1  
CYB5 1  
GAL11 1  
GDE1 1  
GRX3 1  
GTT1 1  
HIS5 1  
ILS1 1  
IMD3 1  
PRB1 1  
SEC13 1  
SNU13 1  
SPO19 1  
YHM2 1  
YPL205C 1  
YPR010C-A 1  
YSH1 1  



























































Appendix 3: Mass Spectrometry results for LFQ proteomic analysis of 
Spc42-3FLAG IP 
Label-free quantitation (LFQ) algorithms in MaxQuant were utilised by Juan Zou 
in the Juri Rappsilber lab (University of Edinburgh) to calculate the LFQ 
intensities indicated in Table A3.  I normalized LFQ intensities for each protein to 
Spc42 LFQ intensity in the same sample. I then input the normalised data into 
Perseus software. 
*Contaminant hits are excluded from Table A3. 
 Wild Type samples cdc14-1 samples 

















ABF2 0 0 0 0 0 35748000 
ABP1 0 0 0 0 0 9656000 































































ADA2 0 0 2164400 0 0 0 
ADD66 0 0 0 12510000 0 0 
ADE1 0 0 67202000 0 0 30095000 
ADE12 0 0 13852000 0 0 0 
ADE13 0 0 0 0 54632000 68418000 
ADE17 0 42104000 53795000 0 32513000 11689000
0 
ADE2 0 0 19944000 0 0 0 
ADE3;MI
S1 
0 0 0 0 0 70359000 
ADE5%2
C7 
0 0 0 0 40880000 28439000 




















 Wild Type samples cdc14-1 samples 













ADH3 0 0 35134000 0 0 0 
ADK1 0 0 65403000 0 41956000 41860000 
ADO1 0 67732000 50946000 0 49843000 33921000 
ADP1 0 14661000 0 0 0 0 
ADY2 0 0 17226000
0 








AGX1 0 94624000 93909000 0 0 10902000
0 
AHA1 0 0 8792200 0 0 0 
AHC1 0 0 61163000
0 
0 0 0 
AHP1 0 75866000 70977000 88736000 77545000 12789000
0 
ALA1 0 0 43155000 0 24650000 26916000 
ALD2;AL
D3 















ALD6 0 0 19515000 0 0 0 
AMS1 0 33441000 0 0 89760000 0 
APA1 0 0 7196000 0 0 0 
APE3 0 70028000 96111000 76346000 73565000 0 
APL6 0 0 34260000 0 0 0 




ARB1 0 0 0 0 4139100 0 
ARC1 0 0 0 0 41757000 0 
ARC18 0 0 0 0 0 0 
ARE2 10650000 0 0 0 0 0 
ARF1 0 57818000 10420000
0 
49899000 69629000 62897000 
ARF2 0 0 24077000 0 0 0 
ARG1 0 50054000 77403000
0 
0 18313000 36551000 
ARG3 0 0 21802000 0 0 0 
ARG4 0 0 90718000 0 0 0 
ARO1 0 0 0 0 0 33036000 
ARO4;AR
O3 
0 43994000 32606000 0 0 41977000 
ARO8 0 0 10797000 0 0 0 
ARP2 0 0 25259000 20111000 24049000 0 
ARP3 0 0 0 0 0 0 

















 Wild Type samples cdc14-1 samples 
Name WT_1 WT_2 WT_3 CDC14_1 CDC14_2 CDC14_3 
ASK10 0 0 0 0 18289000 0 
ASN2;AS
N1 
0 0 0 0 0 32963000 
ATO2 0 0 0 0 0 28404000 


















0 85097000 82500000 

































AVO1 0 4560300 0 0 0 0 
AXL1 0 0 0 0 0 0 
BAT1 0 0 35908000 0 0 0 

























BFR1 0 0 0 0 0 10617000 
BGL2 55318000 0 97300000 92903000 48352000 66401000 




















BNA4 0 0 10868000 0 0 0 
BOS1 0 0 0 0 0 0 
BRE1 11470000
0 
0 0 0 0 0 
BRL1 0 0 0 0 0 0 














































 Wild Type samples cdc14-1 samples 
Name WT_1 WT_2 WT_3 CDC14_1 CDC14_2 CDC14_3 
CBR1 0 0 0 0 0 0 
CCT2 0 0 10517000 0 0 0 
CCT3 0 0 0 0 7275400 0 
CCT4 12190000 0 0 0 0 0 
CCT6 0 0 0 0 14075000 0 
CCT7 0 0 0 0 0 9480500 
CCT8 0 0 8388000 0 0 0 
CDC10 0 0 0 0 28501000 0 


















































CDC5 0 0 0 0 81499000 19910000 
CDC60 0 0 11660000 0 0 0 
CHC1 0 42268000 0 0 28526000 38869000 
CHL4 5770600 0 0 0 0 0 



























CLU1 0 0 0 0 0 19407000 













COF1 0 0 75309000 0 0 0 
COG6 0 0 19460000 0 0 0 













COX1 0 0 12159000
0 
0 0 0 













COX4 0 0 5984500 0 0 0 
COX5A 0 0 21242000 0 0 55250000 
COX9 0 0 43776000 0 0 0 
CPA2 0 0 28110000 0 0 0 




 Wild Type samples cdc14-1 samples 







CPR3 0 0 0 0 8884100 0 
CPR6 0 0 0 0 0 0 
CPS1 58875000 0 46975000 37288000 61054000 0 
CRC1 0 34963000 64816000 0 24201000 24691000 
CRN1 0 0 0 0 0 0 
CST9 0 15146000
0 
0 0 45644000 0 
CTA1 0 10225000
0 
53558000 0 82675000 0 
CTF3 10995000 0 0 0 0 0 
CUP5 17309000 0 0 0 0 0 
CYB2 0 0 13149000
0 











CYS3 0 0 18880000 0 42866000 0 
CYS4 0 0 72279000 0 0 0 
CYT1 0 0 74523000 0 0 29206000 
DBF20;D
BF2 
44592000 0 0 0 0 0 
DBP1 0 0 0 0 37608000 0 
DBP3 17582000
0 
0 0 0 0 0 
DBP9 14708000 0 0 0 0 0 
DCS1 0 27229000 50402000 0 0 42611000 
DCS2 0 0 0 0 0 0 













DED81 0 0 0 0 0 0 
DHH1 0 0 4838400 0 0 0 
DIP2 0 0 0 0 0 0 






DNM1 0 6836500 0 0 0 0 
DOT5 0 0 0 0 0 0 
DPM1 73164000 83787000 50689000 0 80818000 41664000 
DPS1 0 53688000 12048000
0 
0 48909000 49416000 











ECM8 0 0 0 0 0 0 



















 Wild Type samples cdc14-1 samples 
Name WT_1 WT_2 WT_3 CDC14_1 CDC14_2 CDC14_3 
EGD1 0 0 9287200 0 0 0 
EGD2 0 0 57789000 0 0 0 
EHD3 0 7011900 0 0 0 0 
EMG1 29552000 0 0 0 0 0 












































ERG2 0 0 37920000 0 0 0 
ERG20 0 0 29178000 0 41439000 33480000 
ERG28 0 0 1441100 0 0 0 
ERG6 65033000 61483000 98594000 0 12230000
0 
89043000 
ERG9 0 0 23849000 0 0 0 
ERP1 12598000 0 0 0 0 0 
ERV14 0 0 0 0 0 0 
ERV25 0 23290000 0 0 0 0 
ETR1 0 0 59881000 0 0 0 


































































FIG1 0 0 0 0 0 0 
FMP13 0 0 54036000 0 0 0 














0 0 0 0 0 

















 Wild Type samples cdc14-1 samples 
Name WT_1 WT_2 WT_3 CDC14_1 CDC14_2 CDC14_3 
FUR1 0 0 18747000 0 0 0 
FYV6 0 0 0 0 0 0 
GAR1 29360000 0 0 0 0 0 
GAS1 0 25612000 40074000 23464000 55317000 19402000 
GCD11 0 0 15092000 0 0 46435000 
GCV1 0 0 56730000 0 22491000 34603000 
GDH1 85921000 0 24308000
0 
75544000 55647000 0 
GDH2 0 0 0 0 56748000 34130000 
GDI1 0 0 0 0 0 31409000 
GFA1 93329000 91653000 88277000 60513000 17359000
0 
71504000 
GLC3 0 0 0 0 26110000 0 
GLC7 0 0 35171000 0 0 0 

















GLR1 0 0 0 0 16160000 11252000 




































GPR1 0 0 24824000
00 
0 0 0 
GRE3 0 0 9401300 0 0 0 
GRS1;GR
S2 
0 0 5443900 0 0 0 





0 0 0 
GSC2;FK
S1 














0 0 27042000 0 0 23650000 















GVP36 0 0 38849000 0 0 0 
HAP1 0 0 0 0 0 0 




 Wild Type samples cdc14-1 samples 
Name WT_1 WT_2 WT_3 CDC14_1 CDC14_2 CDC14_3 
HAS1 0 0 0 0 0 0 
HEM2 0 0 43240000 0 0 0 





























HIS1 0 0 27137000 0 0 0 
HIS5 0 0 7421600 0 0 0 
HMF1 0 0 0 0 0 1402800 
HMG1;H
MG2 
64668000 0 0 0 0 0 
HOM2 33752000 84185000 39395000
0 
53759000 33786000 92784000 
HOM6 0 74931000 95691000 61355000 56423000 10074000
0 
HRB1 0 4792100 0 0 0 0 









































HSP82 0 78047000 14588000
0 


































































































 Wild Type samples cdc14-1 samples 

































IFM1 0 0 0 0 0 0 
ILS1 0 5119800 0 0 0 0 







0 51598000 89337000 













ILV6 0 0 43115000
0 
0 0 56794000 
IMD4;IM
D3 
0 0 33113000 0 0 0 
IMP3 21864000 0 0 0 0 0 






















IRC24 0 0 20344000 0 0 0 
IRC3 0 0 0 0 0 0 
IVY1 33650000 0 0 0 0 0 
KAP123 0 48912000 76545000 0 0 46137000 




















































0 0 0 0 0 
KOG1 0 17459000
0 
0 0 37790000 68316000 
KRE33 12134000 0 0 0 0 0 
KRI1 15276000 0 0 0 0 0 
KRR1 19817000 0 0 0 0 0 
KRS1 0 0 52716000 0 0 62075000 
KSP1 0 16852000 0 0 0 0 
KTR3 0 0 61998000
0 
0 0 0 




 Wild Type samples cdc14-1 samples 
Name WT_1 WT_2 WT_3 CDC14_1 CDC14_2 CDC14_3 
LAP3 0 43207000 65208000 0 65705000 64765000 
LAP4 0 0 0 0 50124000 0 





















LRO1 0 0 0 0 0 0 
LSB3 0 0 0 0 23045000 17626000 


























13036000 0 0 80782000 
LUG1 10522000
0 
0 0 0 0 0 
LYS12 0 0 15097000 0 0 0 
LYS21;L
YS20 
0 0 61100000 0 0 0 
MAK21 11721000 0 0 0 0 0 
MAM33 0 0 0 0 0 14742000 
MBF1 0 36679000 25275000 29486000 78607000 33213000 































MDH3 0 0 20254000
0 
0 0 0 
MDJ1 16124000 0 0 0 0 0 
MEK1 0 0 0 0 92107000 0 
MEP2 0 0 0 0 8030700 0 
MET17 0 0 19629000
0 
0 63864000 63161000 






MFT1 0 0 0 0 0 0 













MKT1 0 75304000 58209000 0 0 48130000 
MLC1 0 0 0 0 0 0 
MLP1 10034000
0 
0 0 0 0 0 




 Wild Type samples cdc14-1 samples 
Name WT_1 WT_2 WT_3 CDC14_1 CDC14_2 CDC14_3 















MOB1 10905000 0 0 0 0 0 
MPC54 0 0 0 0 49674000 0 



























36345000 0 0 0 49768000 27709000 
MRPL20 16703000 0 0 0 0 0 
MRPL31 0 0 0 41973000 0 0 
MRPL32 10102000 0 0 0 0 0 
MRPL36 31348000 0 0 0 0 0 







MSS51 0 0 0 0 0 0 
MUC1 62282000 0 0 0 0 0 







MYO4 0 0 0 0 0 0 
NAM7 0 0 0 0 0 3575000 
NAN1 37976000 0 0 0 0 0 
NAP1 0 0 4516500 0 0 0 
NAT1 0 0 2270600 0 0 0 
NBP1 78987000
0 
0 0 0 0 0 
NCE102 14909000 0 0 0 13719000 0 







NDI1 0 52444000 12834000
0 
0 55359000 64755000 

















NIC96 96460000 0 13921000 0 0 0 
NIP7 9719700 0 0 0 0 0 
NMA1;N
MA2 













NOP10 16466000 0 0 0 0 0 




 Wild Type samples cdc14-1 samples 
Name WT_1 WT_2 WT_3 CDC14_1 CDC14_2 CDC14_3 
NOP13 4039600 0 0 0 0 0 
NOP15 0 0 0 0 0 0 





































NUM1 0 0 0 0 0 0 
NUP170 34252000 0 0 0 0 0 
NUP57 58619000 0 0 0 0 0 
NUP82 0 0 0 0 0 0 
NUP84 10775000 0 0 0 0 0 













OM45 0 75014000 44508000 0 61021000 43265000 
ORC6 0 0 80357000 0 0 0 













PBI2 0 0 9931300 0 0 0 
PBP1 4926300 0 0 0 0 0 
PBP2 0 1773800 0 0 0 0 
PCA1 0 0 0 0 0 0 













PCS60 0 0 0 0 34220000 0 




































PDI1 0 0 0 0 27533000 0 
PDR10 0 71811000 0 0 0 0 
PDR11 0 0 0 0 0 0 
PEP4 0 0 78969000 0 0 0 
PET10 0 0 78591000 0 0 10488000
0 




 Wild Type samples cdc14-1 samples 
Name WT_1 WT_2 WT_3 CDC14_1 CDC14_2 CDC14_3 















PEX11 0 41244000 0 0 0 0 

















































PHB1 0 0 0 0 0 0 
PHB2 3593000 0 0 0 0 0 
PHO8 0 0 30670000 0 0 0 
PHO86 9594300 0 0 0 0 0 
PHO88 0 64659000 23827000 0 0 0 

























PMI40 0 0 0 0 3966200 0 
PMT2 0 2684000 0 0 0 0 
POL30 0 0 11575000 0 0 0 
POM152 10090000
0 





































PRE10 0 57199000 0 0 14815000
0 
32458000 
PRE2 0 22421000 4776600 0 30454000 5728300 
PRE3 0 57453000 72373000 92021000 85417000 91900000 


























 Wild Type samples cdc14-1 samples 
Name WT_1 WT_2 WT_3 CDC14_1 CDC14_2 CDC14_3 











PRO3 0 0 0 0 0 0 
PRP43 25456000
0 
0 0 0 27639000 0 
PRT1 0 0 0 0 0 0 
PRX1 0 0 45490000 0 63487000 0 
PSA1 55566000 56449000 25097000
0 
0 36696000 90573000 











PUP1 0 16615000 0 0 0 17949000 
PUP2 0 58177000 0 10497000
0 
77696000 71491000 
PUP3 0 0 0 67068000 69333000 32576000 
PWP2 8780200 0 0 0 0 0 
PXA2 0 11661000 0 0 0 0 
PXR1 10829000
0 


























QCR7 0 0 10511000
0 
0 0 0 
QCR8 0 0 51791000 0 0 0 
RAD52 0 18019000 0 0 13892000 6850400 
RAP1 0 8524500 0 0 0 0 
RCL1 4484400 0 0 0 0 0 
RER1 0 0 0 0 0 0 
RET2 6496900 0 0 0 0 0 
RHO1 0 0 25779000 0 0 0 
RIB4 0 63802000 12688000
0 
0 48581000 61623000 
























RKR1 0 0 0 0 0 13279000
00 
RMD1 0 10632000 0 0 0 0 
RNA1 0 0 9435500 0 0 0 





 Wild Type samples cdc14-1 samples 
Name WT_1 WT_2 WT_3 CDC14_1 CDC14_2 CDC14_3 
RNR4 0 0 96552000 0 0 0 
ROK1 0 0 0 0 0 0 
RPA34 23018000
0 
0 0 0 0 0 
RPA49 0 0 0 0 0 0 



































































































































































RPL21A 0 0 15042000
0 





































































































 Wild Type samples cdc14-1 samples 
Name WT_1 WT_2 WT_3 CDC14_1 CDC14_2 CDC14_3 





















































































































RPL37A 13154000 0 0 0 0 0 






































































































































RPN1 0 64630000 0 0 39062000 0 
RPN10 0 0 0 0 0 0 
RPN11 0 0 0 0 13888000 0 





 Wild Type samples cdc14-1 samples 
Name WT_1 WT_2 WT_3 CDC14_1 CDC14_2 CDC14_3 
RPN2;EC
M17 
0 0 17319000 0 21322000 0 
RPN3 0 14515000 0 0 28012000 14557000 
RPN5 0 18868000 0 0 75727000 0 
RPN6 0 0 0 0 60684000 0 



























































































































































































































































































 Wild Type samples cdc14-1 samples 
Name WT_1 WT_2 WT_3 CDC14_1 CDC14_2 CDC14_3 
RPS28A;
RPS28B 

































































































































RPT1 0 0 0 0 42921000 0 
RPT2 0 0 0 0 0 0 
RPT3 0 0 0 0 24128000 0 
RPT4 0 89927000 35174000 27084000 63981000 54252000 
RPT5 0 0 0 0 41846000 0 
RPT6 0 0 2075900 0 0 0 
RRN5 0 41568000 0 0 0 0 
RRP12 7326300 0 0 0 0 0 
RRP15 0 2096800 0 0 0 0 
RRP5 13758000
0 
25975000 32119000 0 26150000 0 
RRP9 15031000 0 0 0 0 0 
RSC1 0 0 0 0 0 0 
RSF2 0 0 0 0 0 0 
RSM18 0 0 0 0 10170000 0 
RSP5 0 0 0 0 0 0 




RVB1 0 0 0 20604000 0 0 
RVB2 0 0 0 32027000 0 0 



























 Wild Type samples cdc14-1 samples 
Name WT_1 WT_2 WT_3 CDC14_1 CDC14_2 CDC14_3 
SAM2 0 0 0 0 25236000 0 
SAP1 0 0 0 0 0 0 
SAR1 0 63341000 58856000 86232000 0 72348000 
SBP1 0 36835000 7830700 0 48581000 9343800 
SCH9 16729000 0 0 0 0 0 


























SDH3 0 0 64839000 0 0 69700000 
SEC14 0 0 19305000 0 0 0 
SEC21 0 0 0 0 37634000 11933000 
SEC23 0 0 38453000 0 31917000 30285000 
SEC26 0 0 0 0 0 0 
SEC28 0 0 0 0 0 9722700 









SEC61 29224000 0 0 0 0 0 
SEC63 0 0 0 0 0 0 
SED5 0 0 0 0 0 0 
SEH1 0 0 0 0 0 0 
SEN1 0 24720000
0 
0 0 0 0 
SER1 0 0 24303000 0 0 0 
SER3 0 0 0 0 0 0 
SER33 0 0 0 0 0 0 















30878000 3199800 24740000 8725800 0 
SGN1 0 0 11004000 0 0 0 
SHE9 0 18485000
0 





















SIS1 0 0 0 0 0 6368000 
SNA2 0 0 24992000 0 0 0 
SNF1 7262800 0 0 0 0 0 
























 Wild Type samples cdc14-1 samples 

































































25596000 0 52252000 28034000
0 
97825000 
SPE3 0 0 0 0 0 0 
SPO14 0 0 92486000 0 0 0 
SPO21 0 0 0 0 27155000 0 
SPO23 0 0 0 0 9681000 0 






SPS4 0 0 0 0 30049000 0 
SPT15 0 0 10323000 0 0 0 
SPT5 40027000 73114000 49627000 85430000 72968000 51756000 
SPT7 0 0 53745000 0 0 0 
SRO9 72446000 0 0 0 0 0 
SRP1 0 0 2744700 0 0 0 
SRP40 10838000
0 

























SSA3 0 11851000 0 0 0 0 
SSA4 0 31004000 0 0 0 0 











































23249000 0 0 0 0 0 
SSO1;SS
O2 
0 0 24562000 0 0 0 
SSS1 0 0 22271000 0 0 0 
SSZ1 0 0 0 0 0 7543500 




 Wild Type samples cdc14-1 samples 
Name WT_1 WT_2 WT_3 CDC14_1 CDC14_2 CDC14_3 
STE6 0 1335300 0 0 0 0 
STI1 0 0 27414000 0 0 0 
STM1 0 30499000 24330000 0 0 65049000 
STO1 0 0 0 0 6432100 0 
SUB2 0 0 27052000 0 0 0 
SUI1 0 0 15501000 0 0 0 
SUI2 0 0 0 0 0 27813000 
SWT1 0 0 0 0 10109000
0 
0 






TCO89 0 76876000 0 0 0 86177000 




































































TFP1 32923000 45567000 22787000 0 60858000 25453000 
TGL3 0 37871000 0 0 0 0 
TGL4 0 35174000 0 0 0 0 
THR1 0 0 76666000 0 13547000 26439000 
THR4 0 0 69778000 0 0 40038000 















TIF5 0 0 0 0 0 10471000 

















TMA29 0 0 14184000
0 
0 0 0 
TNA1 0 0 0 0 0 0 
TOF2 0 17466000 0 0 0 0 
TOM40 0 0 0 0 12128000 0 
TOM70 0 0 0 0 15506000 8213000 
TOR1 0 23343000
0 
0 0 40055000 77180000 





 Wild Type samples cdc14-1 samples 
Name WT_1 WT_2 WT_3 CDC14_1 CDC14_2 CDC14_3 
TOR2 0 10541000
0 
0 0 0 0 

























TPS2 0 0 0 0 0 0 
TRA1 39781000 0 0 0 0 0 
TRP3 13412000 0 0 0 0 0 
TRP5 0 0 13176000 0 0 0 
TRX2;TR
X1 















TSC11 0 0 0 0 0 0 
TUB1;TU
B3 




























TUS1 0 0 38905000
0 
0 0 0 




































URB1 25975000 0 0 0 0 0 
URB2 0 0 0 0 0 0 
UTP10 62280000 0 0 0 0 0 
UTP13 27730000 0 0 0 0 0 
UTP15 75204000 0 0 0 0 0 
UTP21 10143000 0 0 0 0 0 
UTP22 9607600 0 0 0 0 0 
UTP4 20862000 0 0 0 0 0 
UTP5 16059000 0 0 0 0 0 
UTP6 12194000 0 0 0 0 0 
UTP8 31655000 0 0 0 0 0 
UTP9 34295000 0 0 0 0 0 
UTR2 0 0 0 0 0 2573900 





 Wild Type samples cdc14-1 samples 
Name WT_1 WT_2 WT_3 CDC14_1 CDC14_2 CDC14_3 
VAC8 0 0 0 0 0 0 
VAS1 0 0 0 0 0 31251000 









VMA5 0 0 13963000 0 0 0 







VPS1 0 0 0 0 21998000 0 
VTC4 0 15607000
0 
73212000 0 36935000 51447000 
WBP1 12352000 0 0 0 0 0 
WRS1 0 0 0 0 0 0 










0 0 66781000 
YAT2 0 31707000 55739000 0 0 61387000 
YBL028C 0 0 0 0 0 18823000 
YCK2 0 0 0 0 0 0 
YCL057C
-A 
0 0 0 0 0 42142000 
YCP4 0 0 67652000 0 31789000 56917000 
YCS4 0 0 0 0 0 0 
YDJ1 0 0 0 0 0 16539000 
YDL086
W 
0 0 0 0 0 0 
YDL237
W 
0 0 0 0 0 0 
YDR051C 21389000
0 
0 0 0 0 0 





























0 0 0 0 0 0 
YGL059
W 
8804600 0 0 0 0 0 
YGL194C
-A 
31262000 0 0 0 0 0 
YGR130C 0 0 0 0 42550000 0 
YGR207C 0 0 15815000 0 0 0 
YGR250C 0 0 7732100 0 0 0 
YGR283C 0 0 0 0 0 0 
YHB1 0 0 10965000 0 0 0 




 Wild Type samples cdc14-1 samples 
Name WT_1 WT_2 WT_3 CDC14_1 CDC14_2 CDC14_3 
YHM2 0 0 13757000 0 0 0 
YHR020
W 
0 0 19051000 0 0 0 
YHR097
C 
0 4202400 0 0 0 0 
YIL057C 6383400 28637000 0 17887000 10261000 14417000 
YIP3 0 0 0 0 0 0 
YJL043W 0 0 0 0 27159000 0 
YJL045W 0 0 0 0 0 0 
YJR008
W 
0 31225000 11401000 0 12992000 0 
YKL018C
-A 
0 35978000 0 0 37878000 0 
YMR031
C 
0 0 0 0 0 0 
YMR099
C 
0 0 44604000 0 0 37991000 
YMR31 0 11827000 0 0 0 0 
YMR310
C 
0 0 0 0 8787200 0 
YMR315
W 











YNL134C 0 0 17673000 0 0 0 
YNR036
C 
0 0 0 0 13802000 0 
YOL083
W 
0 0 0 0 23248000
0 
0 
YOP1 0 81279000 11199000
0 
0 83716000 98709000 
YOR029
W 
0 0 0 0 0 0 
YOR285
W 
0 0 49435000 0 0 0 
YPK1 0 0 0 0 4354800 0 
YPK2 3123200 0 0 0 0 0 
YPL225
W 
0 0 0 0 0 0 
YPL260
W 
0 0 0 0 1410300 0 
YPR004C 0 17169000 0 0 0 0 
YPR089
W 
0 0 0 0 0 0 
YPR115
W 
0 0 0 0 0 0 
YPS5 0 0 0 0 0 0 
YRA1 0 0 55034000 0 48213000 0 
YSP3 0 0 0 0 0 0 
YSW1 0 78885000 23024000 0 0 0 
ZIP2 0 29510000 0 0 0 0 




 Wild Type samples cdc14-1 samples 
Name WT_1 WT_2 WT_3 CDC14_1 CDC14_2 CDC14_3 
ZUO1 0 0 33828000 0 0 53429000 
ZWF1 0 0 0 0 23328000 0 
Table A3 (Continued): LFQ intensities of Wild Type and cdc14-1 samples.  
